Sentence,class,file
"Mov Disord 2006;21:159–165, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Mov Disord 1998;13:16–19, doi: http://dx.doi.org/10.1002/mds.870130107.",OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Ann Neurol 2008;64:239–246, doi: http://dx.doi.org/10.1002/ana.21465.",OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"J Neurol Neurosurg Psychiatry 1998; 65:65–71, doi: http://dx.doi.org/10.1136/jnnp.65.1.65.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"J Neurol Tremor Other Hyperkinet Mov 165-4252-1.3d 3/9/13 07:36:12 The Charlesworth Group , Wakefield +44(0)1924 369598 - Rev 7.51n/W (Jan 20 2003)Kaindlstorfer C, Granata R, Wenning GK Tremor in MSA – a Review Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Neurosurg Psychiatry 1981;44:347–351, doi: http://dx.doi.org/10.1136/jnnp.44.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Parkinsonism Relat Disord 1997;3:211–214, doi: http://dx.doi.org/10.1016/S1353-8020(97)00022-9.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"JN e u r o l 2002;249:300–304, doi: http://dx.doi.org/10.1007/s00415-002-0773-6.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Eur Neurol 1999;41:212–215, doi: http://dx.doi.org/10.1159/000008053.",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Mov Disord 2006;21:2269–2270, doi: http://dx.doi.org/10.1002/mds.21125.",OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Mov Disord 2004;19:1391–1402, doi: http://dx.doi.org/10.1002/mds.20255.",OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
"Tremor Other Hyperkinet Mov 165-4252-1.3d 3/9/13 07:36:12 The Charlesworth Group , Wakefield +44(0)1924 369598 - Rev 7.51n/W (Jan 20 2003)Tremor in MSA – a Review Kaindlstorfer C, Granata R, Wenning GK Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/19/f8/tre-03-165-4252-1.PMC3779823.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/07/srep02724.PMC3779844.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2724 | DOI: 10.1038/srep02724 5",Non-OADS,/arxiv_data1/oa_pdf/6f/07/srep02724.PMC3779844.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3d/9b/srep02720.PMC3779845.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2720 | DOI: 10.1038/srep02720 6",Non-OADS,/arxiv_data1/oa_pdf/3d/9b/srep02720.PMC3779845.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8d/25/srep02719.PMC3779846.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2719 | DOI: 10.1038/srep02719 9",Non-OADS,/arxiv_data1/oa_pdf/8d/25/srep02719.PMC3779846.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b9/b0/srep02718.PMC3779847.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2718 | DOI: 10.1038/srep02718 5",Non-OADS,/arxiv_data1/oa_pdf/b9/b0/srep02718.PMC3779847.pdf
"37.The US DRIVE Fuel Cell Technical Team Technology Roadmap (Revised August 11, 2011) http://www.uscar.org/guest/tlc/2/Hydrogen-Fuel-Cell-TLC.",Non-OADS,/arxiv_data1/oa_pdf/b0/01/srep02715.PMC3779849.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/01/srep02715.PMC3779849.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2715 | DOI: 10.1038/srep02715 8",Non-OADS,/arxiv_data1/oa_pdf/b0/01/srep02715.PMC3779849.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8a/62/srep02717.PMC3779850.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2717 | DOI: 10.1038/srep02717 7",Non-OADS,/arxiv_data1/oa_pdf/8a/62/srep02717.PMC3779850.pdf
and W.W. Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/4b/srep02716.PMC3779851.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2716 | DOI: 10.1038/srep02716 6",Non-OADS,/arxiv_data1/oa_pdf/e5/4b/srep02716.PMC3779851.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2674 | DOI: 10.1038/srep02674 6",Non-OADS,/arxiv_data1/oa_pdf/59/1d/srep02674.PMC3779852.pdf
UCINET IV Datasets: http://vlado.fmf.uni-lj.si/pub/networks/data/ucinet/ ucidata.htm (accessed: March 2012).,OADS,/arxiv_data1/oa_pdf/ff/43/srep02729.PMC3779854.pdf
Pajek datasets: http://vlado.fmf.uni-lj.si/pub/networks/data/bio/foodweb/ foodweb.htm (accessed: March 2012).,OADS,/arxiv_data1/oa_pdf/ff/43/srep02729.PMC3779854.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/43/srep02729.PMC3779854.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2729 | DOI: 10.1038/srep02729 9",Non-OADS,/arxiv_data1/oa_pdf/ff/43/srep02729.PMC3779854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 145–150Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  145OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S4970 3Emergency medicine residents’ attitudes   and opinions of in-training exam preparation Travis r Eastin Aaron W Bernard Department of Emergency Medicine,   The Ohio state University college   of Medicine, columbus, Oh, UsA correspondence: Travis r Eastin   The Ohio state University college of  Medicine, 760 Prior hall,   456 W 10th Avenue, columbus,  Oh 43210, UsA   Tel +1 614 293 8305   Fax +1 614 293 3124   Email travis.eastin@osumc.ed uPurpose:  Emergency Medicine (EM) residents take the American Board of Emergency  Medicine (ABEM) in-training exam, and performance on this exam has been shown to correlate  to performance on the ABEM qualifying exam.",Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
"Available from: http://www.abem.or g. Accessed December 18,  2010.",Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
"Available  from: https://sites.google.com/site/robcooneysteachingportfolio/home/  publication s. Accessed July 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/e3/8c/amep-4-145.PMC3780280.pdf
The  full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to request  permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2013:4 157–163Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  157OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S4714 5The availability of teaching–pedagogical resources  used for promotion of learning in teaching   human anatomy José Aderval Aragão1,5 Ana T erra Fonseca-Barreto2 ciro José Brito1,3 Danilo ribeiro guerra1 José carlos nunes-Mota4 Francisco Prado reis5 1Master’s Degree Program in Physical  Education, Universidade Federal de  sergipe (UFs), Aracaju, sergipe, Brazil;   2school of Medicine, Universidade  Federal de sergipe (UFs), Aracaju,   sergipe, Brazil; 3Department of  Physical Education, Universidade  Federal de sergipe (UFs), Aracaju,   sergipe, Brazil; 4Department  of Morphology, (UFs), Aracaju,   sergipe, Brazil; 5school of Medicine,   Universidade Tiradentes (UniT),   Aracaju, sergipe, Brazil correspondence: José Aderval Aragão   Universidade Federal de sergipe,   rua Aloisio campos, 500, Bairro Atalaia,  cEP: 49035-020 – Aracaju, sergipe, Brazil   Tel +55 79 91 916 767   Email jaafelipe@infonet.com.b rAbstract:  Five hundred students attending higher education institutions in northeastern Brazil  responded to questionnaires about their anatomy classes; students represented a variety of  different health sciences disciplines.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
"Available from: http://www.enfermaria28.com.br/ Documentos%20Anexos/Tese%20Dr%20MARCO%20AURELIO%20 DE%20AZAMBUJA%20MONTES.pd f. Accessed January 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
Available from: http://www.lbd.dcc.ufmg.br/colecoes/wim/2003/007.,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
"Available from: http://www.emuzeum.cz/admin/clanky/files/280  introtomultimediamuseums.pd f. Accessed January 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  healthcare professional education.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/amep-4-157.PMC3780282.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/6c/lra-6-025.PMC3780284.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpLocal and Regional Anesthesia 2013:6 25–29Local and Regional Anesthesia Dove press submit your manuscript | www.dovepress.co m Dove press  25ORiginAL  ReseARchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/LRA.S4668 6Predicting early epidurals: association of maternal,  labor, and neonatal characteristics with epidural   analgesia initiation at a cervical dilation   of 3 cm or less Albert R Moore William Li Pi shan Roupen hatzakorzian Department of Anaesthesia, Mcgill  University health centre, Royal  Victoria hospital, Montreal,    Quebec, canada correspondence: Albert R Moore   Department of Anaesthesia,   Mcgill University health centre,   Royal Victoria hospital, Room s5.05,   687 Avenue des Pins Ouest, Montreal,   Quebec, canada h3A 1A1   Tel +1 514 934 1934 ext 34880   Fax +1 514 843 1723   email albert.moore@mail.mcgill.c aBackground:  Retrospective studies have associated early epidural analgesia with cesarean  delivery, but prospective studies do not demonstrate a causal relationship.",Non-OADS,/arxiv_data1/oa_pdf/7d/6c/lra-6-025.PMC3780284.pdf
"Local and Regional Anesthesia Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/local-and-regional-anesthesia-journa lLocal and Regional Anesthesia is an international, peer-reviewed,  open access journal publishing on the development, pharmacology,  delivery and targeting and clinical use of local and regional anesthet - ics and analgesics.",Non-OADS,/arxiv_data1/oa_pdf/7d/6c/lra-6-025.PMC3780284.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/6c/lra-6-025.PMC3780284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e9/9c/jir-6-099.PMC3780290.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2013:6 99–108Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  99ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S4842 2estrogen modulates the influence of cardiac  inflammatory cells on function of cardiac  fibroblasts Jennifer l Mclarty1 Jianping li2 scott P levick3 Joseph s Janicki2 1Department of Pathology,    University of alabama at Birmingham,   Birmingham, al, Usa; 2Department  of cell Biology and anatomy,   school of Medicine, University of  south carolina, columbia, sc, Usa;   3Department of Pharmacology and  T oxicology, cardiovascular center,   Medical college of Wisconsin,   Milwaukee, WI, Usa correspondence: Joseph s Janicki   Department of cell Biology and  anatomy, school of Medicine,   University of south carolina,   columbia, sc 29208, Usa   Tel +1 803 216 3810   Fax +1 803 216 3153   email joseph.janicki@uscmed.sc.ed uBackground:  Inflammatory cells play a major role in the pathology of heart failure by stimu - lating cardiac fibroblasts to regulate the extracellular matrix in an adverse way.",Non-OADS,/arxiv_data1/oa_pdf/e9/9c/jir-6-099.PMC3780290.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/e9/9c/jir-6-099.PMC3780290.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/9c/jir-6-099.PMC3780290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/45/jir-6-121.PMC3780292.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Inflammation Research 2013:6 121–128Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  121RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JIR.S3562 9The role of inflammation and interleukin-1   in acute cerebrovascular disease James Galea1 David Brough2 1Manchester Academic Health  Sciences Center, Brain Injury  Research Group, Clinical Sciences  Building, Salford Royal Foundation  Trust, Salford, UK; 2Faculty of Life  Sciences, University of Manchester,    Av Hill Building, Manchester, UK Correspondence: David Brough   Faculty of Life Sciences, University of   Manchester, Av Hill Building, Oxford   Road, Manchester, M13 9PT, UK   Tel +44 161 275 5039   Fax +44 161 275 5948   email david.brough@manchester.ac.u kAbstract:  Acute cerebrovascular disease can affect people at all stages of life, from neonates  to the elderly, with devastating consequences.",Non-OADS,/arxiv_data1/oa_pdf/1c/45/jir-6-121.PMC3780292.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/1c/45/jir-6-121.PMC3780292.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/45/jir-6-121.PMC3780292.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003247).,Non-OADS,/arxiv_data1/oa_pdf/74/11/bmjopen-2013-003247.PMC3780295.pdf
2004. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm161679.htm (accessed 29 June 2011).,OADS,/arxiv_data1/oa_pdf/74/11/bmjopen-2013-003247.PMC3780295.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003478).,Non-OADS,/arxiv_data1/oa_pdf/25/3f/bmjopen-2013-003478.PMC3780296.pdf
2010. http://www.rki.de7.,Non-OADS,/arxiv_data1/oa_pdf/92/2c/bmjopen-2013-003833.PMC3780297.pdf
doi:10.1136/bmjopen-2013- 003347 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003347).,Non-OADS,/arxiv_data1/oa_pdf/e3/0b/bmjopen-2013-003347.PMC3780299.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/0b/bmjopen-2013-003347.PMC3780299.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003250).,Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
2012. http:// yhhiec org uk/wp-content/uploads/2011/10/11070604_Tele_Moni_Workbk pdf; http://www.ucl.ac.uk/nicor/audits/heartfailure/additionalfiles/pdfs/annualreports/annual11.pdf (accessed Mar2012).,Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
"2010. http:// www npc nhs uk/rapidreview/?p=2479 2010, http://www.npc.nhs.uk/ rapidreview/?p=247926.",Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
12 A. D. http://3millionlives.co.uk/ 29.,Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
12 A.D. http://3millionlives.co.uk//wp-content/uploads/2012/03/Concordat-FINAL.pdf 30.,Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
"12 A.D. http://3millionlives.co.uk/wp-content/uploads/2012/ 11/14-November-2012-press-release.pdf Thokala P, Baalbaki H, Brennan A, et al.BMJ Open 2013; 3:e003250.",Non-OADS,/arxiv_data1/oa_pdf/0b/eb/bmjopen-2013-003250.PMC3780300.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003282).,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
Tob J Int 2013. http://www.tobaccojournal.com/ Tightening_legislation_in_tobacco_packaging___innovation_blossoms.51660.0.html (accessed 3 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
Tob J Int 2007. http://www.tobaccojournal.com/The_last_bastion_of_masculinity_has_fallen.48422.0.html (accessed 3 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
"Department of Health, 2012. https://www.gov.uk/ government/uploads/system/uploads/attachment_data/file/170568/dh_133575.pdf (accessed 3 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
The Guardian 2013. http://www.guardian.co.uk/society/2013/jul/12/ plans-plain-cigarette-packaging-shelved?INTCMP=SRCH (accessed 12 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
"Office for National Statistics, 2012. http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77 –257414 (accessed 9 July 2013).",OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
"European Parliament, 2013. http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-%2f%2fEP%2f%2fTEXT%2bIM-PRESS%2b20130708IPR16824%2b0%2bDOC%2bXML%2bV0%2f%2fEN&language=EN (accessed 9 Aug 2013).50.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
"Tobacco Journal International, 2011. http://www.tobaccojournal.com/New_technologies_drive_tear_tape_opportunities.50668.0.html(accessed 16 May 2013).",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/bmjopen-2013-003282.PMC3780301.pdf
MRSA Screening —Operational Guidance 2. http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_092844 (accessed 24 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/6e/be/bmjopen-2013-003126.PMC3780302.pdf
http://idrn.org/audit.php (accessed 28 Jul 2013).,OADS,/arxiv_data1/oa_pdf/6e/be/bmjopen-2013-003126.PMC3780302.pdf
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/general/general_content_000433.jsp (accessed 12 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
Res Soc Admin Pharm 2013. http://dx.doi.org/ 10.1016/j.sapharm.2013.02.007 4.,OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
http://ec.europa.eu/health/files/eudralex/vol-2/c/2009_01_12_readability_guideline_final_en.pdf (accessed 12 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
http://www.mhra.gov.uk/home/groups/pl-a/documents/publication/con1004417.pdf (accessed 21 Apr 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
High Level Group on innovation and provision of medicines.Recommendations for action; 2002. http://ec.europa.eu/enterprise/sectors/healthcare/competitiveness/pharmaceutical-forum/g10en.htm(accessed 20 Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
Human Product Information Annotated Template v 9.0. http://www.emea.europa.eu/docs/en_GB/document_ library/Template_or_form/2009/10/WC500004368.pdf (accessed12 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/23/18/bmjopen-2013-003185.PMC3780304.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003125).,Non-OADS,/arxiv_data1/oa_pdf/07/fc/bmjopen-2013-003125.PMC3780314.pdf
"25. http://www.fhi.no/eway/default.aspx?pid=238&trg=MainArea_ 5811&MainArea_5811=5895:0:15,4438:1:0:0:::0:0 (accessed 9 Apr 2013).",Non-OADS,/arxiv_data1/oa_pdf/07/fc/bmjopen-2013-003125.PMC3780314.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003058).,Non-OADS,/arxiv_data1/oa_pdf/fd/8c/bmjopen-2013-003058.PMC3780315.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003420).,Non-OADS,/arxiv_data1/oa_pdf/32/6f/bmjopen-2013-003420.PMC3780316.pdf
2012. http://www.ginasthma.org/guidelines-gina-report-global-strategy-for-asthma.html 4.,Non-OADS,/arxiv_data1/oa_pdf/32/6f/bmjopen-2013-003420.PMC3780316.pdf
2009. http://heartsurgery.cqc.org.uk/Survival.aspx.,Non-OADS,/arxiv_data1/oa_pdf/32/6f/bmjopen-2013-003420.PMC3780316.pdf
"http://www.icnarc.org Gibbison B, Griggs K, Mukherjee M, et al.BMJ Open 2013; 3:e003420.",Non-OADS,/arxiv_data1/oa_pdf/32/6f/bmjopen-2013-003420.PMC3780316.pdf
2013. http://www.icnarc.org 30.,Non-OADS,/arxiv_data1/oa_pdf/32/6f/bmjopen-2013-003420.PMC3780316.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003336).,Non-OADS,/arxiv_data1/oa_pdf/db/23/bmjopen-2013-003336.PMC3780317.pdf
http://www.tabnet.datasus.gov.br/cgi/deftohtm.exe?,OADS,/arxiv_data1/oa_pdf/db/23/bmjopen-2013-003336.PMC3780317.pdf
http://www.seriesestatisticas.ibge.gov.br/series.aspx?,Non-OADS,/arxiv_data1/oa_pdf/db/23/bmjopen-2013-003336.PMC3780317.pdf
14. http://www.todospelaeducacao.org.br/educacao-no-brasil/ busca-comparativa/resultado/resultado/?tipo=1&id_check_universo%5B%5D=10905&id_universo%5B%5D=10905&id_check_universo%5B%5D=10902&id_universo%5B%5D=10902&id_check_universo %5B%5D=10901&id_universo%5B%5D=10901&id_check_universo %5B%5D=10903&id_universo%5B%5D=10903&id_check_universo%5B%5D=10904&id_universo%5B%5D=10904&criterios=157&id_check_criterio%5B%5D=157&id_criterio%5B%5D=157&comparar=Comparar (accessed Feb 2012).,OADS,/arxiv_data1/oa_pdf/db/23/bmjopen-2013-003336.PMC3780317.pdf
Agencia Nacional de Saúde —downloaded from http://www.ans.gov.,Non-OADS,/arxiv_data1/oa_pdf/db/23/bmjopen-2013-003336.PMC3780317.pdf
doi:10.1136/bmjopen-2013- 003626 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003626).,Non-OADS,/arxiv_data1/oa_pdf/94/67/bmjopen-2013-003626.PMC3780318.pdf
http://www.ons.gov.uk/ons/publications/re-reference-tables.html?edition=tcm%3A77 –262039 (accessed Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/a4/e8/bmjopen-2013-003427.PMC3780319.pdf
http://www.ons.gov.uk/ ons/guide-method/census/census-2001/about-census-2001/census-2001-forms/index.html (accessed Jun 2013).,OADS,/arxiv_data1/oa_pdf/a4/e8/bmjopen-2013-003427.PMC3780319.pdf
http://www.coe.int/t/dg3/children/ (accessed Jun 2013).,Non-OADS,/arxiv_data1/oa_pdf/a4/e8/bmjopen-2013-003427.PMC3780319.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003669).,Non-OADS,/arxiv_data1/oa_pdf/5e/5b/bmjopen-2013-003669.PMC3780320.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ 6 Klinger RY, James OG, Wong TZ, et al.BMJ Open 2013; 3:e003669.",Non-OADS,/arxiv_data1/oa_pdf/5e/5b/bmjopen-2013-003669.PMC3780320.pdf
"To date, over 71 000 Swedes have tested their hearing online (http://www.horseltest.se), and more than 23 000 installations have been made on iOS andAndroid devices.",OADS,/arxiv_data1/oa_pdf/8b/b6/bmjopen-2013-003223.PMC3780321.pdf
2010. http://hearcom.eu/about/DisseminationandExploitation/deliverables/HearCom_D9-5_V2.pdf 10.,Non-OADS,/arxiv_data1/oa_pdf/8b/b6/bmjopen-2013-003223.PMC3780321.pdf
http://www.who.int/pbd/ deafness/hearing_impairment_grades/en/ (accessed 2 Jul 2013).,Non-OADS,/arxiv_data1/oa_pdf/8b/b6/bmjopen-2013-003223.PMC3780321.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003334).,Non-OADS,/arxiv_data1/oa_pdf/18/09/bmjopen-2013-003334.PMC3780322.pdf
"Taean: Planning and Inspection Office of Taean County, 2008. http://law.taean.go.kr/asp/tong/tong_file/2007/02.pdf (accessed 5 Oct 2010).",Non-OADS,/arxiv_data1/oa_pdf/18/09/bmjopen-2013-003334.PMC3780322.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5a/d2/bmjopen-2013-003567.PMC3780329.pdf
"A report for the General Medical Council, August 2012. http://www.gmc-uk.org/The_Impact_of_the_Working_Time_Regulations_on_Medical_Education_and_Training___Final_Report_on_Primary_Research.pdf_51157039.pdf 2.",Non-OADS,/arxiv_data1/oa_pdf/5a/d2/bmjopen-2013-003567.PMC3780329.pdf
"A reportfor the General Medical Council, August 2012. http://www.gmc-uk.org/The_Impact_of_the_Working_Time_Regulations_on_Medical_Education_and_Training___Literature_Review.pdf_51155615.pdf 8.",Non-OADS,/arxiv_data1/oa_pdf/5a/d2/bmjopen-2013-003567.PMC3780329.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-002982).,Non-OADS,/arxiv_data1/oa_pdf/36/b8/bmjopen-2013-002982.PMC3780330.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/36/b8/bmjopen-2013-002982.PMC3780330.pdf
Assessed as up to date on 18 Aug 2010. http://summaries.cochrane.org/CD003566/are-cardioselective-beta-blockers-a-safe-and-effective-treatment-in-patients-with-chronic-obstructive-pulmonary-disease (accessed on1 Mar 2013).,OADS,/arxiv_data1/oa_pdf/36/b8/bmjopen-2013-002982.PMC3780330.pdf
"Global Initiative for Chronic Obstructive LungDisease (GOLD), 2011. http://www.goldcopd.org/ (accessed on1 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/36/b8/bmjopen-2013-002982.PMC3780330.pdf
doi:10.1136/bmjopen-2013- 003692 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003692).,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
"32–34Although the lack of a control group meant that no de ﬁnitiveiAt the time of writing, the purchasing power of $A1 was 0.74 British pounds (GB£) and US$0.66; http://stats.oecd.org/Index.aspx?",Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
https://www.mimsonline.com.au/Search/Search.aspx 19.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
2011. http://www.pbs.gov.au/info/publication/factsheets/shared/Extension_of_the_listing_of_nicotine_patches 20.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.pbs.gov.au/browse/body-system?depth=4&codes=n07ba 21.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://summaries.cochrane.org/CD009329/medications-to-help-people-to-stop-smoking-an-overview-of-reviews 28.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.scotland.gov.uk/Resource/Doc/92240/0022048.pdf 31.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.cherel.org.au/CHeReLQualityAssuranceJuly2008.pdf 44.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Seifa_entry_page 46.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.abs.gov.au/AUSSTATS/abs@.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
https://www.medicareaustralia.gov.au/ statistics/pbs_item.shtml 52.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
http://www.medicareaustralia.gov.au/provider/patients/indigenous.jsp#N10096 54.,Non-OADS,/arxiv_data1/oa_pdf/94/a2/bmjopen-2013-003692.PMC3780331.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003212).,Non-OADS,/arxiv_data1/oa_pdf/00/20/bmjopen-2013-003212.PMC3780332.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003507).,Non-OADS,/arxiv_data1/oa_pdf/c5/67/bmjopen-2013-003507.PMC3780335.pdf
2. http://www.sst.dk/Nyhedscenter/Nyheder/2007/nye_tal_20 –07.aspx (accessed 29 Mar 2013).,OADS,/arxiv_data1/oa_pdf/c5/67/bmjopen-2013-003507.PMC3780335.pdf
WYD P. 2000. http://www.adhd.org.nz/ICD101.html (accessed 15 Feb 2013).,OADS,/arxiv_data1/oa_pdf/c5/67/bmjopen-2013-003507.PMC3780335.pdf
25. http://medical-dictionary.thefreedictionary.com/trimester (accessed 31 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/c5/67/bmjopen-2013-003507.PMC3780335.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003454).,Non-OADS,/arxiv_data1/oa_pdf/32/e3/bmjopen-2013-003454.PMC3780336.pdf
doi:10.1136/bmjopen-2013- 003788 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003788).,Non-OADS,/arxiv_data1/oa_pdf/7b/ea/bmjopen-2013-003788.PMC3780337.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003599).,Non-OADS,/arxiv_data1/oa_pdf/a5/da/bmjopen-2013-003599.PMC3780338.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003568).,Non-OADS,/arxiv_data1/oa_pdf/1a/ec/bmjopen-2013-003568.PMC3780339.pdf
"The asthma hazard index of QACs (0.81 –0.95), glutaraldehyde (0.82) and ethanola- mines (0.64 –0.86) derived from a quantitative structure activity relationship model is above the cut-off value of 0.5, which predicts the potential for inducing OA with asensitivity of 86% and a speci ﬁcity of 99% (Seed MJ, per- sonal communication; http://www.coeh.man.ac.uk/ research/asthma/; last accessed 28 Jan 2012).",Non-OADS,/arxiv_data1/oa_pdf/1a/ec/bmjopen-2013-003568.PMC3780339.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003485).,Non-OADS,/arxiv_data1/oa_pdf/b7/82/bmjopen-2013-003485.PMC3780340.pdf
Interpretation and conclusions England has a well-established and specially funded national programme —the National Service Framework — that sets standards for a number of conditions including the control of CVD and its risk factors that builds on decades of prior excellent work to control cardiovascularrisk factors (http://www.nhs.uk/NHSEngland/NSF/ Pages/Nationalserviceframeworks.aspx; accessed 13 Aug 2012).,Non-OADS,/arxiv_data1/oa_pdf/b7/82/bmjopen-2013-003485.PMC3780340.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003272).,Non-OADS,/arxiv_data1/oa_pdf/c7/26/bmjopen-2013-003272.PMC3780428.pdf
Available from: http://manual.join tcommission.org/releases/a rchive/TJC2010B/MIF0182.html  (accessed 2012 Feb 22)  3.,Non-OADS,/arxiv_data1/oa_pdf/5c/eb/pharmpract-10-092.PMC3780479.pdf
Available from:  http://healthypeople.gov/2020/topics objectives2020/objective slist.aspx?topicid=41 (accessed 2012 Feb 22)  4.,Non-OADS,/arxiv_data1/oa_pdf/5c/eb/pharmpract-10-092.PMC3780479.pdf
Available from: http://www.rxforchange.ucsf.edu/ (accessed 2012 Feb 22)  7.,Non-OADS,/arxiv_data1/oa_pdf/5c/eb/pharmpract-10-092.PMC3780479.pdf
"Available from  http://www.coe.int/t/e/social_cohesion/soc-sp/Medication%20s afety%20culture%20report%20E.pdf (Accessed April 14,  2011).",Non-OADS,/arxiv_data1/oa_pdf/bc/79/pharmpract-10-072.PMC3780480.pdf
"Accessed at http://healthypeople.gov /2020/topicsobjectives2020/objec tiveslist.aspx?topicid=26  (accessed October 21, 2011).",Non-OADS,/arxiv_data1/oa_pdf/84/1f/pharmpract-10-105.PMC3780481.pdf
"Accessed at http://www.marchofdimes.com/per istats/pdfdocs/2008FolicAcidSurveyReport.pdf (accessed  October 21, 2011).",Non-OADS,/arxiv_data1/oa_pdf/84/1f/pharmpract-10-105.PMC3780481.pdf
"Available at: http://www.jointcommission.or g/assets/1/6/NPSG_EPs_Scoring_AHC_20110707.pdf (Accessed  October 21, 2011).",OADS,/arxiv_data1/oa_pdf/ab/57/pharmpract-10-078.PMC3780482.pdf
Available at:  http://www.portalfarma.com/pfarma/taxonomia/general/ gp000016.nsf/voDocumentos/120C1F228EDEF914C125764E00352390/ $File/estadisticas_sanitarias.pdf (Accessed 20  April 2011).,Non-OADS,/arxiv_data1/oa_pdf/be/54/pharmpract-10-083.PMC3780483.pdf
http://blog.vovici.com/blog/bid/18119/Recommended- Sample-Size-for-Accurate-Surveys (accessed 22 August 2011).,Non-OADS,/arxiv_data1/oa_pdf/2f/80/pharmpract-10-097.PMC3780484.pdf
"http://www.ginasthma.com  (Accessed March 8, 2005 ).",Non-OADS,/arxiv_data1/oa_pdf/b2/ab/pharmpract-10-110.PMC3780485.pdf
"Source: U.S. Department of  Education, 2008. http://www.ed.gov (accessed: 12th December 2008)",Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from: http://www.psa.org.au/ (Accessed 15th February  2012)  3.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://www.dohc.ie/publications/nat ional_health_and_lifestyle_surveys.html (Accessed 15th February 2012)  6.  www.healthliteracy.ie.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
EU Health Literacy Survey Re sults announced today | Health Literacy 2011 Available from:  http://healthliteracy.ie/four-out-of-10-people-in-ireland-hav e-low-health-literacy/ (Accessed 13th February 2012)  7.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://www.nala.ie/index.cfm/section/pub lications/top/1/ext/Publications/searc h_pub/1/ (Accessed 13th February 2012)  10.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://iom.edu/Reports/2009/Measures-of-Health -Literacy.aspx (Accessed 13th February 2012)  15.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://www.nala.ie/index.cfm/section/pub lications/top/1/ext/Publications/searc h_pub/1/Type_of_publication_key/0/search _text/Health%20Literacy/page/2 (Accessed 13th February 2012)  20.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://www.ecdc.europa.eu/en/activities/sciadvice/Lists/ ECDC%20Reviews/ECDC_DispForm.aspx?List=512ff74f-77d4- 4ad8-b6d6-bf0f23083f30&ID=892&RootFolder=%2Fen%2Facti vities%2Fsciadvice%2FLi sts%2FECDC%20Reviews  (Accessed 12th February 2012)  28.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
Available from:  http://www.dh.gov.uk/en/Publicationsandstatistics/Pub lications/PublicationsPolicy AndGuidance/DH_085307 (Accessed  12th February 2012)  29.,Non-OADS,/arxiv_data1/oa_pdf/d2/f2/pharmpract-10-143.PMC3780487.pdf
"Bethesda, MD: NCCAM; 2010. http://nccam.nih.gov/health/whatiscam (accessed on July 6, 2011).",OADS,/arxiv_data1/oa_pdf/58/c1/pharmpract-10-125.PMC3780488.pdf
"London: RPS;  2011. http://www.bnf.org (accessed on July 6, 2011).",Non-OADS,/arxiv_data1/oa_pdf/58/c1/pharmpract-10-125.PMC3780488.pdf
"Geneva: WHO; 2011.  http://www.who.int/classifications/icd/en (accessed on July 6, 2011).",OADS,/arxiv_data1/oa_pdf/58/c1/pharmpract-10-125.PMC3780488.pdf
"London: MHRA; 2011.  http://www.mhra.gov.uk/Safetyinformation/  Howwemonitorthesafetyofproducts/Medicines/TheYellowC ardScheme/index.htm (accessed on July 6, 2011).",Non-OADS,/arxiv_data1/oa_pdf/58/c1/pharmpract-10-125.PMC3780488.pdf
Available at:  http://www.fda.gov/downloads/ForConsumers/ConsumerUpdates/ucm049312.pdf.,Non-OADS,/arxiv_data1/oa_pdf/58/92/pharmpract-10-159.PMC3780489.pdf
http://jcmc.indiana.edu/vol6/issue2/sheehan.html  41.,Non-OADS,/arxiv_data1/oa_pdf/58/92/pharmpract-10-159.PMC3780489.pdf
"Accessed  at http://www.gpo.gov/fdsys/pkg/PLAW-108publ173/pdf/PLAW-108publ173.pdf, May 16, 2012.",Non-OADS,/arxiv_data1/oa_pdf/f0/7d/pharmpract-10-119.PMC3780492.pdf
"Prescription Drug Benefit Manual Chapter 7 – Medica tion Therapy Management and Quality Improvement Program  accessed at https://www.cms.gov/Medicare/Prescription-Drug- Coverage/PrescriptionDrugCovContra/downloads/Chapter7.pdf, May 16, 2012.",Non-OADS,/arxiv_data1/oa_pdf/f0/7d/pharmpract-10-119.PMC3780492.pdf
"18 accessed at http://www.gpo.gov/fdsys/pkg/FR-2005-01-28/pdf/05-1321.pdf, May 16,  2012.",Non-OADS,/arxiv_data1/oa_pdf/f0/7d/pharmpract-10-119.PMC3780492.pdf
"The sample size  for each hospital was determined from the Raosoft  sample size calculator (which was available online  http://www.raosoft.com/samplesize.html) by keying  the requested parameters i. e. confidence level of  95%, confidence interval of 5% and p<0.05 together  with the total number of specialists and non- specialists for each hospital.",OADS,/arxiv_data1/oa_pdf/c7/2c/pharmpract-10-136.PMC3780493.pdf
Available from:  http://erc.msh.org/newpages/english/dmpmodule/formul_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/2c/pharmpract-10-136.PMC3780493.pdf
[online] 2011; http://www.cdc.gov/ncbddd/folic acid/global.html (accessed 21 October 2011).,OADS,/arxiv_data1/oa_pdf/c5/97/pharmpract-10-168.PMC3780494.pdf
[online] 2008; http://www.marchofdimes.com/per istats/pdfdocs/2008FolicAcidSurveyReport.pdf (accessed 21  October 2011).,Non-OADS,/arxiv_data1/oa_pdf/c5/97/pharmpract-10-168.PMC3780494.pdf
"http://fightaidsathome.scripps .edu/glossary.html#h (Accessed September 23, 2009).",Non-OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"http://www.thebody.com/content/art2506.html (Accessed September 23,  2009).",Non-OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"MMWR 2008; 57(RR10); 9.  http://www.cdc.gov/mmwr/preview/mmwrhtml /rr5710a2.htm (Accessed September 25, 2009).",OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"http://www.fda.gov/ForConsumers/ByAudience/ForPatient Advocates/HIVandAIDSActivities/ucm117935.htm (Accessed  September 23, 2009).",Non-OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"http://www.ispor.org/sig s/medcompliance/Integrating%20MedCompl.asp (Accessed  November 23, 2009).",OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
21. http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"http://roadtoaids2012.org/cities /birmingham.htm (Accessed February  27, 2012).",Non-OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
"http://www.cdc.gov/nchhstp/stateprofiles/pdf/a labama_profile.pdf (Accessed February 27, 2012).",OADS,/arxiv_data1/oa_pdf/ae/65/pharmpract-10-188.PMC3780495.pdf
Pharmaceutical Market Europe 2011; 55 -61 Available from:  http://www.imshealth.com/ims/Global/Content/Insights/Featured%20Topics/Emerg ing%20Markets/ICG_Turkey_Article1.,Non-OADS,/arxiv_data1/oa_pdf/ba/fc/pharmpract-10-199.PMC3780497.pdf
"Türk Eczacıları Birliği Eşdeğer İlaçlar Raporu, 2009 Available  in:http://www.teb.org.tr/images/upld2/rapor/Mai20090515141252ESDEGERILACRAPORU.pdf  (Accessed: 31.07.2012)   21.",Non-OADS,/arxiv_data1/oa_pdf/ba/fc/pharmpract-10-199.PMC3780497.pdf
"METHODS   This study employed a content analysis approach to  review warning letters issued by the FDA during  2003 through 2008 where replicable and valid  inferences from the text were made.12 First,  investigators downloaded and printed all warning  letters sent to pharmaceutical companies from the  website http://www.fda.gov/cder/warn.",OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
http://fda.gov/cder/ddmac/ [Accessed April 2009]  8.,Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInf ormation/Surveillance/DrugM arketingAdvertisingandComm unications/ucm081617.htm [Accessed November 2009]  9.,Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
http://www.fda.gov /AboutFDA/CentersOffices/CDER/ucm090279.htm [Accessed  November 2009]  11.,Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
http://www.cov.com/files/Publication/0dd2bef8-c1d1-44a5-a7aa- 9871458b0088/Presentation/PublicationAttachment/2b5f e504-baa4-4553-9db8-7f9505ed368a/665.pdf  [Accessed  October 2009]  15.,Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
"(Feb 26, 2006) http://www.forbes.com/2006/02/27/pfizer-merck- genentech-cx_mh_0224topsellingdrugs.html [Accessed April 2009]  16.",Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
"Food and Drug e-Alert; March 30, 2009.  http://www.cov.com/files/Publication/6532be42-767e-4c2c-acc0-0c350eed5d8e/Presentation/PublicationA ttachment/04b38cf7-655e-45d8-a98d- 1cd0f595f212/Trends%20in%20DDMAC%20Enforcement%20Act ivity%20During%20the%20Bush%20Administration.pd f  [Accessed November 2009]  18.",Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
(2004)  http://apps.who.int/medicinedocs/pdf/s8109e/s8109e.pdf  [Accessed July 2011],Non-OADS,/arxiv_data1/oa_pdf/37/bf/pharmpract-10-194.PMC3780498.pdf
"References    1.  International Society of Drug Bulletins, Berlin Declar ation on Pharmacovigilance, J anuary, (2005), Available from  http://www.isdbweb.org/documents/uploads/Declaration/Be rlin_Declaration_Berlin%20Engl.pdf (Accessed on Dec.  2011).",Non-OADS,/arxiv_data1/oa_pdf/15/ee/pharmpract-10-222.PMC3780499.pdf
Availabl e from: http://www.epn.se/start/startsida.aspx (accessed 6th  April 2012).,Non-OADS,/arxiv_data1/oa_pdf/fd/a4/pharmpract-10-207.PMC3780500.pdf
Available at: http://www.ghp.org.uk /login.aspx?reason=notauthonticated (Accessed 23/03/2012).,Non-OADS,/arxiv_data1/oa_pdf/55/7c/pharmpract-11-051.PMC3780502.pdf
Available at  http://cdc.gov/diabetes/ pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/26/pharmpract-11-030.PMC3780503.pdf
Available at http://revista.sedolor.es/pdf/2001_01_05.pdf,Non-OADS,/arxiv_data1/oa_pdf/b4/b6/pharmpract-11-003.PMC3780507.pdf
"Available at: http://www.oilofpisces.com/hypert ension.html (Accessed 31ist January, 2012).",OADS,/arxiv_data1/oa_pdf/14/de/pharmpract-11-024.PMC3780508.pdf
Available at  http://www.portaldapesquisa.com.br/dat abases/sites (Access: 1 May 2011).,Non-OADS,/arxiv_data1/oa_pdf/f8/ac/pharmpract-11-017.PMC3780509.pdf
Available from: http://www.chowk.com/articles/11520 (Accessed 2009 20th  November)  16.,Non-OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
2012; Available from:  http://www.who.int/malaria/publications/world_malari a_report_2012/wmr2012_full_report.pdf (Accessed 2013 15th  January)  24.,Non-OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
2012; Available from: http://www.huffingtonpost.co.uk/dr- sania-nishtar/drug-regulatory-authority _b_2270449.html  (Accessed 2012 25 December)  32.,Non-OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
Nishtar S. Devolving health-Part - II 2011; Availabl e from: http://www.thenews.com.pk/Todays-News-9-65635- Devolving-health-Part---II (Accessed 2012 15th March)  33.,Non-OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
Available from http://edis.ifas.ufl.edu/pdffiles/PD/PD00600.pdf   37.,Non-OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
How to investigate drug use in health facilities:Selected drug us e indicators; Available from:  http://apps.who.int/medicinedocs/pdf/s2289e/s2289e.pdf (Accessed 2002 20th April)  43.,OADS,/arxiv_data1/oa_pdf/cb/01/pharmpract-11-008.PMC3780510.pdf
"http://e-jbm.org/   51 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:51-55 http://dx.doi.org/10.11005/jbm.2013.20.1.51pISSN 2287-6375    eISSN 2287-7029 A Case of Nutritional Osteomalacia in Young Adult  Male Choong-Kyun Noh, Min-Jeong Lee, Bu Kyung Kim, Yoon-Sok Chung Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea Vitamin D is an important hormone that can be a role of bone and calcium metabolism in the human organ.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jbm-20-51.PMC3780826.pdf
"Choong-Kyun Noh, et al.52  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.51 exposure is not enough due to telecommuting and indoor  work environment and UV block has been excessively uti-lized.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jbm-20-51.PMC3780826.pdf
Nutritional Osteomalacia in Young Adult Malehttp://dx.doi.org/10.11005/jbm.2013.20.1.51 http://e-jbm.org/   53 and femoral neck (-4.0) (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jbm-20-51.PMC3780826.pdf
"Choong-Kyun Noh, et al.54  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.51 ficiency in males is rare because males intake relatively  more meats than that of females.",Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jbm-20-51.PMC3780826.pdf
Nutritional Osteomalacia in Young Adult Malehttp://dx.doi.org/10.11005/jbm.2013.20.1.51 http://e-jbm.org/   55 10.,Non-OADS,/arxiv_data1/oa_pdf/ef/bd/jbm-20-51.PMC3780826.pdf
"http://e-jbm.org/   31 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.Effects of a ‘Drug Holiday’ on Bone Mineral Density  and Bone Turnover Marker During Bisphosphonate Therapy Sung Yeol Kong, Dae Young Kim, Eun Jin Han, So Young Park, Chang Hoon Yim, Sung Hoon Kim, Hyun Koo Yoon Department of Internal Medicine, Cheil General Hospital & Women’s Healthcare Center, Kwandong University College of Medicine, Seoul,  Korea Background: Recently long-term safety of bisphosphonate raises issues about the dura- tion of therapy.",Non-OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
"Currently, bisphosphonate therapy raises issues  about adverse events with many years of taking bisphosphonates — osteonecro - sis of the jaw (ONJ), severely suppressed bone turnover, atrial fibrillation, subtro -Corresponding author Hyun Koo Yoon  Department of Internal Medicine, Cheil  General Hospital & Women’s Healthcare  Center, Kwandong University College of Medicine, 17 Seoae-ro 1-gil, Jung-gu,   Seoul 100-380, Korea Tel: +82-2-2000-7244Fax: +82-2-2000-7147 E-mail: hyunkooyoon@hotmail.com Received: December 11, 2012 Revised: January 28, 2013 Accepted: January 28, 2013 No potential conflict of interest relevant to this  article was reported.Original ArticleJ Bone Metab 2013;20:31-35 http://dx.doi.org/10.11005/jbm.2013.20.1.31pISSN 2287-6375    eISSN 2287-7029",Non-OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
"Sung Yeol Kong , et al.32  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.31 chanteric fracture, and esophageal cancer.",Non-OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
Effects of ‘Drug Holiday’ on Bone Metabolismhttp://dx.doi.org/10.11005/jbm.2013.20.1.31 http://e-jbm.org/   33 Fig.,Non-OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
"Sung Yeol Kong , et al.34  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.31 phonate and calcium to alfacalcidol (0.5 μg) or calcitriol  (0.25 μg) and calcium (158-600 mg) because of approved drug for osteoporosis in Korea.",OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
Effects of ‘Drug Holiday’ on Bone Metabolismhttp://dx.doi.org/10.11005/jbm.2013.20.1.31 http://e-jbm.org/   35 12.,Non-OADS,/arxiv_data1/oa_pdf/4a/b7/jbm-20-31.PMC3780827.pdf
"http://e-jbm.org/   25 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:25-30 http://dx.doi.org/10.11005/jbm.2013.20.1.25pISSN 2287-6375    eISSN 2287-7029 Evaluation of the Osteoporosis Health Belief Scale in  Korean Women Tae-Hee Kim1, Young-Sang Lee2, Dong Won Byun3, Seyeon Jang1, Dong-Su Jeon1, Hae-Hyeog Lee1 1Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon;   2Department of Biomedical Technolgy, Soonchunhyang University, Asan;  3Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea Background: The Osteoporosis Health Belief Scale (OHBS) is a 42-item questionnaire de - signed to assess susceptibility, seriousness, calcium benefits, calcium barriers, exercise benefits, exercise barriers, and health motivation related to osteoporosis.",Non-OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
"Tae-Hee Kim, et al.26  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.25 population.",OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
Evaluation of the OHBShttp://dx.doi.org/10.11005/jbm.2013.20.1.25 http://e-jbm.org/   27 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
"Tae-Hee Kim, et al.28  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.25 penia and osteoporosis groups.",OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
Evaluation of the OHBShttp://dx.doi.org/10.11005/jbm.2013.20.1.25 http://e-jbm.org/   29 Health Nurs 2000;17:398-402.,Non-OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
"Tae-Hee Kim, et al.30  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.25 Osteoporosis Health Belief Scale Question   1.",Non-OADS,/arxiv_data1/oa_pdf/9d/24/jbm-20-25.PMC3780828.pdf
"http://e-jbm.org/   57 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.Case ReportJ Bone Metab 2013;20:57-60 http://dx.doi.org/10.11005/jbm.2013.20.1.57pISSN 2287-6375    eISSN 2287-7029 A Case of CATCH22 Syndrome Diagnosed in  Postmenopausal Woman Seung Kyung Lee1, Min Jeong Lee1, Hyo Jin Lee1, Bu Kyung Kim1, Young Bae Sohn2, Yoon-Sok Chung1 Departments of 1Endocrinology and Metabolism, and 2Medical Genetics, Ajou University School of Medicine, Suwon, Korea CATCH 22 Syndrome is caused by chromosome 22q11.2 microdeletion, characterized by developmental abnormalities of the third and fourth pharyngeal pouches.",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jbm-20-57.PMC3780829.pdf
"Seung Kyung Lee, et al.58  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.57 this study was to report a case of CATCH22 syndrome with  literature review; in a woman in her 50's that visited a hos-pital due to spasm and was diagnosed by hypocalcemia.",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jbm-20-57.PMC3780829.pdf
CATCH22 Syndrome in Postmenopausal Womanhttp://dx.doi.org/10.11005/jbm.2013.20.1.57 http://e-jbm.org/   59 Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jbm-20-57.PMC3780829.pdf
"Seung Kyung Lee, et al.60  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.57 hypocalcemia have been reported as well.",Non-OADS,/arxiv_data1/oa_pdf/7e/e9/jbm-20-57.PMC3780829.pdf
"http://e-jbm.org/   11 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.Analysis of Clinical Features of Hip Fracture Patients  with or without Prior Osteoporotic Spinal Compression Fractures Gang Deuk Kim1, Yeung Jin Kim2, Soo Uk Chae2, Deok Hwa Choi3 Departments of 1Radiology, 2Orthopeadic Surgery, and 3Anesthesiology and Pain Medicine, School of Medicine, Wonkwang University  Hospital, Iksan, Korea Background: To analyze and compare the clinical characteristics including bone mineral density (BMD) in a group who had operation of hip fracture with or without prior osteo - porotic spinal compression fractures.",Non-OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
This paper was supported by Wonkwang University  in 2013.Original ArticleJ Bone Metab 2013;20:11-15 http://dx.doi.org/10.11005/jbm.2013.20.1.11pISSN 2287-6375    eISSN 2287-7029,Non-OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
"Gang Deuk Kim, et al.12  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.11 of subsequent vertebral fracture while there are only a few  reports of non-vertebral fracture, especially, hip fractures af-ter percutanous vertebroplasty in osteoporotic spinal com - pression fracture.",Non-OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
"Hip Fracture with or without Prior Spinal Fractureshttp://dx.doi.org/10.11005/jbm.2013.20.1.11 http://e-jbm.org/   13 in group II were 61 (54.0%) and 52 (46.0%) patients, retro - spectively, which have a statistical significance (P <0.001).",Non-OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
"Gang Deuk Kim, et al.14  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.11 ture risk.",OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
Hip Fracture with or without Prior Spinal Fractureshttp://dx.doi.org/10.11005/jbm.2013.20.1.11 http://e-jbm.org/   15 vention Diagnosis and Therapy.,Non-OADS,/arxiv_data1/oa_pdf/97/47/jbm-20-11.PMC3780830.pdf
"http://e-jbm.org/   43 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:43-45 http://dx.doi.org/10.11005/jbm.2013.20.1.43pISSN 2287-6375    eISSN 2287-7029 Domestic Characteristics and Trends of Publications  on Bone Metabolism in South Korea between 1998 and 2012 Young-Kyun Lee1, Sanghwan Kim1, Ki-Choul Kim2, Dong-Won Byun3 1Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam;   2Department of Orthopaedic Surgery, Dankook University School of Medicine, Cheonan;   3Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Hospital, Seoul, Korea Background: This study was undertaken to investigate the trends in domestic publica-tions on bone metabolism during the last decade, and to document the characteristics of articles in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/4b/9f/jbm-20-43.PMC3780831.pdf
"Young-Kyun Lee, et al.44  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.43 of bone metabolism articles published in KJBM between  1998 and 2012.",OADS,/arxiv_data1/oa_pdf/4b/9f/jbm-20-43.PMC3780831.pdf
Articles on bone metabo - lism were retrieved from database of KJBM (http://ksbmr.org/html/member/sub3/03_sub_01.asp).,OADS,/arxiv_data1/oa_pdf/4b/9f/jbm-20-43.PMC3780831.pdf
"Publications on Bone Metabolism in South Koreahttp://dx.doi.org/10.11005/jbm.2013.20.1.43 http://e-jbm.org/   45 DISCUSSION In this study, we found out that the total number of arti- cles has increased, and articles on basic research reached  about 20% of KJBM, which has been the representative  journal for bone metabolism.",OADS,/arxiv_data1/oa_pdf/4b/9f/jbm-20-43.PMC3780831.pdf
Osteoporos Int 2012. doi: http://dx.doi.org/10.1007/s00198-012-2250-0.,OADS,/arxiv_data1/oa_pdf/4b/9f/jbm-20-43.PMC3780831.pdf
"http://e-jbm.org/   37 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:37-41 http://dx.doi.org/10.11005/jbm.2013.20.1.37pISSN 2287-6375    eISSN 2287-7029 Changes in Serum Osteocalcin are Not Associated  with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate Seong-hun Hong1, Ja-won Koo1, Jin Kyung Hwang1, You-Cheol Hwang1, In-Kyung Jeong1, Kyu Jeung Ahn1,   Ho-Yeon Chung1, Deog-Yoon Kim2 Departments of 1Endocrinology and Metabolism, 2Nuclear Medicine, Kyung Hee University School of Medicine, Kyung Hee University  Hospital at Gangdong, Seoul, Korea  Background: Bisphosphonate is used in osteoporosis treatment to repress osteoclast activity, which then decreases levels of osteocalcin (OC).",Non-OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
"Seong-hun Hong , et al.38  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.37 Bisphosphonates can reduce fracture risk through the  reduction of osteoclastic activity and significantly decrease  serum OC concentration.",Non-OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
Correlation of Changes in Osteocalcin and Glucosehttp://dx.doi.org/10.11005/jbm.2013.20.1.37 http://e-jbm.org/   39 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
"Seong-hun Hong , et al.40  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.37 carboxylated form was not associated with IR, but total OC  and the protein in its Gla form were inversely associated with IR.",OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
Correlation of Changes in Osteocalcin and Glucosehttp://dx.doi.org/10.11005/jbm.2013.20.1.37 http://e-jbm.org/   41 10.,Non-OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
J Bone Miner Res 2013. doi: http://dx.doi.org/10.1002/jbmr.1865.,Non-OADS,/arxiv_data1/oa_pdf/10/c4/jbm-20-37.PMC3780832.pdf
"http://e-jbm.org/   47 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.Case ReportJ Bone Metab 2013;20:47-50 http://dx.doi.org/10.11005/jbm.2013.20.1.47pISSN 2287-6375    eISSN 2287-7029 Osteoporotic Lumbar Compression Fracture in  Patient with Ankylosing Spondylitis Treated with Kyphoplasty Gang Deuk Kim1, Soo Uk Chae2, Yeung Jin Kim2, Deok Hwa Choi3 Departments of 1Radiology, 2Orthopedic Surgery and 3Anesthesiology and Pain Medicine, School of Medicine, Wonkwang University  Hospital, Iksan, Korea Ankylosing spondylitis (AS) is an inflammatory disease primarily affecting the spine.",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jbm-20-47.PMC3780833.pdf
"Gang Deuk Kim , et al.48  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.47 CASE  A 73-year-old male patient had lower back and both  buttock pain that was occurred after fall from standing po - sition 2 weeks before, the symptoms progressed and be - came intolerable in spite of analgesia.",Non-OADS,/arxiv_data1/oa_pdf/93/d1/jbm-20-47.PMC3780833.pdf
Osteoporotic Lumbar Compression Fracture of Ankylosing Spondylitishttp://dx.doi.org/10.11005/jbm.2013.20.1.47 http://e-jbm.org/   49 DISCUSSION In AS spontaneous fusion of the sacroiliac joints and spine  occurs due to chronic inflammation leading to initial back  pain followed by generalized stiffness of the spine.,Non-OADS,/arxiv_data1/oa_pdf/93/d1/jbm-20-47.PMC3780833.pdf
"Gang Deuk Kim , et al.50  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.47 tical BMD were 279.2 mg/cm3 and 11.2 mg/cm3 of lumbar  vertebrae (L1-4).",OADS,/arxiv_data1/oa_pdf/93/d1/jbm-20-47.PMC3780833.pdf
"http://e-jbm.org/   1 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:1-10 http://dx.doi.org/10.11005/jbm.2013.20.1.1pISSN 2287-6375    eISSN 2287-7029 Sarcopenia: Definition, Epidemiology, and  Pathophysiology Tae Nyun Kim1, Kyung Mook Choi2 1Department of Internal Medicine, Cardiovascular and Metabolic Disease Center, Inje University, Busan;   2Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Korea The epidemiological trends that characterize our generation are the aging of the popu-lation.",Non-OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"Tae Nyun Kim, et al.2  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.1 2025 and 34.4% in 2050.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"What is Sarcopenia?http://dx.doi.org/10.11005/jbm.2013.20.1.1 http://e-jbm.org/   3 sured ASM and the ASM predicted by linear regression  analysis used to model the relationship between ASM as a dependent variable, and age, height (meters) and total fat  mass (kg) as the independent variables.",Non-OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"Tae Nyun Kim, et al.4  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.1 These researchers found that the likelihood of functional  impairment and disability was approximately two times greater in the older men and three times greater in the  older women with severe sarcopenia than in the older men  and women with a normal SMI, respectively.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"What is Sarcopenia?http://dx.doi.org/10.11005/jbm.2013.20.1.1 http://e-jbm.org/   5 using alternative methods, such as SMI index and residu- als, is similar.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"Tae Nyun Kim, et al.6  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.1 trogens, insulin.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
What is Sarcopenia?http://dx.doi.org/10.11005/jbm.2013.20.1.1 http://e-jbm.org/   7 IL-6.,Non-OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"Tae Nyun Kim, et al.8  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.1 dynapenia to define the age-related loss of muscle strength  in 2008.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
Available from: http://www.index.go.kr/egams/stts/jsp/potal/stts/PO_STTS_IdxMain.jsp?,OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
What is Sarcopenia?http://dx.doi.org/10.11005/jbm.2013.20.1.1 http://e-jbm.org/   9 atr Soc 2002;50:889-96.,OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"Tae Nyun Kim, et al.10  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.1 43.",OADS,/arxiv_data1/oa_pdf/83/ba/jbm-20-1.PMC3780834.pdf
"http://e-jbm.org/   17 Copyright © 2013 The Korean Society for Bone and  Mineral Research This is an Open Access article distributed under the terms  of the Creative Commons Attribution Non-Commercial Li-cense (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribu-tion, and reproduction in any medium, provided the original work is properly cited.J Bone Metab 2013;20:17-23 http://dx.doi.org/10.11005/jbm.2013.20.1.17pISSN 2287-6375    eISSN 2287-7029 National Healthcare Budget Impact Analysis of the  Treatment for Osteoporosis and Fractures in Korea Hwabok Yi1, Yong-Chan Ha2, Young-Kyun Lee3, Young-Taik Lim4 1Department of Public Health Science, Graduate School of Public Health, Seoul National University, Seoul;   2Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul;   3Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam;   4Department of Obstetrics and Gynecology, The Catholic University of Korea, College of Medicine, Seoul, Korea Background: This study was to determine the impact on the national healthcare expen-diture for the treatment of osteoporosis and fractures if the coverage period for osteo - porosis medication was extended from maximum a year to continuous period as re - quired.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
"Hwabok Yi, et al.18  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.17 duced quality of life.",OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Impact on National Healthcare Expenditure for Osteoporosis Treatmenthttp://dx.doi.org/10.11005/jbm.2013.20.1.17 http://e-jbm.org/   19 by Health Insurance Review and Assessment Service (HIRA).,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
"Hwabok Yi, et al.20  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.17 RESUL TS 1.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Impact on National Healthcare Expenditure for Osteoporosis Treatmenthttp://dx.doi.org/10.11005/jbm.2013.20.1.17 http://e-jbm.org/   21 osteoporotic fractures.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
"Hwabok Yi, et al.22  http://e-jbm.org/ http://dx.doi.org/10.11005/jbm.2013.20.1.17 of a year and patients are hugely challenged to discontin- ue their treatment.",Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Impact on National Healthcare Expenditure for Osteoporosis Treatmenthttp://dx.doi.org/10.11005/jbm.2013.20.1.17 http://e-jbm.org/   23 4.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Available from: http://www.nhic.or.kr/portal/site/main/MENU_WBDDG0201/ 7.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Available from: http://www.mw.go.kr/front_new/jb/sjb0402vw.jsp?PAR_MENU_ID=03&MENU_ID =030402&page =15&CONT_SEQ =  258980&SEARCHKEY =DEPT_NM&SEARCH_FLAG =03 8.,OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Available from: http://www.nhic.or.kr/portal/site/main/MENU_WBDDG0201 9.,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
Available from: http://www.hira.or.kr/dummy.do?pgmid =HIRAA910001000000&cmsurl =/cms/information/04/   01/01/druginfo_notice.html,Non-OADS,/arxiv_data1/oa_pdf/a9/e8/jbm-20-17.PMC3780835.pdf
"2, 2012  OORRIIGGIINNAALL  AARRTTIICCLLEE  http://dx.doi.org/10.11005/jbm.2012.19.2.95",Non-OADS,/arxiv_data1/oa_pdf/b8/f5/jbm-19-95.PMC3780918.pdf
"2, 2012  CCAASSEE  RREEPPOORRTT  http://dx.doi.org/10.11005/jbm.2012.19.2.139",Non-OADS,/arxiv_data1/oa_pdf/8c/1b/jbm-19-139.PMC3780919.pdf
http://dx.doi.org/10.11005 http://dx.doi.org/10.11005/jbm.2012.19.2.121,Non-OADS,/arxiv_data1/oa_pdf/68/97/jbm-19-121.PMC3780920.pdf
"2, 2012  OORRIIGGIINNAALL  AARRTTIICCLLEE  http://dx.doi.org/10.11005/jbm.2012.19.2.83",Non-OADS,/arxiv_data1/oa_pdf/f4/65/jbm-19-83.PMC3780921.pdf
"[5,12]  Moreover, the mortality rate of men was higher than that (24.0%) of the general population (http://www.kosis.kr).",Non-OADS,/arxiv_data1/oa_pdf/f4/65/jbm-19-83.PMC3780921.pdf
Available from: http://www.kosis.kr  11.,Non-OADS,/arxiv_data1/oa_pdf/f4/65/jbm-19-83.PMC3780921.pdf
"2, 2012  CCAASSEE  RREEPPOORRTT  http://dx.doi.org/10.11005/jbm.2012.19.2.129",Non-OADS,/arxiv_data1/oa_pdf/78/5d/jbm-19-129.PMC3780922.pdf
http://dx.doi.org/10.11005/jbm.2012.19.2.147,Non-OADS,/arxiv_data1/oa_pdf/d6/20/jbm-19-147.PMC3780923.pdf
"2, 2012  CCAASSEE  RREEPPOORRTT  http://dx.doi.org/10.11005/jbm.2012.19.2.159",Non-OADS,/arxiv_data1/oa_pdf/97/99/jbm-19-159.PMC3780924.pdf
http://dx.doi.org/10.11005/jbm.2012.19.2.103,OADS,/arxiv_data1/oa_pdf/8e/22/jbm-19-103.PMC3780925.pdf
"2, 2012  CCAASSEE  RREEPPOORRTT  http://dx.doi.org/10.11005/jbm.2012.19.2.153",Non-OADS,/arxiv_data1/oa_pdf/ea/cc/jbm-19-153.PMC3780926.pdf
"2, 2012  OORRIIGGIINNAALL  AARRTTIICCLLEE  http://dx.doi.org/10.11005/jbm.2012.19.2.87",Non-OADS,/arxiv_data1/oa_pdf/d3/a2/jbm-19-87.PMC3780927.pdf
"2, 2012  OORRIIGGIINNAALL  AARRTTIICCLLEE  http://dx.doi.org/10.11005/jbm.2012.19.2.111",Non-OADS,/arxiv_data1/oa_pdf/27/29/jbm-19-111.PMC3780928.pdf
"2, 2012  CCAASSEE  RREEPPOORRTT  http://dx.doi.org/10.11005/jbm.2012.19.2.133",Non-OADS,/arxiv_data1/oa_pdf/ee/47/jbm-19-133.PMC3780929.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.105 Infect Chemother 2013;45(1):105-107 pISSN 2093-2340 · eISSN 2092-6448 Received: October 16, 2012   Revised:  November 14, 2012  Accepted: January 17, 2013 Corresponding Author : Soo Wan Kim, MD Department of Internal Medicine, Chonnam National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea Tel: +82-62-220-6271  Fax: +82-62-225-8578 E-mail: skimw@chonnam.ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgSerratia marcescens  Peritonitis in a Diabetic Patient  Receiving Continuous Ambulatory Peritoneal Dialysis   Ji Hyoun Kang, Min Jee Kim, Yong Un Kang, Chang Seong Kim, Joon Seok Choi,   Eun Hui Bae, Seong Kwon Ma, and Soo Wan Kim Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea  We report a case of Serratia marcescens  peritonitis in a 45-year-old man with insulin-dependent diabetes mellitus undergo - ing continuous ambulatory peritoneal dialysis (CAPD).",Non-OADS,/arxiv_data1/oa_pdf/0c/6e/ic-45-105.PMC3780930.pdf
"http://dx.doi.org/10.3947/ic.2013.45.1.105  •  Infect Chemother 2013;45(1):10 5-107 www.icjournal.org  107 In summary, we report an unusual case of  S. marcescens  peri - tonitis.",Non-OADS,/arxiv_data1/oa_pdf/0c/6e/ic-45-105.PMC3780930.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.94 Infect Chemother 2013;45(1):94-98 pISSN 2093-2340 · eISSN 2092-6448 Received: September 28, 2012   Revised:  January 7, 2013  Accepted: January 29, 2013 Corresponding Author : Kang-Won Choe, MD, PhD Department of Internal Medicine, Armed Forces Capital Hospital,    2Gil 66 Ho, Yul-dong, Bundang-gu, Seongnam 463-040, Korea Tel: +82-31-725-6315  Fax: +82-31-706-0987 E-mail: choekw@snu.ac.kr *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/ef/84/ic-45-94.PMC3780931.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.94  •  Infect Chemother 2013;45(1):94-9 8 www.icjournal.org  95 formation of the membrane attack complex and eventually  incr eases the incidence of menin gococcal dis ease [3].,Non-OADS,/arxiv_data1/oa_pdf/ef/84/ic-45-94.PMC3780931.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.94  •  Infect Chemother 2013;45(1):94-9 8 www.icjournal.org  97 fold lower compared with healthy people.,Non-OADS,/arxiv_data1/oa_pdf/ef/84/ic-45-94.PMC3780931.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.22 Infect Chemother 2013;45(1):22-31 pISSN 2093-2340 · eISSN 2092-6448 Received: January 29, 2013 Corresponding Author : Jae-Hoon Song, MD, PhD  Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University  School of Medicine, Irwon-ro 81, Gangnam-gu, Seoul 135-710, Korea  Tel: + 82-2-3410-0320  Fax:  +82-2-3410-0023 E-mail: songjh@skku.edu Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgAntimicrobial Resistance in Asia: Current Epidemiology  and Clinical Implications Cheol-In Kang1, and Jae-Hoon Song1,2 1Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine; 2Asia Pacific Foundation for  Infectious Diseases (APFID), Seoul, Korea Antimicrobial resistance has become one of the most serious public health concerns worldwide.",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.22  •  Infect Chemother 2013;45(1):2 2-31 www.icjournal.org  23 resistant  S. aureus , VISA or VRSA, respectively), glycopeptide- resistant enterococci (vancomycin-resistant enterococci,  VRE), extended-spectrum beta-lactamase (ESBL)-producing  Enterobacteriaceae, and MDR nonfermenters are being found  with increasing frequency around the world.",Non-OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.22  •  Infect Chemother 2013;45(1):2 2-31 www.icjournal.org  25 [2, 28].",OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.22  •  Infect Chemother 2013;45(1):2 2-31 www.icjournal.org  27 P .,Non-OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.22  •  Infect Chemother 2013;45(1):2 2-31 www.icjournal.org  29 Thaipadungpanit J, Day NP , Peacock SJ.",OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.22  •  Infect Chemother 2013;45(1):2 2-31 www.icjournal.org  31 2007;60:913-20.,Non-OADS,/arxiv_data1/oa_pdf/1e/e8/ic-45-22.PMC3780932.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.108 Infect Chemother 2013;45(1):108-109 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Hee Jin Cheong, MD, PhD Division of Infectious Disease, Department of Internal Medicine,  Korea University Guro Hospital, Korea University College of Medicine,  Guro-dong, Guro-gu, Seoul 152-703, Korea Tel: +82-2-2626-3050   Fax: +82-2-2626-1105  E-mail: heejinmd@korea.ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgInfection and Chemotherapy : We Are Ready to Fly Hee Jin Cheong Department of Internal Medicine, Korea University College of Medicine, Seoul, KoreaEditorial  On behalf of the editorial board, I am pleased to announce  that Infection and Chemotherapy  is being published as an  open-access English journal beginning in March, 2013 with  volume 45, issue 1 to facilitate its international competitive - ness.",Non-OADS,/arxiv_data1/oa_pdf/4a/57/ic-45-108.PMC3780933.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.108  •  Infect Chemother 2013;45(1):10 8-109 www.icjournal.org  109 worked to keep  Infection and Chemotherapy  worthy of its  name as a professional journal.,Non-OADS,/arxiv_data1/oa_pdf/4a/57/ic-45-108.PMC3780933.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.113 Infect Chemother 2013;45(1):113-115 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Sang-Oh Lee, MD, PhD Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of  Medicine, 388-1 Pungnap 2-dong, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3301  Fax: +82-2-3010-6970 E-mail: soleemd@amc.seoul.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgCommencement of the Meningococcal Vaccination  for the Republic of Korea Army Sang-Oh Lee Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaEditorial On December 11, 2012, the Korean military authorities  made an official announcement that all recruits will receive  a quadrivalent (group A, C, Y, and W-135) meningococcal  conjugate vaccine (Menveo®, Novartis Vaccines and  Diagnostics, Cambridge, MA, USA) which commenced on  November 17, 2012 [1].",Non-OADS,/arxiv_data1/oa_pdf/ef/af/ic-45-113.PMC3780934.pdf
Available at: http://news.sbs.co.kr/section_news/news_ read.jsp?news_id=N1001527495.,Non-OADS,/arxiv_data1/oa_pdf/ef/af/ic-45-113.PMC3780934.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.113  •  Infect Chemother 2013;45(1):11 3-115 www.icjournal.org  115 6 November 2012.,Non-OADS,/arxiv_data1/oa_pdf/ef/af/ic-45-113.PMC3780934.pdf
Available at: http://www.mdtoday.co.kr/ mdtoday/index.html?no=207728.,Non-OADS,/arxiv_data1/oa_pdf/ef/af/ic-45-113.PMC3780934.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.32 Infect Chemother 2013;45(1):32-43 pISSN 2093-2340 · eISSN 2092-6448 Received: March 11, 2013 Corresponding Author : Jong-Yil Chai Department of Parasitology and Tropical Medicine, Seoul National University   College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744, Korea Tel:  +82-2-740-8342  Fax: +82-2-765-6142 E-mail: cjy@snu.ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgPraziquantel Treatment in Trematode and Cestode  Infections: An Update Jong-Yil Chai Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul, Korea Status and emerging issues in the use of praziquantel for treatment of human trematode and cestode infections are briefly  reviewed.",Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  33 reporting successful results have been published.,OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  35 28].,Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  37 2.,Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  39 diarrhea, dizziness, sleepiness, and headache [77].",Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  41 34.,Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.32  •  Infect Chemother 2013;45(1):3 2-43 www.icjournal.org  43 from Egyptian villages that tolerate high doses of praziquan- tel.,Non-OADS,/arxiv_data1/oa_pdf/40/85/ic-45-32.PMC3780935.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.85 Infect Chemother 2013;45(1):85-93 pISSN 2093-2340 · eISSN 2092-6448 Received: June 7, 2012   Revised:  September 21, 2012  Accepted: October 23, 2012 Corresponding Author : Sang Taek Heo, MD Department of Internal Medicine, Jeju National University School of Medicine,   1 Ara 1-dong, 102 Jejudaehak-ro, Jeju-si, Jeju Special-Governing Province 690-756, Korea Tel: +82-64-717-1296  Fax: +82-64-717-1131  E-mail: neosangtaek@naver.com Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgSkin and Soft Tissue Infection due to Rapidly Growing  Mycobacteria: Case Series and Literature Review Jung Re Yu1, Sang Taek Heo1, Keun Hwa Lee2, Jinseok Kim1, Jae Kyung Sung1, Young Ree Kim3,  and Jae Wang Kim4 Departments of 1Internal Medicine, 2Microbiology and Immunology, 3Laboratory Medicine, and 4Dermatology, Jeju National University  School of Medicine, Jeju, Korea Background:  Nontuberculous mycobacteria (NTM) are ubiquitous in soil and water.",Non-OADS,/arxiv_data1/oa_pdf/89/e4/ic-45-85.PMC3780936.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.85  •  Infect Chemother 2013;45(1):85-9 3 www.icjournal.org  87 Table 1.,OADS,/arxiv_data1/oa_pdf/89/e4/ic-45-85.PMC3780936.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.85  •  Infect Chemother 2013;45(1):85-9 3 www.icjournal.org  89 charge from the lesion after having frequently visited a public  bath.,Non-OADS,/arxiv_data1/oa_pdf/89/e4/ic-45-85.PMC3780936.pdf
"http://dx.doi.org/10.3947/ic.2013.45.1.85  •  Infect Chemother 2013;45(1):85-9 3 www.icjournal.org  91 confirmed  in the NTM culture, and antimicrobial susceptibil - ity testing results were as shown in Table 3.",Non-OADS,/arxiv_data1/oa_pdf/89/e4/ic-45-85.PMC3780936.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.85  •  Infect Chemother 2013;45(1):85-9 3 www.icjournal.org  93 Case of Cutaneous Infection with Mycobacterium Chelo - nae.,Non-OADS,/arxiv_data1/oa_pdf/89/e4/ic-45-85.PMC3780936.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.69 Infect Chemother 2013;45(1):69-75 pISSN 2093-2340 · eISSN 2092-6448 Received: July 9, 2012   Revised:  October 12, 2012  Accepted: October 13, 2012 Corresponding Author : Yee Gyung Kwak, MD Department of Internal Medicine, Inje University Ilsan Paik Hospital, 2240 Daewha-dong, Ilsanseo-gu, Goyang 411-706, Korea Tel: +82-31-910-7926  Fax: +82-31-910-7219 E-mail: ygkwak@paik.ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgClinical Characteristics of Vivax Malaria and Analysis  of Recurred Patients Yee Gyung Kwak1, Hyo Keun Lee1, Min Kim1, Tae Hyun Um2, and Chong Rae Cho2 Departments of 1Internal Medicine and 2Laboratory Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea Background:  Plasmodium vivax  malaria is an acute debilitating illness characterized by recurrent paroxysmal fever and  relapses from hypnozoites in the liver.",Non-OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.69  •  Infect Chemother 2013;45(1):6 9-75 www.icjournal.org  71 were diagnos ed.,OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.69  •  Infect Chemother 2013;45(1):6 9-75 www.icjournal.org  73 and 7 and 4 patients were residents of Goyang and Paju,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.69  •  Infect Chemother 2013;45(1):6 9-75 www.icjournal.org  75 rean J Med 2009;77:52-4.,OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
Available at: http://stat.cdc.,OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
Avail - able at: http://www.cdc.gov/malaria/diagnosis_treat - ment/clinicians2.html.,Non-OADS,/arxiv_data1/oa_pdf/92/eb/ic-45-69.PMC3780937.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.51 Infect Chemother 2013;45(1):51-61 pISSN 2093-2340 · eISSN 2092-6448 Received: May 4, 2012   Revised:  July 26, 2012  Accepted: September 25, 2012 Corresponding Author : Dong-Gun Lee, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, College of Medi - cine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul  137-701, Korea Tel: +82-2-2258-6003  Fax: +82-2-535-2494 E-mail: symonlee@catholic.ac.kr *  Part of this study was presented at the 2010 Autumn Symposium of the Korean  Society of Infectious Diseases (Nov. 4-5, 2010), Seoul, Korea Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgEpidemiology and Clinical Features of Bloodstream  Infections in Hematology Wards: One Year  Experience at the Catholic Blood and Marrow  Transplantation Center Jae-Cheol Kwon1,4, Si-Hyun Kim2,4, Jae-Ki Choi3,4, Sung-Yeon Cho3,4, Yeon-Joon Park5,  Sun Hee Park3,4, Su-Mi Choi3,4, Dong-Gun Lee3,4, Jung-Hyun Choi3,4, and Jin-Hong Yoo3,4 1Division of Infectious Diseases, Department of Internal Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang; 2Division  of Infectious Diseases, Department of Internal Medicine, Korea University College of Medicine, Seoul; 3Division of Infectious Diseases,  Department of Internal Medicine, 4Vaccine Bio Research Institute, and 5Department of Laboratory Medicine, College of Medicine, The  Catholic University of Korea, Seoul, Korea Background: The aim of this study was to investigate the clinical features and epidemiology of bloodstream infections (BSIs)  in 2 distinctive hematological wards of the Catholic Blood and Marrow Transplantation (BMT) center.",Non-OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.51  •  Infect Chemother 2013;45(1):5 1-61 www.icjournal.org  53 2.,Non-OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.51  •  Infect Chemother 2013;45(1):5 1-61 www.icjournal.org  55 during the same period of hospitalization.,Non-OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.51  •  Infect Chemother 2013;45(1):5 1-61 www.icjournal.org  57 tical significance was observed (Table 4).,OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.51  •  Infect Chemother 2013;45(1):5 1-61 www.icjournal.org  59 the highest ratio among GPB.,Non-OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.51  •  Infect Chemother 2013;45(1):5 1-61 www.icjournal.org  61 Yoo JH, Kim DW, Lee JW, Min WS, Shin WS, Kim CC.",OADS,/arxiv_data1/oa_pdf/2d/9e/ic-45-51.PMC3780938.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.44 Infect Chemother 2013;45(1):44-50 pISSN 2093-2340 · eISSN 2092-6448 Received: April 24, 2012  Revised:  August 24, 2012  Accepted:  October 22, 2012 Corresponding Author : Sung-Han Kim Department of Infectious Diseases, Asan Medical Center, University of  Ulsan College of Medicine, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Korea  Tel: +82-2-3010-3305  Fax: +82-2-3010-6970 E-mail: kimsunghanmd@hotmail.com * There are  no potential conflicts of interest for any of the authors.",Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ic-45-44.PMC3780939.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.44  •  Infect Chemother 2013;45(1):4 4-50 www.icjournal.org  45 cal diﬃculties in collecting specimens; these clinical samples are  sometimes paucibacillary, decreasing the sensitivity of diagnos- tic tests [3].",Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ic-45-44.PMC3780939.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.44  •  Infect Chemother 2013;45(1):4 4-50 www.icjournal.org  47 PBMCs were plated per well.,Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ic-45-44.PMC3780939.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.44  •  Infect Chemother 2013;45(1):4 4-50 www.icjournal.org  49 Evolution of tuberculosis control and prospects for reduc- ing tuberculosis incidence, prevalence, and deaths globally.",Non-OADS,/arxiv_data1/oa_pdf/b0/d1/ic-45-44.PMC3780939.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.62 Infect Chemother 2013;45(1):62-68 pISSN 2093-2340 · eISSN 2092-6448 Received:  January 13, 2012   Revised:  May 21, 2012  Accepted: May 30, 2012 Corresponding Author : Chang-Seop Lee, MD, PhD Department of Internal Medicine, Chonbuk National University Medical School,  20 Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea  Tel: +82-63-250-2391  Fax: +82-63-254-1609 E-mail: lcsmd@jbnu.ac.kr *These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ic-45-62.PMC3780940.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.62  •  Infect Chemother 2013;45(1):6 2-68 www.icjournal.org  63 Introduction Skin and soft tissue infections (SSTIs) are one of the most  comm on clinical diseases acquired from the comm unity and  nosocomially.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ic-45-62.PMC3780940.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.62  •  Infect Chemother 2013;45(1):6 2-68 www.icjournal.org  65 group (P=0.018).,OADS,/arxiv_data1/oa_pdf/b7/b3/ic-45-62.PMC3780940.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.62  •  Infect Chemother 2013;45(1):6 2-68 www.icjournal.org  67 be made.,Non-OADS,/arxiv_data1/oa_pdf/b7/b3/ic-45-62.PMC3780940.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.110 Infect Chemother 2013;45(1):110-112 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Sang-Won Park Department of Internal Medicine, Seoul National University Boramae Medical  Center, 20, Boramae-ro 5-gil, Dongjak-gu, Seoul 156-707, Korea Tel: +82-2-870-2224   Fax: +82-2-870-3863 E-mail: hswon1@snu.ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgImmunologic Diagnosis of Active Tuberculosis Sang-Won Park Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, KoreaEditorial Clinically evident active pulmonary or extrapulmonary  tuberculos is (TB) does not pose a signific ant diagnos tic chal- lenge, but the diagnosis of subclinical or atypical forms of TB is  much more troublesome.",Non-OADS,/arxiv_data1/oa_pdf/fb/96/ic-45-110.PMC3780941.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.110  •  Infect Chemother 2013;45(1):11 0-112 www.icjournal.org  111 and the NPV 99 to 100% [3-6].,OADS,/arxiv_data1/oa_pdf/fb/96/ic-45-110.PMC3780941.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.76 Infect Chemother 2013;45(1):76-84 pISSN 2093-2340 · eISSN 2092-6448 Received:  July 8, 2012   Revised:  October 19, 2012  Accepted: October 23, 2012 Corresponding Author : Jin Han Kang, MD, PhD Department of Pediatrics, The Catholic University of Korea, Seoul St. Mary's Hospital,  222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82-2-2258-6183  Fax: +82-2-537-4544 E-mail: kjhan@catholic .ac.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgNasophary ngeal Carriage Rate and Serotype s of  Streptococcus pneumoniae  and Antimicrobial  Susceptibility in Healthy Korean Children  Younger than 5 Years Old: Focus on Influence of  Pneumococcal Conjugate Va ccination  Eu Kyoung Lee1, Ja Kyung Jun1, Ui Yoon Choi1, Hyo-Jin Kwon2, Kyung-Hyo Kim3, and Jin Han Kang1 1Department of Pediatrics, College of Medicine, The Catholic University of Korea; 2Department of Pediatrics, College of Medicine, Korea  University; 3Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, Korea Backgroun d: Even after p neumococcal vaccination introduction, Streptococcus pneumoniae  (pneumoccocus) is still an impor - tant cause of respiratory and invasive severe infection.",Non-OADS,/arxiv_data1/oa_pdf/15/7b/ic-45-76.PMC3780942.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.76  •  Infect Chemother 2013;45(1):7 6-84 www.icjournal.org  77 Introduction Streptococcus pneumoniae  is the most common causative  agent for acute respiratory infections or central nervous system  infections such as pneumonia, otitis media, and sinusitis and  severe invasive infections such as sepsis, meningitis in children  less than 5 years of age [1-4].",Non-OADS,/arxiv_data1/oa_pdf/15/7b/ic-45-76.PMC3780942.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.76  •  Infect Chemother 2013;45(1):7 6-84 www.icjournal.org  79 group and non-vaccinated group.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/ic-45-76.PMC3780942.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.76  •  Infect Chemother 2013;45(1):7 6-84 www.icjournal.org  81 64 µg/mL and 128 µg/mL, respectively.",Non-OADS,/arxiv_data1/oa_pdf/15/7b/ic-45-76.PMC3780942.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.76  •  Infect Chemother 2013;45(1):7 6-84 www.icjournal.org  83 conducted during the winter season when the carriage rate is  highest.,Non-OADS,/arxiv_data1/oa_pdf/15/7b/ic-45-76.PMC3780942.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.11 Infect Chemother 2013;45(1):11-21 pISSN 2093-2340 · eISSN 2092-6448 Received: January 24, 2013    Corresponding Author : John M Nicholls, MD Department of Pathology, Hong Kong University, Room 127 University Pathology   Building, Queen Mary Hospital, Pok Fu Lam, Hong Kong, Hong Kong  Tel: +852-22554883  Fax: +852-28725197 E-mail: Nicholls@Pathology.Hku.Hk Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgThe Battle Between Influenza and the Innate  Immune Response in the Human Respiratory Tract John M Nicholls Department of Pathology, Hong Kong University, Hong Kong, Hong Kong  Influenza is a viral infection of the respiratory tract.",Non-OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.1.11  •  Infect Chemother 2013;45(1):1 1-21 www.icjournal.org  13 The first barrier - mucin The mucus that is present in the airways is a mixture of cells,  cellular debris and polypetpides held together by macromo - lecular consituents called mucins that are either in the fluid or  on the surface of cells.",Non-OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.1.11  •  Infect Chemother 2013;45(1):1 1-21 www.icjournal.org  15 however appear to be closely involved in later stages of the in- flammatory response, either through direct activation using the  interferon receptor pathway (see below) or through type I IFN- mediated trans-presentation of IL-15 by dendritic cells (reviewed  by Hwang and colleagues [47]).",Non-OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.1.11  •  Infect Chemother 2013;45(1):1 1-21 www.icjournal.org  17 chemokines CCL2, CCL5 and CD11b+ cells and decrease IFN γ secretion but did not affect IFNα, CCL2, IL6 or TNFα, thus  showing that endothelial cells are able to actually modulate  the inflammatory response [71].",Non-OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
  http://dx.doi.org/10.3947/ic.2013.45.1.11  •  Infect Chemother 2013;45(1):1 1-21 www.icjournal.org  19 of SARS.,OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
  http://dx.doi.org/10.3947/ic.2013.45.1.11  •  Infect Chemother 2013;45(1):1 1-21 www.icjournal.org  21 68.,OADS,/arxiv_data1/oa_pdf/25/8c/ic-45-11.PMC3780943.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.99 Infect Chemother 2013;45(1):99-104 pISSN 2093-2340 · eISSN 2092-6448 Received: July 26, 2012   Revised:  September 13, 2012  Accepted: September 26, 2012 Corresponding Author : Hye-Ryoun Kim  Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of  Radiological and Medical Sciences, 215-4, Gongneung-dong, Nowon-gu, Seoul  139-706, Korea Tel: +82-2-970-1206  Fax: +82-2-970-2438  E-mail: slowly7@kcch.re.kr Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgEndobronchial Mycobacterium avium  Infection in an  Immunocompetent Patient Seung-Hwa Kang1, Se-Kwon M un1, Min-Jae Lee1, So-Yeon Kim1, Hyung-Gyu Choi1, Junsu Byun1, Cheol Hyeon Kim1, Hye-Ryoun Kim1, and Soo Yeon Cho2 Department s of 1Internal Medicine, and 2Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences,  Seoul, Korea Although Mycobacterium avium  complex (MAC) is the most common pathogen in nontuberculous mycobacterial (NTM)  pulmonary diseases, endobronchial lesions caused by MAC infections are very rare even in an immunocompromised host.",Non-OADS,/arxiv_data1/oa_pdf/f8/14/ic-45-99.PMC3780944.pdf
"http://dx.doi.org/10.3947/ic.2013.45.1.99  •  Infect Chemother 2013;45(1):99-1 04 www.icjournal.org  101 clavulanate), but did not show any interval changes on chest  radiography.",Non-OADS,/arxiv_data1/oa_pdf/f8/14/ic-45-99.PMC3780944.pdf
http://dx.doi.org/10.3947/ic.2013.45.1.99  •  Infect Chemother 2013;45(1):99-1 04 www.icjournal.org  103 a combination of these phenotypes.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/ic-45-99.PMC3780944.pdf
"1  Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.1.1 Infect Chemother 2013;45(1):1-10 pISSN 2093-2340 · eISSN 2092-6448 Received: February 9, 2013 Corresponding Author : David M Livermore Innovations Centre, Norwich Medical School, University of East Anglia, Norwich, NR4  7TJ, United Kingdom Tel: +44-(0)1603-597-568  Fax: +44-20-8327-6264 E-mail: d.livermore@uea.ac.uk Copyrights © 2013 by The Korean Society of Infectious Diseases | Korean Society for Chemotherapy www.icjournal.orgRevolutionising Bacteriology to Improve Treatment  Outcomes and Antibiotic Stewardship David M Livermore, and John Wain Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, United Kingdom Laboratory investigation of bacterial infections generally takes two days: one to grow the bacteria and another to identify  them and to test their susceptibility.",Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.1  •  Infect Chemother 2013;45(1):1-1 0 www.icjournal.org  3 resistant Staphylococcus aureus [MRSA] but received ceftriax- one as the hospital’s standard therapy for the clinical syndrome)  [17] or because the particular strain of bacteria had acquired  resistance (e.g.,Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
" http://dx.doi.org/10.3947/ic.2013.45.1.1  •  Infect Chemother 2013;45(1):1-1 0 www.icjournal.org  5 detection tests [46]; alternatively false negative results may arise  if the target gene is altered so that it is no longer recognised, as  happened with Chlamydia in Sweden [47].",Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
"Several, notably the Curetis Unyvero  (http://www.curetis.com), Idaho FilmArray [48] and Luminex  systems seek a few key resistances but aim, primarily, to answer  the question ‘What is the pathogen?’, allowing early refinement  of treatment.",Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.1  •  Infect Chemother 2013;45(1):1-1 0 www.icjournal.org  7 these tests done.,Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
 http://dx.doi.org/10.3947/ic.2013.45.1.1  •  Infect Chemother 2013;45(1):1-1 0 www.icjournal.org  9 procalcitonin in critically ill trauma patients.,Non-OADS,/arxiv_data1/oa_pdf/f3/d9/ic-45-1.PMC3780945.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.211 Infect Chemother 2013;45(2):211-216 pISSN 2093-2340 · eISSN 2092-6448 Received: October 7, 2012   Revised:  January 17, 2013  Accepted: March 14, 2013 Corresponding Author : Woo Joo Kim, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, Korea University  Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu,  Seoul 152-703, Korea  Tel: +82-2-2626-3051  Fax: +82-2-2626-1105 E-mail: wjkim@medimail.co.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/ic-45-211.PMC3780946.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.211  •  Infect Chemother 2013;45(2) :211-216 www.icjournal.org  213 vs. 31%, P = 0.02) were risk factors for depression.",Non-OADS,/arxiv_data1/oa_pdf/13/a4/ic-45-211.PMC3780946.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.211  •  Infect Chemother 2013;45(2) :211-216 www.icjournal.org  215 entation or stage of disease.,Non-OADS,/arxiv_data1/oa_pdf/13/a4/ic-45-211.PMC3780946.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.241 Infect Chemother 2013;45(2):241-243 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Dae Sun Jo, MD, PhD Department of Pediatrics, Chonbuk National University Hospital, 20, Geonji-ro,  Deokjin-gu, Jeonju 561-712, Korea Tel: +82-63-250-1978  Fax: +82-63-250-1464 E-mail: drjo@chonbuk.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/c9/ic-45-241.PMC3780947.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.241  •  Infect Chemother 2013;45(2) :241-243 www.icjournal.org 243 Med  2012;366:2267-75.,Non-OADS,/arxiv_data1/oa_pdf/e4/c9/ic-45-241.PMC3780947.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.145 Infect Chemother 2013;45(2):145-158 pISSN 2093-2340 · eISSN 2092-6448 Received: May 13, 2013 Corresponding Author : Hoan Jong Lee, MD, PhD Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-769, Korea Tel: +82-2-2072-3633, Fax: +82-2-745-4703 E-mail: hoanlee@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  147 effects in terms of effectiveness are limited.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  149 pneumoniae  isolates among 50 clinical isolates from 1974 to  1983 in a single institution were resistant to penicillin [25].,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  151 tant in understanding the serotype replacement phenomenon  following the introduction of the PCV7.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  153 9.6% (35/363) for children aged ≥  5 years.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  155 pected in the future.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.145  •  Infect Chemother 2013;45(2) :145-158 www.icjournal.org  157 JAMA 2006;295:1668-74.,Non-OADS,/arxiv_data1/oa_pdf/e6/e7/ic-45-145.PMC3780948.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.225 Infect Chemother 2013;45(2):225-229 pISSN 2093-2340 · eISSN 2092-6448 Received: March 1, 2013   Revised:  May 23, 2013  Accepted: May 23, 2013 Corresponding Author : Sang-Won Park, MD Department of Internal Medicine, Seoul National University Boramae Medical   Center, 20 Boramae-ro 5-Gil, Dongjak-Gu, Seoul 156-707, Korea Tel: +82-2-870-2224  Fax: +82-2-870-3863  E-mail: hswon1@snu.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/16/ic-45-225.PMC3780949.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.225  •  Infect Chemother 2013;45(2) :225-229 www.icjournal.org  227 was started.,Non-OADS,/arxiv_data1/oa_pdf/8f/16/ic-45-225.PMC3780949.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.225  •  Infect Chemother 2013;45(2) :225-229 www.icjournal.org  229 bacterial therapy, fungal disease was not initially considered.",Non-OADS,/arxiv_data1/oa_pdf/8f/16/ic-45-225.PMC3780949.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.244 Infect Chemother 2013;45(2):244-251 pISSN 2093-2340 · eISSN 2092-6448 Received: April 17, 2013 Corresponding Author :  Jin-Hong Yoo, MD, PhD Division of Infectious Diseases, Department of Internal Medicine, The Catholic  University of Korea College of Medicine, Bucheon St.Mary's Hospital, 2 Sosa- dong, Wonmi-gu, Bucheon 420-717, Korea Tel: +82-1577-0675  Fax: +82-32-340-2669 E-mail: jhyoo@catholic.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
http://dx.doi.org/10.3947/ic.2013.45.2.244  •  Infect Chemother 2013;45(2) :244-251 www.icjournal.org 245,OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.244  •  Infect Chemother 2013;45(2) :244-251 www.icjournal.org  247 disease at university hospitals all over the country.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.244  •  Infect Chemother 2013;45(2) :244-251 www.icjournal.org  249 stantial content but is made for nearly all healthcare profes - sionals.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
7) HIV iChart This app is a smartphone version of HIV-drug interactions  on-line utility in http://www.hiv-druginteractions.org (Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
Supplementary material Supplementary data including two figures can be found  with this article online http://www.icjournal.org/src/sm/ic- 45-244-s001.pdf.,OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.244  •  Infect Chemother 2013;45(2) :244-251 www.icjournal.org  251 References    1.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
http://www.prezi.com.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
http://www.thinkwise.co.kr.,Non-OADS,/arxiv_data1/oa_pdf/93/18/ic-45-244.PMC3780950.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.234 Infect Chemother 2013;45(2):234-238 pISSN 2093-2340 · eISSN 2092-6448 Received:  January 14, 2013   Revised:  April 3, 2013  Accepted: April 6, 2013 Corresponding Author  : Cheol-In Kang, MD Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University  School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-0324  Fax: +82-2-3410-0064 E-mail: collacin@hotmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/7e/ic-45-234.PMC3780951.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.234  •  Infect Chemother 2013;45(2) :234-238 www.icjournal.org  235 non-typhoidal Salmonella  in a patient who was diagnosed  with concomitant lymphoma.,Non-OADS,/arxiv_data1/oa_pdf/7d/7e/ic-45-234.PMC3780951.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.234  •  Infect Chemother 2013;45(2) :234-238 www.icjournal.org  237 tomated microbial analyzing system (Microscan system, gram  negative combo panel type 53, Siemens Healthcare, Sacramen - to, CA, USA) to identify Salmonella  to the genus level.",OADS,/arxiv_data1/oa_pdf/7d/7e/ic-45-234.PMC3780951.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.117 Infect Chemother 2013;45(2):117-136 pISSN 2093-2340 · eISSN 2092-6448 Received: April 16, 2013 Corresponding Author : Keiichi Hiramatsu, MD, PhD Professor of Bacteriology, Department of Bacteriology and Infection Control Sci - ence, Juntendo University, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan  Tel: +81-3-5802-1040, Fax: +81-3-5684-7830 E-mail: khiram06@juntendo.ac.jp This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
The phylogenic tree was drawn by Phylodendron-Phylogenetic tree printer (http://iubio.bio.indiana.edu/treeapp/treeprint-sample1.html).,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  119 Table 1.,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  121 tained among S. aureus  strains as compared to that between  the two S. epidermidis  strains.,Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  123 icillin [46].,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  125 type-VIII SCC mec  elements, whereas it is absent from type-IV  and V SCC mec  elements [69].",Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  127 mecB  has yet to be found in staphylococcal species.,Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
All the used  nucleotide sequences were obtained from GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/).,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
The phylogenetic tree was generated using the neighbor joining  method in the ClustalW program (http://clustalw.ddbj.nig.ac.jp/top-j.html).,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
The tree was visualized in the Phylodendron Web Form (http://iubio.bio.indiana.edu/treeapp/ treeprint-form.html).,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  129 grow even in the presence of 1,024 mg/L of methicillin (Fig.",Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  131 Australia.,Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  133 functions: integrons.,OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.117  •  Infect Chemother 2013;45(2) :117-136 www.icjournal.org  135 of Enterococcus hirae  S185: modular design and structural  organization of the protein.,Non-OADS,/arxiv_data1/oa_pdf/71/b5/ic-45-117.PMC3780952.pdf
"http://dx.doi.org/10.3947/ic.2013.45.2.175 Infect Chemother 2013;45(2):175-183 pISSN 2093-2340 · eISSN 2092-6448 Received: February 5, 2013   Revised:  March 29, 2013  Accepted: March 29, 2013 Corresponding Author : Hyunjoo Pai, MD Department of Internal Medicine, Hanyang University College of Medicine,  232 Wangsimni-ro, Seongdong-gu, Seoul 133-792, Korea Tel: +82-2-2290-8356  Fax: +82-2-2298-9183 E-mail: paihyunjoo@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/7b/ic-45-175.PMC3780953.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.175  •  Infect Chemother 2013;45(2) :175-183 www.icjournal.org  177 Taurocholate agar, Oxoid Ltd., Cambridge, UK) supplemented  with 7% horse blood.",Non-OADS,/arxiv_data1/oa_pdf/28/7b/ic-45-175.PMC3780953.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.175  •  Infect Chemother 2013;45(2) :175-183 www.icjournal.org  179 tween the 2 groups in stool frequency, abdominal pain, and  tenderness.",Non-OADS,/arxiv_data1/oa_pdf/28/7b/ic-45-175.PMC3780953.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.175  •  Infect Chemother 2013;45(2) :175-183 www.icjournal.org  181 strains was determined as the major cause of the increase in  the CDI incidence since 2002 [9].,Non-OADS,/arxiv_data1/oa_pdf/28/7b/ic-45-175.PMC3780953.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.175  •  Infect Chemother 2013;45(2) :175-183 www.icjournal.org  183 27.,Non-OADS,/arxiv_data1/oa_pdf/28/7b/ic-45-175.PMC3780953.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.202 Infect Chemother 2013;45(2):202-210 pISSN 2093-2340 · eISSN 2092-6448 Received: September 3, 2012   Revised:  December 8, 2012  Accepted: December 10, 2012 Corresponding Author : Kyong Ran Peck, MD, PhD  Division of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School  of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82-2-3410-0329  Fax: +82-2-3410-0064  Email: krpeck@skku.edu  Co-Corresponding Author: Sang Moo Lee, MD, PhD  Office of Health Technology Evaluation, National Evidence-based Healthcare  Collaborating Agency, 174 Yulgok-ro, Jongno-gu, Seoul 110-450, Korea  Tel: +82-2-2174-2850  Fax: +82-2-747-4918  Email: lsm@neca.re.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.202  •  Infect Chemother 2013;45(2) :202-210 www.icjournal.org  203 Introduction Staphylococcus aureus  is one of the major causative organ - isms for community- and hospital-acquired infections as  causing invasive diseases, not only in adults but also in neo - nates and children [1].",Non-OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.202  •  Infect Chemother 2013;45(2) :202-210 www.icjournal.org  205 [12, 13, 15, 22-24].",OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.202  •  Infect Chemother 2013;45(2) :202-210 www.icjournal.org  207 tive cohort studies [14, 23] was 3.20 (95% CI: 1.66 to 6.15, P =  0.0005), whereas the pooled OR from the 5 retrospective ones  [12, 13, 15, 22, 24] was 1.60 (95% CI: 0.75 to 3.40, P = 0.22).",Non-OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.202  •  Infect Chemother 2013;45(2) :202-210 www.icjournal.org  209 acquired S. aureucs  infections accounted for mortality in 23  out of 242 patients (9.5%), and at the time of death, all of these  subjects had either bacteremia or catheter-associated infec - tion.",Non-OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
Available at: http://www.ohri.ca/programs/clini - cal_epidemiology/oxford.asp.,Non-OADS,/arxiv_data1/oa_pdf/cf/67/ic-45-202.PMC3780954.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.239 Infect Chemother 2013;45(2):239-240 pISSN 2093-2340 · eISSN 2092-6448 Corresponding Author : Jun Yong Choi, MD, PhD Department of Internal Medicine, Yonsei University College of Medicine,   50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-1974, Fax: +82-2-393-6884 Email: seran@yuhs.ac This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/81/ic-45-239.PMC3780955.pdf
Available at: http://www.europeanaidsclinicalsociety.org/ index.php?option=com_content&view=article&id=59&Ite mid=41.,Non-OADS,/arxiv_data1/oa_pdf/ef/81/ic-45-239.PMC3780955.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.159 Infect Chemother 2013;45(2):159-174 pISSN 2093-2340 · eISSN 2092-6448 Received: May 30, 2013 Corresponding Author : Theodore F Tsai, MD, MPH Novartis Vaccines and Diagnostics Inc., 350 Massachusetts Ave, Cambridge,   MA 02139 USA.",Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
"Tel: +1-617-871-8052  Fax: +1-510-597-5851 E-mail: theodore.tsai@novartis.com  This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  161 older adults to IIV are lower when compared with responses  in younger adults [8-10].,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  163 this age group is the loss of mobility and ability for indepen - dent living in survivors of the illness [27-29].,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
"Age-specific hospitalizations for influenza-related illness, US,  by week, 2012-13 season (http://www.cdc.gov/flu/weekly/).Age group 0-4 yr 5-17 yr 18-49 yr 50-64 yr 65+ yr WeekRates per 100,000 population Figure 7.",Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
"Influenza-related hospitalizatons, US, 2012-13 season by age group and underlying medical condition (http://www.cdc.gov/ flu/weekly/).",Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  165 hospitalizations (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  167 generalized muscular pain.,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  169 70].,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  171 Available at: http://www.stat.go.jp/english/data/hand - book/.,OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
Available at: http://www.vch.ca/your_health/ health_topics/communicable_diseases/for_health_pro - fessionals/physician_updates/physicians__update/.,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
Available at: http://www.cdc.gov/flu/weekly/.,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.159  •  Infect Chemother 2013;45(2) :159-174 www.icjournal.org  173 nation in elderly subjects in northern Italy.,Non-OADS,/arxiv_data1/oa_pdf/ae/fe/ic-45-159.PMC3780956.pdf
"http://dx.doi.org/10.3947/ic.2013.45.2.184 Infect Chemother 2013;45(2):184-193 pISSN 2093-2340 · eISSN 2092-6448 Received: November 10, 2012   Revised:  March 5, 2013  Accepted: March 7, 2013 Corresponding Author : Jae-Yeon Jang, PhD Department of Preventive Medicine and Public Health, Ajou University School of  Medicine, 164 World Cup-ro, Youngtong-gu, Suwon, Korea  Tel: +82-31-219-5293  Fax: +82-31-219-5084 E-mail: free5293@gmail.com This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.184  •  Infect Chemother 2013;45(2) :184-193 www.icjournal.org  185 Introduction Malaria is a mosquito‐borne infectious disease of humans  and other animals caused by a parasite of the genus Plasmo - dium  [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.184  •  Infect Chemother 2013;45(2) :184-193 www.icjournal.org  187 malaria in an at-risk region).,Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.184  •  Infect Chemother 2013;45(2) :184-193 www.icjournal.org  189 10.5 days (SD = 7.9 days) for long incubation period cases,  about 1.7 days longer than the 8.8 days (SD = 6.7 days) for  short incubation period cases ( P = 0.0012).",Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.184  •  Infect Chemother 2013;45(2) :184-193 www.icjournal.org  191 tigation of civilians [15].,Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.184  •  Infect Chemother 2013;45(2) :184-193 www.icjournal.org  193 climate change.,Non-OADS,/arxiv_data1/oa_pdf/cb/79/ic-45-184.PMC3780957.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.217 Infect Chemother 2013;45(2):217-224 pISSN 2093-2340 · eISSN 2092-6448 Received: January 25, 2013   Revised:  February 21, 2013  Accepted: February 21, 2013 Corresponding Author : Hee Jin Cheong, MD, PhD Division of Infectious Diseases, Department of Internal Medicine,   Korea University Guro Hospital, Korea University College of Medicine,   148 Gurodong-ro, Guro-gu, Seoul 152-703, Korea  Tel: +82-2-2626-3050  Fax: +82-2-2626-1105 E-mail: heejinmd@medimail.co.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/82/ic-45-217.PMC3780958.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.217  •  Infect Chemother 2013;45(2) :217-224 www.icjournal.org  219 2.,Non-OADS,/arxiv_data1/oa_pdf/17/82/ic-45-217.PMC3780958.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.217  •  Infect Chemother 2013;45(2) :217-224 www.icjournal.org  221 pertussis ( P = 0.02), and awareness of the necessity of Tdap  vaccination for adults ( P < 0.01) (Table 6).",Non-OADS,/arxiv_data1/oa_pdf/17/82/ic-45-217.PMC3780958.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.217  •  Infect Chemother 2013;45(2) :217-224 www.icjournal.org  223 bearing age are necessary before and after pregnancy.,Non-OADS,/arxiv_data1/oa_pdf/17/82/ic-45-217.PMC3780958.pdf
Supplementary material Supplementary data regarding one questionnaire of survey  can be found with this article online http://www.icjournal.,Non-OADS,/arxiv_data1/oa_pdf/17/82/ic-45-217.PMC3780958.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.137 Infect Chemother 2013;45(2):137-144 pISSN 2093-2340 · eISSN 2092-6448 Received: June 5, 2013 Corresponding Author : Min Ja Kim, MD, PhD Department of Internal Medicine, Korea University College of Medicine,   126-1, 5Ga, Anam-dong, Seongbuk-Gu, Seoul 136-705, Korea Tel: +82-2-920-5685, Fax: +82-2-920-5616 E-mail: macropha@korea.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/81/ic-45-137.PMC3780959.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.137  •  Infect Chemother 2013;45(2) :137-144 www.icjournal.org  139 the mid 1980s through the late 1990s by Korean research insti - tutions.,OADS,/arxiv_data1/oa_pdf/2f/81/ic-45-137.PMC3780959.pdf
"Current status and future challenges According to the data of the National Notifiable Disease Sur - veillance System from the Korea Centers for Disease Control  and Prevention (KCDC) (http://is.cdc.go.kr/nstat) [42], the in - cidence of leptospirosis dramatically decreased between 1991",Non-OADS,/arxiv_data1/oa_pdf/2f/81/ic-45-137.PMC3780959.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.137  •  Infect Chemother 2013;45(2) :137-144 www.icjournal.org  141 and 1997 (average annual incidence, 0.02/100,000 popula - tion) even in the endemic areas, but has increased since then.",Non-OADS,/arxiv_data1/oa_pdf/2f/81/ic-45-137.PMC3780959.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.137  •  Infect Chemother 2013;45(2) :137-144 www.icjournal.org  143 CRC Press Inc.; 1994;121-44.,Non-OADS,/arxiv_data1/oa_pdf/2f/81/ic-45-137.PMC3780959.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.230 Infect Chemother 2013;45(2):230-233 pISSN 2093-2340 · eISSN 2092-6448 Received:  February 15, 2013   Revised:  May 15, 2013  Accepted: May 20, 2013 Corresponding Author :  Jin-Soo Lee, MD Department of Internal Medicine, Inha University Hospital,   27 Inhang-ro, Jung-Gu, Incheon, 400-711, Korea Tel: +82-32-890-3616  Fax: +82-32-882-6578 E-mail: ljinsoo@inha.ac.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/10/ic-45-230.PMC3780960.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.230  •  Infect Chemother 2013;45(2) :230-233 www.icjournal.org  231 tient's vital signs at admission were as follows: temperature of  38.2°C, blood pressure of 126/70 mmHg, pulse rate of 124  beats/min, and a respiratory rate of 20 breaths/min.",Non-OADS,/arxiv_data1/oa_pdf/15/10/ic-45-230.PMC3780960.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.230  •  Infect Chemother 2013;45(2) :230-233 www.icjournal.org  233 phy for patients with fever of unknown origin.,Non-OADS,/arxiv_data1/oa_pdf/15/10/ic-45-230.PMC3780960.pdf
"Infection &  Chemotherapyhttp://dx.doi.org/10.3947/ic.2013.45.2.194 Infect Chemother 2013;45(2):194-201 pISSN 2093-2340 · eISSN 2092-6448 Received: September 26, 2012   Revised:  January 12, 2013  Accepted: January 16, 2013 Corresponding Author : Heungjeong Woo, MD  Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital  40, Seokwoo-dong, Hwaseong 445-170, Korea Tel: +82-31-8086-2385  Fax: +82-31-8086-2709 Email: infwoo@hallym.or.kr This i s an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/e7/ic-45-194.PMC3780961.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.194  •  Infect Chemother 2013;45(2) :194-201 www.icjournal.org  195 Introduction The mortality of severe burn patients has been reduced rapid - ly since the pathophysiologic mechanism has been established  followed by the availability of effective treatments, yet infections  are the leading cause of death among burn patients [1, 2].",Non-OADS,/arxiv_data1/oa_pdf/df/e7/ic-45-194.PMC3780961.pdf
"  http://dx.doi.org/10.3947/ic.2013.45.2.194  •  Infect Chemother 2013;45(2) :194-201 www.icjournal.org  197 microorganism, and the difference in each mean number of  days was statistically significant ( P = 0.047).",OADS,/arxiv_data1/oa_pdf/df/e7/ic-45-194.PMC3780961.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.194  •  Infect Chemother 2013;45(2) :194-201 www.icjournal.org  199 to 3.2).,Non-OADS,/arxiv_data1/oa_pdf/df/e7/ic-45-194.PMC3780961.pdf
  http://dx.doi.org/10.3947/ic.2013.45.2.194  •  Infect Chemother 2013;45(2) :194-201 www.icjournal.org  201   7.,Non-OADS,/arxiv_data1/oa_pdf/df/e7/ic-45-194.PMC3780961.pdf
"In 1907 he was awarded a DSc for his submis- sion Statistical Studies in Immunity and Incubation PeriodThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/26/dyt067.PMC3780995.pdf
"It should be noted that though our focus is on time series regression, other tools for the analysis of timeThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/78/dyt092.PMC3780998.pdf
"We replicated one CpG site in the promoter of the WDR85 gene in an independent sample ofThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/57/dyt094.PMC3781000.pdf
"7–11This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/1e/dyt115.PMC3781004.pdf
"J Interact Technol Pedagogy 2012; available at http://jitp.commons.gc.cuny.edu/philosophy-through-the- macroscope-technologies-representations-and-the-history-of-the-profession/ (27 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/03/1e/dyt115.PMC3781004.pdf
"14Lexis W. Einleitung in die Theorie der Bevo ¨lkerungsstatistik [Introduction to the theory of population statistics], 1875; available at http://www.worldcat.org/title/einlei- tung-in-die-theorie-der-bevolkerungsstatistik/oclc/27127671 (27 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/03/1e/dyt115.PMC3781004.pdf
"Vienna, Austria: R Foundation for Statistical Computing, 2011; http://www.r-project.org/ (27 June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/03/1e/dyt115.PMC3781004.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 06/19/13; Accepted: 06/19/13http://dx.doi.org/10.4161/epi.25559proteins may lead to the development  of new approaches to intersect with the functionality of this family of chromatin remodeling proteins to correct associated pathogenesis.,Non-OADS,/arxiv_data1/oa_pdf/64/86/epi-8-677.PMC3781185.pdf
"www.landesbioscience.com Epigenetics 679Epigenetics 8:7, 679–684; July 2013; © 2013 Landes Bioscience AutophA gic punctum point-of-ViE w Keywords:  5-methylcytosine, DNA  demethylation, reprogramming, Gadd45,  Ing1, H3K4me3 Submitted: 04/03/13Revised: 05/07/13Accepted: 05/08/13 http://dx.doi.org/10.4161/epi.24977 Correspondence to: Lars Schomacher;   Email: l.schomacher@imb-mainz.deDNA cytosine methylation is a revers - ible epigenetic mark regulating gene  expression.",Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Proc Natl Acad Sci U S A 2006; 103:6853-8; PMID:16624880; http://dx.doi.org/10.1073/ pnas.0601109103 18.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
J Am Chem Soc 2006; 128:12510- 9; PMID:16984202; http://dx.doi.org/10.1021/ja0634829 19.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
DNA  Repair (Amst) 2007; 6:489-504; PMID:17116428; http://dx.doi.org/10.1016/j.dnarep.2006.10.013 20.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nucleic Acids Res 2000; 28:4157-65;  PMID:11058112; http://dx.doi.org/10.1093/ nar/28.21.4157 21.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2010; 463:1101-5; PMID:20098412; http://dx.doi.org/10.1038/ nature08829 23.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
FASEB J 2013; 27:1107-13;  PMID:23212122; http://dx.doi.org/10.1096/fj.12- 222125 25.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
EMBO J 2010; 29:1877- 88; PMID:20442707; http://dx.doi.org/10.1038/ emboj.2010.80 26.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2007; 445:671-5; PMID:17268471; http://dx.doi.org/10.1038/ nature05515 28.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Mol Cell 2009; 33:344-53;  PMID:19217408; http://dx.doi.org/10.1016/j.mol - cel.2009.01.015 29.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Mol Cell 2012; 47:622-32; PMID:22771116; http://dx.doi.org/10.1016/j.mol - cel.2012.05.050References 1.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2001; 293:1068-70; PMID:11498573; http://dx.doi.org/10.1126/sci - ence.1063852 4.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
J Biol Chem 2004; 279:48350-9; PMID:15339928; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Curr Biol  2000; 10:475-8; PMID:10801417; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Mech Dev 2002; 117:15-23;  PMID:12204247; http://dx.doi.org/10.1016/S0925- 4773(02)00181-8 8.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2008; 452:45-50; PMID:18322525; http://dx.doi.org/10.1038/nature06544 10.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2007; 131:861-72; PMID:18035408;  http://dx.doi.org/10.1016/j.cell.2007.11.019 11.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2006; 126:663- 76; PMID:16904174; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nat Rev Genet 2010; 11:204-20;  PMID:20142834; http://dx.doi.org/10.1038/ nrg2719 13.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nat Rev Mol Cell Biol  2010; 11:607-20; PMID:20683471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2010; 463:554-8; PMID:20054296; http://dx.doi.org/10.1038/ nature08732 15.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Proc Natl Acad Sci U S A 2006; 103:11796-801; PMID:16864782; http://dx.doi.org/10.1073/ pnas.0603563103 16.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2006; 124:495- 506; PMID:16469697; http://dx.doi.org/10.1016/j.cell.2005.12.034for DNA demethylation via Ing1 and  Gadd45a ( Fig.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Epigenetics 2009; 4:98-9; PMID:19229137; http://dx.doi.org/10.4161/ epi.4.2.7858 60.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
PLoS Genet 2008;  4:e1000013; PMID:18369439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2009; 323:1074- 7; PMID:19119186; http://dx.doi.org/10.1126/sci - ence.1166859 63.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2008; 135:1201-12; PMID:19109892;  http://dx.doi.org/10.1016/j.cell.2008.11.042 64.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2011; 146:67- 79; PMID:21722948; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2001; 293:1074-80; PMID:11498575;  http://dx.doi.org/10.1126/science.1063127 66.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Genome Res 2007; 17:691- 707; PMID:17567990; http://dx.doi.org/10.1101/ gr.5704207 67.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Genes Dev  2013; 27:261-73; PMID:23388825; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2005; 121:859-72; PMID:15960974; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2013; 152:1146-59; PMID:23434322; http://dx.doi.org/10.1016/j.cell.2013.02.00444.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
PLoS One  2012; 7:e43279; PMID:22916236; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2011; 477:606- 10; PMID:21892189; http://dx.doi.org/10.1038/ nature10443 47.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Proc Natl Acad Sci U S A 2011; 108:3642-7; PMID:21321204; http://dx.doi.org/10.1073/ pnas.1014033108 48.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2011; 334:194; PMID:21940858;  http://dx.doi.org/10.1126/science.1212483 50.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Chemistry 2011; 17:13782-8;  PMID:22069110; http://dx.doi.org/10.1002/ chem.201102782 51.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2013; 339:448-52; PMID:23223451; http://dx.doi.org/10.1126/sci - ence.1229277 52.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Biochim Biophys Acta 2005; 1723:256-64; PMID:15794921; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Differentiation 2009; 77:1-11;  PMID:19281759; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Trends Cell Biol  2012; 22:220-7; PMID:22341196; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
PLoS One 2011; 6:e14500; PMID:21249130; http://dx.doi.org/10.1371/journal.pone.0014500 57.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Oncogene 2002; 21:6228-33; PMID:12214253; http://dx.doi.org/10.1038/ sj.onc.120577430.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Mol Cell 2010; 38:54-66; PMID:20385089;  http://dx.doi.org/10.1016/j.molcel.2010.03.004 31.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science 2009; 324:929-30; PMID:19372393; http://dx.doi.org/10.1126/sci - ence.1169786 32.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science  2009; 324:930-5; PMID:19372391; http://dx.doi.org/10.1126/science.1170116 33.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2010; 466:1129- 33; PMID:20639862; http://dx.doi.org/10.1038/ nature09303 34.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science  2011; 333:1303-7; PMID:21817016; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Science  2011; 333:1300-3; PMID:21778364; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell Res  2011; 21:1670-6; PMID:22124233; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Angew Chem Int Ed Engl 2011; 50:7008-12; PMID:21721093;  http://dx.doi.org/10.1002/anie.201103899 38.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
J Biol Chem 2011; 286:35334-8; PMID:21862836; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nature 2011; 470:419-23; PMID:21278727;  http://dx.doi.org/10.1038/nature09672 40.,Non-OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2013; 153:692-706;  PMID:23602152; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Cell 2013;  153: 678-91; PMID :23602153 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
Nat Chem Biol 2012; 8:751-8; PMID:22772155; http://dx.doi.org/10.1038/nchem - bio.1042,OADS,/arxiv_data1/oa_pdf/35/1e/epi-8-679.PMC3781186.pdf
"1,2 Transplantation was the last component to  *Correspondence to: Carlos López-Larrea; Email: inmuno@hca.es Submitted: 04/09/13; Revised: 05/17/13; Accepted: 05/28/13http://dx.doi.org/10.4161/epi.25201Great efforts in the field of solid organ transplantation are being  devoted to identifying biomarkers that allow a transplanted patient’s immune status to be established.",Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenomics 2011; 3:697- 713; PMID:22126290; http://dx.doi.org/10.2217/ epi.11.99 2.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T rends Genet  2012; 28:506-14; PMID:22824525; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ranspl Immunol 2010; 23:104-10; PMID:20471480; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ransplantation 2012; 94:1-7; PMID:22437848;  http://dx.doi.org/10.1097/TP .0b013e31824db9bd5.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
PLoS One 2013; 8:e56931; PMID:23451113;  http://dx.doi.org/10.1371/journal.pone.0056931 6.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Adv Genet 2010; 70:27-56; PMID:20920744; http://dx.doi.org/10.1016/B978-0-12-380866-0.60002-2 7.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Cell Res 2011; 21:381- 95; PMID:21321607; http://dx.doi.org/10.1038/cr.2011.22,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity 2009; 30:646- 55; PMID:19464987; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Eur J Immunol  2011; 41:936-51; PMID:21381020; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T rends Immunol  2013; 34:107-13; PMID:23228885; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Am J T ransplant  2011; 11:2162-72; PMID:21749644; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Sci  Signal 2012; 5:ra45; PMID:22715468; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Cell Cycle  2012; 11:3351-2; PMID:22918251; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin  Organ T ransplant 2009; 14:643-9; PMID:19779342;  http://dx.doi.org/10.1097/MOT.0b013e328332bd4a 49.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Rev Immunol  2012; 12:306-15; PMID:22421787; http://dx.doi.org/10.1038/nri3173 50.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood 2011; 117:2839-46;  PMID:21228329; http://dx.doi.org/10.1182/blood- 2010-06-293027 51.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Chromosome Res 2009; 17:485-96;  PMID:19521787; http://dx.doi.org/10.1007/s10577- 009-9040-3 25.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunology 2009; 126:299- 305; PMID:19178593; http://dx.doi.org/10.1111/ j.1365-2567.2008.03026.x 26.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nature  2012; 487:249-53; PMID:22763435; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood 2013; 121:2402-14;  PMID:23325835; http://dx.doi.org/10.1182/blood- 2012-09-378653 28.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity 2012; 37:785-99;  PMID:23123060; http://dx.doi.org/10.1016/j.immu- ni.2012.09.010 29.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
J Exp Med 2008; 205:3133-44; PMID:19047438; http://dx.doi.org/10.1084/ jem.20081937 30.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin Organ T ransplant  2010; 15:411-5; PMID:20613526; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr  Opin Immunol 2011; 23:648-54; PMID:21752619;  http://dx.doi.org/10.1016/j.coi.2011.06.005 32.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
J Immunol 2011; 187:5615- 26; PMID:22048764; http://dx.doi.org/10.4049/jim- munol.1101058 33.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity  2009; 30:616-25; PMID:19464984; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood 2010; 115:965-74; PMID:19996091; http://dx.doi.org/10.1182/blood- 2009-02-207118 37.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunology 2011; 134:235-45; PMID:21977994;  http://dx.doi.org/10.1111/j.1365-2567.2011.03483.x8.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nature 2012; 489:57-74; PMID:22955616;  http://dx.doi.org/10.1038/nature11247 9.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenomics 2012; 4:317-24; PMID:22690667; http://dx.doi.org/10.2217/ epi.12.18 10.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Biotechnol  2012; 30:224-6; PMID:22398613; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nature 2007; 449:419-26; PMID:17898760;  http://dx.doi.org/10.1038/nature06175 13.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenetics 2011; 6:45-51; PMID:20818162;  http://dx.doi.org/10.4161/epi.6.1.13314 14.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ransplant Res 2012; 1:13; PMID:23369513;  http://dx.doi.org/10.1186/2047-1440-1-13 16.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Exp Hematol 2012; 40:783- 91; PMID:22728031; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Clin  Cancer Res 2007; 13:3933-41; PMID:17606727;  http://dx.doi.org/10.1158/1078-0432.CCR-06-2903 18.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Cell Immunol  2008; 253:54-8; PMID:18522857; http://dx.doi.org/10.1016/j.cellimm.2008.04.016 19.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Immunol 2009; 10:92-100;  PMID:19011628; http://dx.doi.org/10.1038/ni.1673 20.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Clin Dev Immunol 2012; 2012:925135; PMID:22474485; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Rev Immunol  2009; 9:91-105; PMID:19151746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity  2009; 30:155-67; PMID:19144320; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Immunol 2007; 8:732-42;  PMID:17546033; http://dx.doi.org/10.1038/ni1474,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Rev Genet  2012; 13:679-92; PMID:22945394; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ransplant Proc  2005; 37:2354-9; PMID:15964415; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ranspl Immunol  2009; 21:198-202; PMID:19409992; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Rev Immunol 2012; 12:417- 30; PMID:22627860; http://dx.doi.org/10.1038/nri3227 89.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Front Immunol 2012; 3:184; PMID:22811678; http://dx.doi.org/10.3389/ fimmu.2012.00184 90.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity 2013; 38:414-23; PMID:23521883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin Organ T ransplant 2013;  18:51-8; PMID:23254705; http://dx.doi.org/10.1097/ MOT.0b013e32835c5016 92.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nature 2010; 468:1119- 23; PMID:21068722; http://dx.doi.org/10.1038/ nature09589 94.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenetics 2012;  7:344-9; PMID:22419066; http://dx.doi.org/10.4161/ epi.19509 95.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenomics 2012; 4:459-67; PMID:22920184;  http://dx.doi.org/10.2217/epi.12.36 96.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Immunol 2004; 5:1069-77;  PMID:15361869; http://dx.doi.org/10.1038/ni1119 69.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood  2008; 112:1673-82; PMID:18552207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood  2011; 118:3559-69; PMID:21828137; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Reproduction  2011; 142:621-32; PMID:21911441; http://dx.doi.org/10.1530/REP-11-0148 73.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Mol Cell Biol 2009; 29:1421- 31; PMID:19124609; http://dx.doi.org/10.1128/ MCB.01158-08 75.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Genome  Med 2011; 3:37; PMID:21658299; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nat Rev Nephrol 2010; 6:614-28;  PMID:20736923; http://dx.doi.org/10.1038/nrne- ph.2010.113 77.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
T ransplantation 2013; 95:148- 54; PMID:23222918; http://dx.doi.org/10.1097/ TP .0b013e3182789a24 78.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin Organ T ransplant 2013; 18:1-5; PMID:23283248; http://dx.doi.org/10.1097/ MOT.0b013e32835c8025 79.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Am J T ransplant  2012; 12:2710-8; PMID:23009139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Am J T ransplant 2012; 12:1370-7;  PMID:22486792; http://dx.doi.org/10.1111/j.1600- 6143.2012.04035.x 81.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Am  J T ransplant 2011; 11:1916-26; PMID:21827613;  http://dx.doi.org/10.1111/j.1600-6143.2011.03638.x53.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunity  2011; 35:400-12; PMID:21943489; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin HIV AIDS  2012; 7:50-7; PMID:22134341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
J Innate Immun  2011; 3:395-402; PMID:21411978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
FEBS Lett 2007; 581:1317- 22; PMID:17349632; http://dx.doi.org/10.1016/j.feb- slet.2007.02.045 57.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Int J Cancer 2011; 128:2911-22; PMID:20960460; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Blood 2009; 114:3422-30;  PMID:19628706; http://dx.doi.org/10.1182/blood- 2009-01-200170 59.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenetics 2013;  8:66-78; PMID:23235109; http://dx.doi.org/10.4161/ epi.23115 60.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
J Clin Invest 2010; 120:1836-47; PMID:20501946; http://dx.doi.org/10.1172/JCI39933 62.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Curr Opin Immunol 2010; 22:177-84; PMID:20207529; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Immunol Res 2011; 50:105-12;  PMID:21717070; http://dx.doi.org/10.1007/s12026- 011-8225-y 64.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Epigenetics 2009; 4:462-8; PMID:19875937;  http://dx.doi.org/10.4161/epi.4.7.10052 65.,Non-OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
Nucleic Acids Res 2012; 40:11339- 51; PMID:23074194; http://dx.doi.org/10.1093/nar/ gks957 66.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
EMBO J  2011; 30:2388-404; PMID:21552207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/da/epi-8-694.PMC3781188.pdf
"www.landesbioscience.com Epigenetics 703Epigenetics 8:7, 703–709; July 2013; © 2013 Landes Bioscience REsEaR ch papER REsEaR ch papER *Correspondence to: Santosh K. Ghosh; Email: skg12@case.edu; Aaron Weinberg; Email: axw47@case.edu Submitted: 01/23/13; Revised: 05/06/13; Accepted: 05/13/13http://dx.doi.org/10.4161/epi.25028Introduction The oral epithelium, the most abundant structural tissue lining  the oral mucosa, is an important line of defense against infec - tious microorganisms.",Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Oral Surg Oral Med Oral Pathol Oral  Radiol Endod 2000; 89:299-304; PMID:10710453;  http://dx.doi.org/10.1016/S1079-2104(00)70092-8 2.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Lancet  2001; 357:1411-2; PMID:11356441; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Oral Surg Oral  Med Oral Pathol Oral Radiol Endod 2001; 92:623-8; PMID:11740479; http://dx.doi.org/10.1067/ moe.2001.118902 4.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
J Oral Pathol Med  2010; 39:397-406; PMID:20202089; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Oral Dis 2001; 7:205-10; PMID:11575869;  http://dx.doi.org/10.1034/j.1601-0825.2001.70401.x 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Adv Dent Res 2006; 19:57-62; PMID:16672551;  http://dx.doi.org/10.1177/154407370601900112 8.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Front Biosci 2009; 14:1785-92;  PMID:19273162; http://dx.doi.org/10.2741/3340 10.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Lancet Oncol 2009; 10:61-71; PMID:19111246; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Clin Cancer Res  2007; 13:5183-94; PMID:17785575; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Cancer Res 2007; 67:1221-7; PMID:17283158; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3377 14.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Cancer Res  2007; 67:10920-8; PMID:18006837; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Annu Rev Genomics Hum Genet 2004; 5:479-510; PMID:15485357; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Clin Exp Metastasis 1998; 16:471-9; PMID:10091942;  http://dx.doi.org/10.1023/A:1006589626307 17.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Curr Opin Neurol 2001; 14:171-6; PMID:11262731;  http://dx.doi.org/10.1097/00019052-200104000- 0000618.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Am J Pathol 2003; 163:1911-9;  PMID:14578190; http://dx.doi.org/10.1016/S0002- 9440(10)63549-3 19.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Nat Rev Genet 2005; 6:597-610; PMID:16136652;  http://dx.doi.org/10.1038/nrg1655 21.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
N Engl J Med 2008; 358:1148-59; PMID:18337604; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Lancet Neurol 2009; 8:1056-72;  PMID:19833297; http://dx.doi.org/10.1016/S1474- 4422(09)70262-5 23.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Med Hypotheses 2009; 73:770- 80; PMID:19501473; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Adv Nutr 2010; 1:8- 16; PMID:22043447; http://dx.doi.org/10.3945/ an.110.1004 26.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Annu Rev Biochem 2005; 74:481-514;  PMID:15952895; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Nat Rev Genet  2008; 9:465-76; PMID:18463664; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
J Biol Chem  2010; 285:36523-31; PMID:20847052; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Infect  Immun 2011; 79:4578-87; PMID:21911466; http://dx.doi.org/10.1128/IAI.05586-11 47.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Science 1998; 280:599- 602; PMID:9554853; http://dx.doi.org/10.1126/sci- ence.280.5363.599 49.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Cell Res 2005; 15:11- 8; PMID:15686620; http://dx.doi.org/10.1038/ sj.cr.7290257 50.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Clin Chem 2007; 53:757- 65; PMID:17317882; http://dx.doi.org/10.1373/ clinchem.2006.08143037.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Genes Dev 1999; 13:26- 34; PMID:9887097; http://dx.doi.org/10.1101/ gad.13.1.26 38.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Science 2001; 293:1089- 93; PMID:11498579; http://dx.doi.org/10.1126/sci- ence.1063443 39.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Nat  Genet 2007; 39:61-9; PMID:17128275; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Genes Dev 1996; 10:1991-2002; PMID:8769643;  http://dx.doi.org/10.1101/gad.10.16.1991 41.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Nat Genet  2007; 39:391-6; PMID:17322882; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Cell  2001; 104:829-38; PMID:11290321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Mucosal Immunol 2011; 4:409-19; PMID:21248725; http://dx.doi.org/10.1038/mi.2010.83 44.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Infect Immun 2000; 68:2907- 15; PMID:10768988; http://dx.doi.org/10.1128/ IAI.68.5.2907-2915.200028.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Bioessays 1998; 20:615-26; PMID:9780836;  http://dx.doi.org/10.1002/(SICI)1521- 1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H 30.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
J Oral Sci 2011; 53:1-13; PMID:21467809;  http://dx.doi.org/10.2334/josnusd.53.1 31.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Proc Natl Acad Sci U S A 1997; 94:448- 52; PMID:9012803; http://dx.doi.org/10.1073/ pnas.94.2.448 32.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Mol  Cell Biol 2003; 23:543-54; PMID:12509453; http://dx.doi.org/10.1128/MCB.23.2.543-554.2003 33.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
J Biol Chem 1999; 274:35381-7; PMID:10585406;  http://dx.doi.org/10.1074/jbc.274.50.35381 34.,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
J Exp Med 1997; 185:953-61; PMID:9120401;  http://dx.doi.org/10.1084/jem.185.5.953 35.,Non-OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
Biochem Biophys  Res Commun 2003; 310:529-36; PMID:14521942;  http://dx.doi.org/10.1016/j.bbrc.2003.09.043,OADS,/arxiv_data1/oa_pdf/eb/b6/epi-8-703.PMC3781189.pdf
"Nat Med 2012; 18:1217-23; http://dx.doi.org/10.1038/nm.2843.Keywords:  endothelial surface layer,  glycocalyx, sepsis, acute lung injury,  acute respiratory distress syndrome, pul - monary edema, nitric oxide, cGMP Abbreviations:  ESL, endothelial surface  layer; ALI, acute lung injury; ARDS,  acute respiratory distress syndrome; GAG, glycosaminoglycan; NO, nitric oxide; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhe - sion molecule-1; Kf, filtration coefficient; EBD, Evans Blue Dye; cGMP, cyclic guanosine monophosphate; V T, tidal  volume; eNOS, endothelial nitric oxide synthase Submitted: 11/28/12Revised: 12/27/12Accepted: 01/04/13Citation: Yang Y, Schmidt P. The endo - thelial glycocalyx: An important regula - tor of the pulmonary vascular barrier.",Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Tissue Barriers 2013; 1:e23494; http://dx.doi.org/10.4161/tisb.23494 *Correspondence to: Eric P .,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
J Clin Invest 2012;  122:2731-40; PMID:22850883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Physiol Rev 2006;  86:279-367; PMID:16371600; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Physiology (Bethesda) 2011; 26:334-47;  PMID:22013192; http://dx.doi.org/10.1152/physi - ol.00011.2011.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Annu Rev Biomed Eng 2007; 9:121-67; PMID:17373886; http://dx.doi.org/10.1146/ annurev.bioeng.9.060906.151959.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Circ Res 2008; 102:770- 6; PMID:18258858; http://dx.doi.org/10.1161/ CIRCRESAHA.107.160226.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Circ Res  2009; 104:1313-7; PMID:19423849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Pflugers Arch 2000; 440:653- 66; PMID:11007304; http://dx.doi.org/10.1007/ s004240000307.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Blood 2010; 116:1924-31; PMID:20530797; http://dx.doi.org/10.1182/blood-2010-01-266072.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Microcirculation 2005; 12:17-31; PMID:15804971;  http://dx.doi.org/10.1080/10739680590894993.12.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Arch Immunol Ther Exp (Warsz) 2010; 58:45-56; PMID:20049646;  http://dx.doi.org/10.1007/s00005-009-0061-6.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Circ Res  2003; 93:e136-42; PMID:14563712; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Am J Physiol Lung Cell Mol Physiol 2008;  295:L1056-65; PMID:18849438; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Nat Med 2012; 18:1217- 23; PMID:22820644; http://dx.doi.org/10.1038/ nm.2843.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Biophys  J 2003; 85:637-45; PMID:12829517; http://dx.doi.org/10.1016/S0006-3495(03)74507-X.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Am J Physiol Lung Cell Mol Physiol 2007; 293:L328-35; PMID:17483194;  http://dx.doi.org/10.1152/ajplung.00390.2006.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Shock 2008; 30:623- 7; PMID:18497712; http://dx.doi.org/10.1097/ SHK.0b013e3181777da3.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Nat Immunol 2005; 6:902- 10; PMID:16056228; http://dx.doi.org/10.1038/ni1233.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
J Clin Invest 1997; 99:526- 33; PMID:9022088; http://dx.doi.org/10.1172/ JCI119189.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Nat Rev Immunol 2006; 6:633-43; PMID:16917509; http://dx.doi.org/10.1038/ nri1918.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Arthritis Rheum 2005; 52:2331-42;  PMID:16052590; http://dx.doi.org/10.1002/ art.21222.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Anesthesiology 2007; 107:776- 84; PMID:18073553; http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
J Pathol 2012; 226:562- 74; PMID:22102407; http://dx.doi.org/10.1002/ path.3964.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Am J Physiol Lung Cell Mol Physiol 2007; 292:L1452-8; PMID:17351062; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
J  Biol Chem 2004; 279:42732-41; PMID:15292174;  http://dx.doi.org/10.1074/jbc.M405382200.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Crit Care Med 2008; 36:2973-9; PMID:18824906; http://dx.doi.org/10.1097/ CCM.0b013e31818b8c6b.37.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Circ Res 2005;  96:488-500; PMID:15774861; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
N Engl J Med 2006; 354:2564-75; PMID:16714767; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
FASEB  J 2006; 20:9-22; PMID:16394262; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Am  J Physiol Lung Cell Mol Physiol 2012; 302:L816- 28; PMID:22160307; http://dx.doi.org/10.1152/ ajplung.00080.2011.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Am J  Physiol Lung Cell Mol Physiol 2012; 302:L1067- 77; PMID:22387293; http://dx.doi.org/10.1152/ajplung.00190.2011.,Non-OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Biochem Biophys  Res Commun 2007; 355:228-33; PMID:17291452;  http://dx.doi.org/10.1016/j.bbrc.2007.01.137.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
Free Radic Biol Med 2009; 47:600-7;  PMID:19500664; http://dx.doi.org/10.1016/j.fre - eradbiomed.2009.05.034.,OADS,/arxiv_data1/oa_pdf/87/e1/tisb-1-e23494.PMC3781215.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Dysphagia in Head and Neck Cancer Patients:   Pretreatment Evaluation, Predictive Factors, and  Assessment during Radio-Chemotherapy,  Recommendations Nerina Denaro1·Marco C. Merlano1·Elvio G. Russi2 1Oncology Department, 2Radiation Oncology Department, Azienda Ospedaliera Santa Croce e Carle, Cuneo, ItalyClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ea/ba/ceo-6-117.PMC3781223.pdf
"3: 117-126, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.117 Review INTRODUCTION Progress in head and neck cancer (HNC) treatments has improved  tumour response and loco-regional control rates.",Non-OADS,/arxiv_data1/oa_pdf/ea/ba/ceo-6-117.PMC3781223.pdf
http://dx.doi.org/10.1038/bjc.2013.458.,Non-OADS,/arxiv_data1/oa_pdf/ea/ba/ceo-6-117.PMC3781223.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Clinical Significance of β-Tricalcium Phosphate and  Polyphosphate for Mastoid Cavity Obliteration  during Middle Ear Surgery: Human and Animal  Study  Han-Bin Lee* ·Hye Jin Lim* ·Minhyuk Cho ·Suk-Min Y ang ·Keehyun Park ·Hun Yi Park ·Yun-Hoon Choung Department of Otolaryngology, Ajou University School of Medicine, Suwon, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/a6/41/ceo-6-127.PMC3781224.pdf
"3: 127-134, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.127 Original Article INTRODUCTION A mastoidectomy is performed as a surgical method to com - pletely remove inflammatory tissues or cholesteatoma and to  prevent recurrence in chronic otitis media (COM) patients.",Non-OADS,/arxiv_data1/oa_pdf/a6/41/ceo-6-127.PMC3781224.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Agreement between the Facial Nerve Grading System  2.0 and the House-Brackmann Grading System in  Patients with Bell Palsy Ho Yun Lee ·Moon Suh Park ·Jae Y ong Byun ·Ji Hyun Chung ·Se Y oung Na ·Seung Geun Y eo Department of Otorhinolaryngology-Head and Neck Surgery, Kyung Hee University School of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/32/9d/ceo-6-135.PMC3781225.pdf
"3: 135-139, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.135 Original Article INTRODUCTION The House-Brackmann (HB) scale, which was first introduced in  1983 and selected as the standard by the Facial Nerve Disorders (FND) Committee in 1985, provides a gross impression by clas - sifying facial motor function into 6 grades when diagnosing a patient with facial palsy.",Non-OADS,/arxiv_data1/oa_pdf/32/9d/ceo-6-135.PMC3781225.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Temperature Enhances Activation and Inactivation  Kinetics of Potassium Currents in Inner Hair Cells  Isolated from Guinea-Pig Cochlea Takashi Kimitsuki1·Shizuo Komune2 1Department of Otolaryngology, Kyushu Central Hospital, Fukuoka;   2Department of Otolaryngology, Graduate School of Medical Sciences, Kyushu University Faculty of Medicine, Fukuoka, JapanClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/77/d6/ceo-6-140.PMC3781226.pdf
"3: 140-145, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.140 Original Article INTRODUCTION In the mammalian cochlea, there are two types of hair cells that  subserve distinct functions and receive characteristic patterns of innervations.",Non-OADS,/arxiv_data1/oa_pdf/77/d6/ceo-6-140.PMC3781226.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Postoperative Olfactory Results in Chronic  Rhinosinusitis with Nasal Polyposis According to  Wound Healing Status Dae Woo Kim1·Jin-Y ong Kim2·Sang-Wook Kim2,3·Sea-Yuong Jeon2,3 1Department of Otorhinolaryngology, Boramae Medical Center, Seoul National University College of Medicine, Seoul;   2Department of Otorhinolaryngology, Gyeongsang National University School of Medicine, Jinju; 3Gyeongsang Institute of Health Sciences,  Gyeongsang National University, Jinju, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f2/be/ceo-6-146.PMC3781227.pdf
"3: 146-151, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.146 Original Article INTRODUCTION Chronic rhinosinusitis (CRS) is one of the main causes of olfacto - ry dysfunction, accounting for 15%-30% of cases involving loss of smell [1-3].",Non-OADS,/arxiv_data1/oa_pdf/f2/be/ceo-6-146.PMC3781227.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The Role of Platelet-Derived Growth Factor in the  Pathogenesis of Sinonasal Polyps:  Immunohistochemical Assessment in Epithelial,  Subepithelial and Deep Layers of the Mucosa Nuray Bayar Muluk1·Osman Kür şat Arıkan2·Pınar Atasoy3·Rahmi Kılıç1·Eda Tuna Y alçinozan4 1ENT Department, Kirikkale University Faculty of Medicine, Kirikkale; 2ENT Department, Adana Numune Education and Training Hospital,  Adana; 3Pathology Department, Kirikkale University Faculty of Medicine, Kirikkale; 4ENT Department, Artvin State Hospital, Artvin, TurkeyClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/05/c7/ceo-6-152.PMC3781228.pdf
"3: 152-160, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.152 Original Article INTRODUCTION Nasal polyposis is considered an inflammatory condition in na - sal and paranasal sinus cavities and is often encountered by oto - laryngology clinics.",Non-OADS,/arxiv_data1/oa_pdf/05/c7/ceo-6-152.PMC3781228.pdf
Available from: http://en.wikipedia.org/wiki/Platelet-derived_growth_factor.,OADS,/arxiv_data1/oa_pdf/05/c7/ceo-6-152.PMC3781228.pdf
Available from: http://www.multi-targetedtherapy.com/pdgfSignaling.asp.,Non-OADS,/arxiv_data1/oa_pdf/05/c7/ceo-6-152.PMC3781228.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Effect of Isolated Uvulopalatopharyngoplasty on  Subjective Obstructive Sleep Apnea Symptoms  Ji Ho Choi1*·Y oung Joon Jun1*·Tae Hoon Kim1·Heung Man Lee1·Sang Hag Lee1·Soon Y oung Kwon1  Hyuk Choi2·Seung Hoon Lee1 1Department of Otorhinolaryngology-Head and Neck Surgery, Korea University College of Medicine, Seoul; 2Department of Medical Sciences,  Korea University Graduate School of Medicine, Seoul, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/ceo-6-161.PMC3781229.pdf
"3: 161-165, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.161 Original Article INTRODUCTION Obstructive sleep apnea (OSA) is a common disorder character - ized by recurrent reductions or cessations in breathing due to  partial or complete upper airway obstructions during sleep.",Non-OADS,/arxiv_data1/oa_pdf/d8/fe/ceo-6-161.PMC3781229.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Persistent Dysphonia after Laryngomicrosurgery for  Benign Vocal Fold Disease Y oo Seob Shin ·Jae Won Chang ·Suk Min Y ang ·Hee Won Wu ·Min Hyuk Cho ·Chul-Ho Kim Department of Otolaryngology, Ajou University School of Medicine, Suwon, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/ee/83/ceo-6-166.PMC3781230.pdf
"3: 166-170, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.166 Original Article INTRODUCTION Benign vocal fold disease (BVFD), such as vocal polyp, vocal  nodule, intracordal cyst or Reinke’s edema is one of the most common causes which deteriorate the voice [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/83/ceo-6-166.PMC3781230.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Vascular Leiomyoma in the Head and Neck Region:  11 Years Experience in One Institution Tae Mi Y oon1·Hyung Chae Y ang2·Y oo-Duk Choi3·Dong Hoon Lee1·Joon Kyoo Lee1·Sang Chul Lim1 1Department of Otorhinolaryngology-Head and Neck Surgery, Chonnam National University Hwasun Hospital, Chonnam National University  Medical School, Hwasun; Departments of 2Otorhinolaryngology-Head and Neck Surgery and 3Pathology, Chonnam National University Hospital,  Chonnam National University Medical School, Gwangju, KoreaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f8/eb/ceo-6-171.PMC3781231.pdf
"3: 171-175, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.171 Original Article INTRODUCTION Vascular leiomyoma, which is derived from the smooth muscle  of blood vessels, may occur anywhere in the skin or subcutane - ous tissue [1].",Non-OADS,/arxiv_data1/oa_pdf/f8/eb/ceo-6-171.PMC3781231.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Selective Delivery of a Therapeutic Gene for  Treatment of Head and Neck Squamous Cell  Carcinoma Using Human Neural Stem Cells Seong Keun Kwon1*·Seung U Kim2,3·Jae-Jun Song1·Chang Gun Cho1·Seok-Won Park1 1Department of Otorhinolaryngology-Head and Neck Surgery, Dongguk University Ilsan Hospital, Goyang;   2Institute for Regenerative Medicine, Gachon University Gil Hospital, Incheon, Korea; 3Division of Neurology, Department of Medicine,   UBC Hospital, University of British Columbia, Vancouver, BC, CanadaClinical and Experimental Otorhinolaryngology    Vol.",Non-OADS,/arxiv_data1/oa_pdf/f5/7c/ceo-6-176.PMC3781232.pdf
"3: 176-183, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.176 Original Article INTRODUCTION Despite recent advances in ablative surgical resection, radiother - apy, and chemotherapy, recurrence and metastasis remains sig -nificant problems in the treatment of head and neck squamous  cell carcinoma (HNSCC).",Non-OADS,/arxiv_data1/oa_pdf/f5/7c/ceo-6-176.PMC3781232.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Primary Burkitt’s Lymphoma in the Nasal Cavity  and Paranasal Sinuses Dong Hwan Lee ·Myeong Sang Yu ·Bong-Jae Lee Department of Otolaryngology, Asan Meidcal Center, University of Ulsan College of Medicine, Seoul, KoreaCase Report INTRODUCTION Burkitt’s lymphoma was first described as a mandibular malig - nancy of children in 1958 [1].",Non-OADS,/arxiv_data1/oa_pdf/ee/02/ceo-6-184.PMC3781233.pdf
"3: 184-186, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.184 pISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/ee/02/ceo-6-184.PMC3781233.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.A Thyroglossal Duct Cyst Causing Obstructive Sleep  Apnea in Adult Hahn Jin Jung1·Jeong-Whun Kim1·Chul Hee Lee1·Y oung Jun Chung2·Ji-Hun Mo2  1Department of Otorhinolaryngology-Head and Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of  Medicine, Seongnam; 2Department of Otorhinolaryngology-Head and Neck Surgery, Dankook University College of Medicine, Cheonan, Korea Case Report INTRODUCTION Obstructive sleep apnea (OSA) is a highly prevalent disease that  is characterized by recurrent episodes of upper airway obstruc - tion and it usually results from the structural compromise of the upper airway accompanied with decrease in muscle tone.",Non-OADS,/arxiv_data1/oa_pdf/9c/6e/ceo-6-187.PMC3781234.pdf
"3: 187-190, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.187 pISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/9c/6e/ceo-6-187.PMC3781234.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Congenital Epidermoid Cyst of the Oral Cavity:  Prenatal Diagnosis by Sonography Seung Wan Park1·Jung Ju Lee1·Soo Ahn Chae1·Byoung Hoon Y oo1·Gwang Jun Kim2·Sei Y oung Lee3 Departments of 1Pediatrics, 2Obstetrics and Gynecology, and 3Otorhinolaryngology, Chung-Ang University College of Medicine, Seoul, KoreaCase Report INTRODUCTION Congenital cystic lesions of the oral cavity are very rare [1].",Non-OADS,/arxiv_data1/oa_pdf/51/5a/ceo-6-191.PMC3781235.pdf
"3: 191-193, September 2013 http://dx.doi.org/10.3342/ceo.2013.6.3.191 pISSN 1976-8710   eISSN 2005-0720",Non-OADS,/arxiv_data1/oa_pdf/51/5a/ceo-6-191.PMC3781235.pdf
Health risks from exposure to low levels of radiation: BEIR VII phase 2 (2006) http://www.nap.edu/catalog.php?record_id=11340 ).,Non-OADS,/arxiv_data1/oa_pdf/7e/70/13244_2013_Article_283.PMC3781241.pdf
Available via: http://www.nice.org.uk/nicemedia/live/10901/28906/ 28906.pdf [Accessed 8th July 2013] 20.,Non-OADS,/arxiv_data1/oa_pdf/51/82/13244_2013_Article_285.PMC3781245.pdf
Availablevia: http://www.dh.gov.uk/prod_consum_dh/groups/dh_ digitalassets/@dh/@en/docum ents/digitalasset/dh_4014366.pdf [Accessed 8th July 2013] 21.,OADS,/arxiv_data1/oa_pdf/51/82/13244_2013_Article_285.PMC3781245.pdf
Available via: http://www.rcr.ac.uk/content.aspx?,Non-OADS,/arxiv_data1/oa_pdf/95/14/13244_2013_Article_274.PMC3781246.pdf
Available via:http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm .,OADS,/arxiv_data1/oa_pdf/95/14/13244_2013_Article_274.PMC3781246.pdf
Available via:http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG: 1993L0042:20071011:en:PDF .,Non-OADS,/arxiv_data1/oa_pdf/95/14/13244_2013_Article_274.PMC3781246.pdf
Available via:http://www.ciscomcon.com/sw/swchannel/registration/internet/registration.cfm?SWAPPID=91&R egPageID=350200&SWTHEMEID= 12949&traffictype=Direct .,OADS,/arxiv_data1/oa_pdf/95/14/13244_2013_Article_274.PMC3781246.pdf
https://www.chf.org.au/pdfs/rep/rep-1027-DI-scoping-paper.pdf .,Non-OADS,/arxiv_data1/oa_pdf/f9/7f/13244_2013_Article_284.PMC3781249.pdf
http://www.wicourts.gov/sc/opinion/DisplayDocument.pdf?content=pdf&seqNo=81164 .,Non-OADS,/arxiv_data1/oa_pdf/f9/7f/13244_2013_Article_284.PMC3781249.pdf
"Available online: http://deainfo.nci.nih.gov/a dvisory/pcp/annualReports/ pcp08-09rpt/PCP_Report_08-09_508.pdf (accessed December 5, 2012) 9.",OADS,/arxiv_data1/oa_pdf/b8/fc/13244_2013_Article_272.PMC3781253.pdf
"Available online: http://ec.europa.eu/energy/ nuclear/radioprotection/publication/doc/118_update_en.pdf - Update Mars 2008 (accessed December 5, 2012) 24.",Non-OADS,/arxiv_data1/oa_pdf/b8/fc/13244_2013_Article_272.PMC3781253.pdf
Available via http://gm.acr.org/Secondary MainMenuCategories/quality_ safety/app_criteri a/pdf/ExpertPanelonP ediatricImaging/ SeizuresChildDoc7.aspx .,OADS,/arxiv_data1/oa_pdf/b8/fc/13244_2013_Article_272.PMC3781253.pdf
http://www.fda.gov/cdrh/ct/risks .,Non-OADS,/arxiv_data1/oa_pdf/b8/fc/13244_2013_Article_272.PMC3781253.pdf
Available from URL: http://www.ranzcr.,Non-OADS,/arxiv_data1/oa_pdf/b8/fc/13244_2013_Article_272.PMC3781253.pdf
Stockholms läns landsting (in Swedish)http://www.produktionssamordni ng.se/Global/Vardsamordning/ Dokument/Publikationer/Fokusrapporter/FR_Kartl%C3%A4ggning_ av_magnetisk_resonanstomografi.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/bc/ae/13244_2013_Article_276.PMC3781254.pdf
"Referral guidelines for imaging (2001) Office for Official Publications of the European Communities, Luxembourg http://ec.europa.eu/energy /nuclear/rad ioprotection/ publication/doc/118_en.pdf 9.",Non-OADS,/arxiv_data1/oa_pdf/bc/ae/13244_2013_Article_276.PMC3781254.pdf
Swedish Radiation Safety Authority:03 http://www.stralsake rhetsmyndigheten.se/Glo bal/Publikationer/ Rapport/Stralskydd/2009/SSM-Rapport-2009-03.pdf 11.,OADS,/arxiv_data1/oa_pdf/bc/ae/13244_2013_Article_276.PMC3781254.pdf
Available at: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/d0/ab/40256_2013_Article_29.PMC3781304.pdf
http://www.thrivestudy.org .,Non-OADS,/arxiv_data1/oa_pdf/ee/70/40256_2013_Article_37.PMC3781306.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp) Combined analysis of exome sequencing points toward a major role for transcription regulation during braindevelopment in autism Molecular Psychiatry (2013) 18,1054–1056; doi:10.1038/mp.2012.148; published online 13 November 2012 Four recent studies of the coding regions of the human genome (the ‘exome’), suggest that new ( de novo ) mutations in hundredsLetters to the Editor 1054 Molecular Psychiatry (2013), 1053 – 1057 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/97/15/41380_2013_Article_BFmp2012168.PMC3781315.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Emotional memory regulation by hippocampal p11 TM Eriksson et al 1105 &2013 Macmillan Publishers Limited Molecular Psychiatry (2013), 1096 – 1105",Non-OADS,/arxiv_data1/oa_pdf/5d/4c/mp2012130a.PMC3781317.pdf
"Published by Elsevier B.V. http://dx.doi.org/10.1016/j.jad.2013.05.005 nCorresponding author at: Africa Centre for Health and Population Studies, University of KwaZulu-Natal, R618 Enroute Somkhele, PO Box 198, Mtubatuba, KwaZulu-Natal, 3935 South Africa.",Non-OADS,/arxiv_data1/oa_pdf/77/f0/main.PMC3781323.pdf
"JAIDS Journal of Acquired Immune De ﬁciency Syndromes 56, 146 –150, http://dx.doi.org/10.1097/QAI.0b013e318201df63 .",Non-OADS,/arxiv_data1/oa_pdf/77/f0/main.PMC3781323.pdf
"JAIDS Journal ofAcquired Immune De ﬁciency Syndromes 58, 181 –187, http://dx.doi.org/ 10.1097/QAI.0B013E31822D490A .",Non-OADS,/arxiv_data1/oa_pdf/77/f0/main.PMC3781323.pdf
Available from: 〈http://www.who.int/healthinfo/systems/sage/en/index1.html 〉(accessed 01.03.2013).,OADS,/arxiv_data1/oa_pdf/77/f0/main.PMC3781323.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2740 | DOI: 10.1038/srep02740 7",Non-OADS,/arxiv_data1/oa_pdf/b7/cd/srep02740.PMC3781391.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/ba/srep02732.PMC3781392.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2732 | DOI: 10.1038/srep02732 6",Non-OADS,/arxiv_data1/oa_pdf/bc/ba/srep02732.PMC3781392.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1c/98/srep02737.PMC3781393.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2737 | DOI: 10.1038/srep02737 6",Non-OADS,/arxiv_data1/oa_pdf/1c/98/srep02737.PMC3781393.pdf
"20, 76–87, doi:http://dx.doi.org/10.1016/0022- 3697(61)90138-x (1961).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"65, 615–617, doi:http://dx.doi.org/10.1016/ j.scriptamat.2011.06.041 (2011).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"111, 043517, doi:http://dx.doi.org/10.1063/ 1.3682480 (2012).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"88, 5703–5709, doi:http://dx.doi.org/ 10.1063/1.1319327 (2000).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"549, 190–194, doi:http://dx.doi.org/10.1016/j.jallcom.2012.08.138 (2013).",OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"86, 241902, doi:http://dx.doi.org/10.1063/1.1941456 (2005).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"B 49, 2030–2034, doi:http://dx.doi.org/10.1103/ PhysRevB.49.2030 (1994).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"97, 063514, doi:http://dx.doi.org/10.1063/1.1861151 (2005).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"94, 5451–5473, doi:http://dx.doi.org/10.1063/ 1.1611263 (2003).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"B 81, 094203, doi:http://dx.doi.org/ 10.1103/PhysRevB.81.094203 (2010).",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"Calphad 26, 539–553, doi:http://dx.doi.org/10.1016/s0364-5916(02)80006- 2 (2002).",OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2731 | DOI: 10.1038/srep02731 4",Non-OADS,/arxiv_data1/oa_pdf/fd/c8/srep02731.PMC3781394.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2741 | DOI: 10.1038/srep02741 5",Non-OADS,/arxiv_data1/oa_pdf/ea/98/srep02741.PMC3781397.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/2d/srep02739.PMC3781398.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2739 | DOI: 10.1038/srep02739 6",Non-OADS,/arxiv_data1/oa_pdf/2f/2d/srep02739.PMC3781398.pdf
http://dx.doi.org/10.1002/adma.201302147.,Non-OADS,/arxiv_data1/oa_pdf/65/9c/srep02733.PMC3781399.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/9c/srep02733.PMC3781399.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2733 | DOI: 10.1038/srep02733 7",Non-OADS,/arxiv_data1/oa_pdf/65/9c/srep02733.PMC3781399.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c8/0a/srep02730.PMC3781400.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2730 | DOI: 10.1038/srep02730 7",Non-OADS,/arxiv_data1/oa_pdf/c8/0a/srep02730.PMC3781400.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/18/19/srep02735.PMC3781401.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2735 | DOI: 10.1038/srep02735 9",Non-OADS,/arxiv_data1/oa_pdf/18/19/srep02735.PMC3781401.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/bf/srep02607.PMC3781402.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2607 | DOI: 10.1038/srep02607 8",Non-OADS,/arxiv_data1/oa_pdf/12/bf/srep02607.PMC3781402.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1e/71/srep02734.PMC3781403.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2734 | DOI: 10.1038/srep02734 8",Non-OADS,/arxiv_data1/oa_pdf/1e/71/srep02734.PMC3781403.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7a/1b/3618.PMC3781437.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7f/66/3338.PMC3781438.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/12/10/3341.PMC3781439.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/05/6e/3331.PMC3781440.pdf
Available from http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm083378.htm.Accessed 2 July 2013FIG.,Non-OADS,/arxiv_data1/oa_pdf/05/6e/3331.PMC3781440.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4d/b5/3362.PMC3781441.pdf
Differential gene expression was determined using ABarraysoftware (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/4d/b5/3362.PMC3781441.pdf
Signal intensities across microarrays were normalized via quantile normalization (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/4d/b5/3362.PMC3781441.pdf
Additional detailsare available at http://pages.ingenuity.com/IngenuityUpstreamRegulatorAnalysis-Whitepaper.html.,Non-OADS,/arxiv_data1/oa_pdf/4d/b5/3362.PMC3781441.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/48/2a/e23.PMC3781442.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e3/28/3426.PMC3781443.pdf
"See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.ADIPONECTIN IN INSULIN RESISTANCE AND TYPE 2 DIABETES 3590 DIABETES, VOL.",Non-OADS,/arxiv_data1/oa_pdf/27/27/3589.PMC3781444.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/de/46/3333.PMC3781445.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/68/16/e24.PMC3781446.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/35/21/3599.PMC3781447.pdf
"In preliminary studies in human embryonic kidney (HEK293T) cells expressing recombinant ADAMTS13 proteins carryingthe four nonsynonymous SNPs with a .0.05 minor allele frequency in the European population (rs34024143 [Arg7Trp], rs2301612 [Glu448Gln], rs28647808 [Pro618Ala], and rs685523 [Ala900Val] [http://www.ncbi.nlm.nih.gov/snp,CEU population]), we found that protease secretion and activity were reduced only with the 618Ala with respect to wild-type protein (Supplementary Figs.",Non-OADS,/arxiv_data1/oa_pdf/35/21/3599.PMC3781447.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/93/4a/3500.PMC3781448.pdf
Available from http://www.cdc.gov/diabetes/ pubs/pdf/ndfs_2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/4a/3500.PMC3781448.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0d/f5/3316.PMC3781450.pdf
"Despite immunohistochemical depiction of robust GLP-1R immu- nopositivity in human pancreatic cancer cells (22), using transcriptome analysis of publicly available databases (oncomine.com, version 4.4.3, and Genome Expression Omnibus, http://www.ncbi.nlm.nih.gov/geo/) we have been unable to ﬁnd evidence that Glp1r mRNA transcripts are overexpressed in these tumors.",Non-OADS,/arxiv_data1/oa_pdf/0d/f5/3316.PMC3781450.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9c/af/e27.PMC3781451.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/65/b6/3570.PMC3781452.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3b/c2/3459.PMC3781453.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/23/36/e25.PMC3781454.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6f/cd/3582.PMC3781455.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9c/da/e26.PMC3781456.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/32/c0/3336.PMC3781458.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/92/15/3523.PMC3781459.pdf
Adverse events (AEs) related to the procedure were recorded and classi ﬁed according to the terminology criteria for AEs in Trials of Adult Pancreatic Islet Transplantation version 4.1 (16 July2008) (http://www.isletstudy.org/CITDocs/CIT-TCAE%20V4.pdf).,Non-OADS,/arxiv_data1/oa_pdf/92/15/3523.PMC3781459.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4c/d8/3488.PMC3781460.pdf
"Sections were scanned by digital microscopy (Nikon Coolscope; Nikon, Egg, Switzerland), quanti ﬁcation was achieved using ImageJ software (Na- tional Institutes of Health; http://rsb.info.nih.gov/nih-image/), and a- and b-cell mass was calculated as previously described (22).",OADS,/arxiv_data1/oa_pdf/4c/d8/3488.PMC3781460.pdf
Population data by sex and year of birth were provided by the Italian Na- tional Institute of Statistics (http://www.demo.istat.it/).,OADS,/arxiv_data1/oa_pdf/f4/23/3542.PMC3781461.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f4/23/3542.PMC3781461.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/22/48/3305.PMC3781462.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/17/f1/e19.PMC3781463.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/18/ac/e16.PMC3781464.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/13/95/3404.PMC3781465.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/94/97/3561.PMC3781466.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6c/69/3418.PMC3781467.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0a/2e/3373.PMC3781468.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/af/ac/3394.PMC3781469.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/be/cc/3636.PMC3781470.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/03/3610.PMC3781471.pdf
"Data were analyzed using the STATA statistical software (version 12.1; StataCorp, College Station, TX) and RGui, version 2.13.2 (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/a6/03/3610.PMC3781471.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/db/98/3469.PMC3781472.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d4/88/3437.PMC3781473.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d4/5c/3479.PMC3781474.pdf
Available from http://www.jdrfnpod.org/online-pathology.php.,Non-OADS,/arxiv_data1/oa_pdf/e1/2b/e18.PMC3781475.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e1/2b/e18.PMC3781475.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2a/76/3627.PMC3781476.pdf
"The PLINK software package (24) was used for data handling, and R (http://www.r-project.org) and Stata 11 (StataCorp, College Station, TX) were used for analysis.",OADS,/arxiv_data1/oa_pdf/2a/76/3627.PMC3781476.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0e/e6/3532.PMC3781477.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9d/83/3547.PMC3781478.pdf
See  http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.DIGESTS,Non-OADS,/arxiv_data1/oa_pdf/af/3b/3643.PMC3781479.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/17/49/3350.PMC3781480.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/99/2e/3307.PMC3781481.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0e/89/3324.PMC3781482.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/22/a2/3553.PMC3781483.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/3384.PMC3781484.pdf
All PCR primers were designed with Primer3 soft-ware (http://frodo.wi.mit.edu/primer3/) using published sequence data obtained from the National Center for Biotechnology Information database (Supple- mentary Table 1).Bile acids determination and sample preparation.,OADS,/arxiv_data1/oa_pdf/a7/4e/3384.PMC3781484.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/59/3448.PMC3781485.pdf
The data ﬁles have been deposited in the NCBI GEO database GSE41248 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE41248).,OADS,/arxiv_data1/oa_pdf/a6/59/3448.PMC3781485.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1e/1c/3514.PMC3781486.pdf
See http://creativecommons.org/licenses/by -nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/89/cf/3329.PMC3781487.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a4/02/3187.PMC3781488.pdf
"Corresponding author: Hillary A. Keenan, hillary.keenan@joslin.harvard.edu.Received 4 February 2013 and accepted 16 April 2013.DOI: 10.2337/dc13-0294This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0294/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/49/8f/3222.PMC3781490.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/49/8f/3222.PMC3781490.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/2d/e3/3216.PMC3781492.pdf
"NCT01271777, www.clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2012/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ed/7b/2923.PMC3781493.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ed/7b/2923.PMC3781493.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/23/46/3328.PMC3781495.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a6/d4/3018.PMC3781496.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4a/3f/2931.PMC3781497.pdf
Received 25 February 2013 and accepted 23 May 2013.DOI: 10.2337/dc13-0465 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0465/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d8/a8/3346.PMC3781498.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d8/a8/3346.PMC3781498.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/52/85/3177.PMC3781499.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/d4/92/3227.PMC3781501.pdf
"NCT00707031, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2709/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
Available from http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/ucm073137.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
Available from http://www.emea.europa.eu/docs/en_GB/document_ library/Scienti ﬁc_guideline/2009/09/ WC500002928.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
Available from http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/ucm071624.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
Available fromhttp://www.ema.euro pa.eu/docs/en_GB/ document_library/Scienti ﬁc_guideline/ 2012/06/WC500129256.pdf.,Non-OADS,/arxiv_data1/oa_pdf/23/49/2945.PMC3781502.pdf
DOI: 10.2337/dc13-0184This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0184/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/3162.PMC3781503.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f6/e8/3162.PMC3781503.pdf
"Corresponding author: Ralph A. DeFronzo, albarado@uthscsa.edu.Received 15 February 2013 and accepted 4 April 2013.DOI: 10.2337/dc13-0387This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0387/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/06/37/3169.PMC3781504.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/06/37/3169.PMC3781504.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/e6/e6/3107.PMC3781505.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f9/6a/3139.PMC3781506.pdf
"Corresponding author: Peter T. Katzmarzyk, peter.katzmarzyk@pbrc.edu.Received 25 January 2013 and accepted 9 April 2013.DOI: 10.2337/dc13-0219This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0219/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/46/4b/3128.PMC3781507.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/46/4b/3128.PMC3781507.pdf
"Corresponding author: Ineke J. Riphagen, i.j.riphagen@umcg.nl.Received 23 October 2012 and accepted 8 April 2013.DOI: 10.2337/dc12-2165This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2165/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/03/a5/3201.PMC3781508.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/03/a5/3201.PMC3781508.pdf
"Corresponding author: C. Raina Elley, c.elley@auckland.ac.nz.Received 22 January 2013 and accepted 16 April 2013.DOI: 10.2337/dc13-0190This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0190/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
"In practical use, we would expect the equations to be hidden behind clinicalsoftware or clinical decision support, which is now used quite extensively in primary care cardiovascular risk assess-ment and prompting of managementdecision making (e.g., http://www.nzssd .org.nz/cvd/ [27]).",Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
Available from http://www.dpt.org.nz/.,Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
Available from http://www.anzdata.org.au/anzdata/anzdatareport/ 34threport/2011c00_front%20pages_ v1.6.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
Available from http://www.health.govt .nz/publication/diabetes-new-zealand-models-and-forecasts-1996-2011.,Non-OADS,/arxiv_data1/oa_pdf/98/20/3113.PMC3781509.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/3b/52/3040.PMC3781510.pdf
"NCT00831389, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0010/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/48/41/2909.PMC3781513.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/48/41/2909.PMC3781513.pdf
"Corresponding author: Gang Hu, gang.hu@pbrc.edu.Received 22 January 2013 and accepted 2 March 2013.DOI: 10.2337/dc13-0189This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0189/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/7d/25/3287.PMC3781514.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/7d/25/3287.PMC3781514.pdf
*A complete list of participants in the DCCT/EDIC Research Group can be found at http://www.nejm.org/doi/ full/10.1056/NEJMoa1111732#t=articleResults (N Engl J Med 2011;365:2366 –2376).,OADS,/arxiv_data1/oa_pdf/df/7a/3146.PMC3781515.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/df/7a/3146.PMC3781515.pdf
"Corresponding author: Trevor J. Orchard, orchardt@edc.pitt.edu.Received 31 January 2013 and accepted 29 April 2013.DOI: 10.2337/dc13-0266This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0266/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/49/b9/2974.PMC3781516.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/49/b9/2974.PMC3781516.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1f/d1/3297.PMC3781519.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/21/73/3195.PMC3781520.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f4/b1/3283.PMC3781521.pdf
Patients were enrolled in this Institutional Review Board –approved ob- servational study (http://www.clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/f4/b1/3283.PMC3781521.pdf
"Corresponding author: Andrew Odegaard, odeg0025@umn.edu.Received 6 February 2013 and accepted 17 April 2013.DOI: 10.2337/dc13-0316This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0316/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ad/30/3100.PMC3781522.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ad/30/3100.PMC3781522.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/a4/f3/2952.PMC3781523.pdf
"NCT00017953, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0315/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f7/91/2937.PMC3781524.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f7/91/2937.PMC3781524.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/34/bf/2895.PMC3781525.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/53/cb/2902.PMC3781526.pdf
All HbA 1cvalues also were presented in millimoles per mole according to the NGSP ’sH b A 1cconverter (available athttp://www.ngsp.org/convert1.asp).,OADS,/arxiv_data1/oa_pdf/53/cb/2902.PMC3781526.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c1/4c/3240.PMC3781527.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/cc/f6/2988.PMC3781528.pdf
Availablefrom http://si-folkesundhed.dk/upload/ inuit_health_in_transition_greenland_ methods_5_2nd_revision.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cc/f6/2988.PMC3781528.pdf
Available from https://sites.google.,Non-OADS,/arxiv_data1/oa_pdf/cc/f6/2988.PMC3781528.pdf
"Corresponding author: Jessica A. Marcinkevage, jmarcinkevage@cdc.gov.Received 7 November 2012 and accepted 5 April 2013.DOI: 10.2337/dc12-2312This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2312/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ac/58/3033.PMC3781530.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ac/58/3033.PMC3781530.pdf
Available from http://www.ats.ucla.,Non-OADS,/arxiv_data1/oa_pdf/ac/58/3033.PMC3781530.pdf
"NCT00643474, www.clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0092/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/56/d8/2887.PMC3781531.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/56/d8/2887.PMC3781531.pdf
Available from http://www.idf.org/guidelines/type-2-diabetes.,Non-OADS,/arxiv_data1/oa_pdf/56/d8/2887.PMC3781531.pdf
Avail- able from http://www.idf.org/guidelines/self-monitoring.,Non-OADS,/arxiv_data1/oa_pdf/56/d8/2887.PMC3781531.pdf
Available from http://www.siditalia.it/linee-guida.html.,Non-OADS,/arxiv_data1/oa_pdf/56/d8/2887.PMC3781531.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/21/0b/3009.PMC3781532.pdf
Available from http://www.nhmrc.gov.au/publications/synopses/ di7todi13syn.htm.,OADS,/arxiv_data1/oa_pdf/21/0b/3009.PMC3781532.pdf
"Available from http://www.dva care.diabetesjournals.org D IABETES CARE,VOLUME 36, O CTOBER 2013 3013Caughey and Associates",Non-OADS,/arxiv_data1/oa_pdf/21/0b/3009.PMC3781532.pdf
"Corresponding author: Lorraine Smith, lorraine.smith@sydney.edu.au.Received 27 August 2012 and accepted 29 April 2013.DOI: 10.2337/dc12-1743This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1743/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/c8/6b/2968.PMC3781533.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c8/6b/2968.PMC3781533.pdf
Available from http://www.sign.ac.uk/guidelines/fulltext/50/annexb.html.,Non-OADS,/arxiv_data1/oa_pdf/a9/2d/3361.PMC3781534.pdf
Available from http://www.fda.gov/downloads/Drugs/GuidanceCompliance-RegulatoryInformation/guidances/ucm071627.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/2d/3361.PMC3781534.pdf
Avail- able from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolic DrugsAdvisoryCommittee/UCM327015.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a9/2d/3361.PMC3781534.pdf
Available from http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/a9/2d/3361.PMC3781534.pdf
Available from http://conference2.idf.org/prog.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a9/2d/3361.PMC3781534.pdf
"Corresponding author: Elham Rahme, elham.rahme@mcgill.ca.Received 6 December 2012 and accepted 28 March 2013.DOI: 10.2337/dc12-2543This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2543/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/1e/99/3002.PMC3781536.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/1e/99/3002.PMC3781536.pdf
Available from http://www.stat.gouv.,OADS,/arxiv_data1/oa_pdf/1e/99/3002.PMC3781536.pdf
Available from http://www.ramq.gouv.qc.ca/en/citizens/prescription-drug-insurance/Pages/eligibility.aspx.,Non-OADS,/arxiv_data1/oa_pdf/1e/99/3002.PMC3781536.pdf
"National In- stitutes of Health Consensus Development Conference on Diagnosing Gestational Di- abetes Mellitus: Final Statement, 2013.Available from http://prevention.nih.gov/ cdp/conferences/2013/gdm/resources.aspx.Accessed 24 May 2013 2.",Non-OADS,/arxiv_data1/oa_pdf/98/62/2879.PMC3781537.pdf
DOI: 10.2337/dc12-2671This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2671/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0f/15/3062.PMC3781538.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0f/15/3062.PMC3781538.pdf
DOI: 10.2337/dc12-2323 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2323/-/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/3121.PMC3781539.pdf
*A complete list of principal Cardiovascular Health Study investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm.,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/3121.PMC3781539.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/c7/cc/3121.PMC3781539.pdf
"Corresponding author: Jean-Pierre Després, jean-pierre.despres@criucpq.ulaval.ca.Received 12 November 2012 and accepted 28 March 2013.DOI: 10.2337/dc12-2353This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2353/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f2/21/3254.PMC3781540.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f2/21/3254.PMC3781540.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ae/1c/3333.PMC3781541.pdf
"NCT00360893, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2109/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f0/fc/3131.PMC3781542.pdf
*A complete list of participants in the DCCT/EDIC Research Group can be found at http://dx.doi.org/10.1056/ NEJMoa1111732 (N Engl J Med 2011;365:2366 –2376).,OADS,/arxiv_data1/oa_pdf/f0/fc/3131.PMC3781542.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f0/fc/3131.PMC3781542.pdf
"NCT01688622, clinicaltrials.govThis article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0178/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/95/cd/3321.PMC3781543.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/95/cd/3321.PMC3781543.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/dd/86/3015.PMC3781544.pdf
"NCT01784965, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0354/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/15/30/3276.PMC3781545.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/15/30/3276.PMC3781545.pdf
"ISRCTN35851744, www.isrctn.org.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1865/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/52/aa/3054.PMC3781546.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/52/aa/3054.PMC3781546.pdf
"IDF Diabetes Atlas, Fifth Edition [Internet].Available from http://www.idf.org/diabetesatlas/5e/the -global-burden.",Non-OADS,/arxiv_data1/oa_pdf/52/aa/3054.PMC3781546.pdf
"Corresponding author: Katharine Barnard, k.barnard@southampton.ac.uk.Received 6 March 2013 and accepted 9 June 2013.DOI: 10.2337/dc13-0560 This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0560/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/30/aa/3337.PMC3781547.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/30/aa/3337.PMC3781547.pdf
Available from: http://www.nationalhealthexecutive.com/Health-Care-News/antidepressant.,Non-OADS,/arxiv_data1/oa_pdf/30/aa/3337.PMC3781547.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/47/33/3093.PMC3781549.pdf
Available from http://www.cdc.gov/nchs/tutorials/Nhanes/index_ continuous.htm.,OADS,/arxiv_data1/oa_pdf/47/33/3093.PMC3781549.pdf
Available from http://www.ers.usda.gov/topics/food-nutrition- assistance/food-security-in-the-us/survey- tools.aspx#.UWOAAIVyHqs.,Non-OADS,/arxiv_data1/oa_pdf/47/33/3093.PMC3781549.pdf
Available from http://www.healthypeople.,Non-OADS,/arxiv_data1/oa_pdf/47/33/3093.PMC3781549.pdf
Available from http://www.cdc.gov/nchs/nhanes/nhanes1999- 2000/FSQ.htm#Analytic_Notes.,OADS,/arxiv_data1/oa_pdf/47/33/3093.PMC3781549.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/0d/82/3154.PMC3781550.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f6/81/2881.PMC3781551.pdf
"Corresponding author: Ananth U. Nayak, ananth.nayak@nhs.net.Received 30 May 2012 and accepted 29 April 2013.DOI: 10.2337/dc12-1040This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-1040/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/29/21/3247.PMC3781552.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/29/21/3247.PMC3781552.pdf
Available from http://www.retinalscreening.,Non-OADS,/arxiv_data1/oa_pdf/29/21/3247.PMC3781552.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4b/ad/3305.PMC3781553.pdf
"Corresponding author: Elizabeth Selvin, lselvin@jhsph.edu.Received 30 December 2012 and accepted 28 March 2013.DOI: 10.2337/dc12-2715This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2715/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/13/40/2995.PMC3781554.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/13/40/2995.PMC3781554.pdf
"Abbreviated Report of a WHO Consultation [Internet],2011 Available from http://www.who.int/ diabetes/publications/report-hba1c_2011.",Non-OADS,/arxiv_data1/oa_pdf/13/40/2995.PMC3781554.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/5d/5f/2960.PMC3781555.pdf
Available from http://www.hcup- us.ahrq.gov/reports/statbriefs/sb93.pdf.,OADS,/arxiv_data1/oa_pdf/5d/5f/2960.PMC3781555.pdf
"Corresponding author: Solomon K. Musani, smusani@umc.edu.Received 9 December 2012 and accepted 15 April 2013.DOI: 10.2337/dc12-2562This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2562/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/3084.PMC3781556.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/ae/a3/3084.PMC3781556.pdf
"Corresponding author: Chih-Chiang Chien, ccchien58@yahoo.com.tw.Received 22 October 2012 and accepted 3 April 2013.DOI: 10.2337/dc12-2148This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2148/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/78/8f/3027.PMC3781558.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/78/8f/3027.PMC3781558.pdf
Data were obtained from the NHIRD (Bureau of National Health Insurance; www.doh.gov.tw/stati stic/index.htm [in Chinese]; http://www.doh.gov.tw/EN2006/index_EN.aspx [in English]) and released for research by the Taiwan National Health Research Institute.,OADS,/arxiv_data1/oa_pdf/78/8f/3027.PMC3781558.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/3070.PMC3781560.pdf
Available from http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/3070.PMC3781560.pdf
Available from http://www.phac-aspc.gc.ca /publicat/clinic- clinique/pdf/s10c6 8e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/96/ed/3070.PMC3781560.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9a/54/3262.PMC3781561.pdf
See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/de/9e/e173.PMC3781562.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/6e/1e/3234.PMC3781566.pdf
"Corresponding author: Pearl G. Lee, pearllee@med.umich.edu.Received 20 February 2013 and accepted 11 April 2013.DOI: 10.2337/dc13-0412This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0412/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/9d/2e/3076.PMC3781567.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/9d/2e/3076.PMC3781567.pdf
Available from http://www.bsc.gwu.edu/dpp/PROTOCOL.PDF.,Non-OADS,/arxiv_data1/oa_pdf/9d/2e/3076.PMC3781567.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/4e/1c/2981.PMC3781568.pdf
"Corresponding author: Nolwenn Regnault, nolwenn.regnault@inserm.fr.Received 8 February 2013 and accepted 6 April 2013.DOI: 10.2337/dc13-0333This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0333/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/dc/d4/3045.PMC3781569.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/dc/d4/3045.PMC3781569.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/85/c4/3313.PMC3781571.pdf
Available from http://www.rrh.org.au.,Non-OADS,/arxiv_data1/oa_pdf/85/c4/3313.PMC3781571.pdf
"NCT00069784, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2238/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f7/ae/2915.PMC3781572.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/2915.PMC3781572.pdf
Available athttp://www.who.int/diabetes/publications/ diagnosis_diabetes2011/en/index.html.,Non-OADS,/arxiv_data1/oa_pdf/f7/ae/2915.PMC3781572.pdf
"NCT00006305, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0012/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/f1/bb/3208.PMC3781573.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/f1/bb/3208.PMC3781573.pdf
"NCT00006305, clinicaltrials.gov.This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc12-2265/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/77/a7/3269.PMC3781574.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/77/a7/3269.PMC3781574.pdf
"Corresponding author: Miguel Angel Luque-Fernandez, mluquefe@hsph.harvard.edu.Received 1 April 2013 and accepted 15 June 2013.DOI: 10.2337/dc13-0778This article contains Supplementary Data online at http://care.diabetesjournals.org/lookup/suppl/doi:10 .2337/dc13-0778/-/DC1.",Non-OADS,/arxiv_data1/oa_pdf/b4/ee/3353.PMC3781575.pdf
See http://creativecommons.org/ licenses/by-nc-nd/3.0/ for details.,Non-OADS,/arxiv_data1/oa_pdf/b4/ee/3353.PMC3781575.pdf
Target protein sequences were chosen from th e FunGene site ( http://fungene.cme.msu.edu ) at various distances from the known deﬁned community sequences.,OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
The online version ofFrameBot is available on RDP’s FunGene site ( http://fungene.cme.msu .edu).,OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
"The command line FrameBot program, source code, and manual are distributed under the terms of the GNU GPLv3 and are freely availableon SourceForge ( https://sourceforge.net/projects/rdpframebot ).",OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
(31; http://www.es.ucsc.edu/~wwwzehr/research/database ).,OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
"An ad- ditional 218 nifH andnifH -like genes (2 belonging to group I, the remain- der from groups IV and V) not matching Zehr reference sequences wereextracted from IMG ( http://img.jgi.doe.gov ) based on annotation and added to the reference set to create the augmented Zehr reference set.From these, we extracted the protein region (excluding primers) corre-sponding to that ampliﬁed by the Poly primers, and for each proteinsequence we obtained the corresponding DNA sequence region fromGenBank.",OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
The National Ecological Observatory Network (NEON) consists of 20 ecosystem types (termed Domains) from the tun-dra to the tropics and provides a continent-scale system for observingbiological change ( http://www.neoninc.org ).,Non-OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
Reads from de- ﬁned communities that passed the initial quality and FrameBot ﬁlterswere compared to the expected nucleotide sequences using the RDP De-ﬁned Community Analysis Tool ( http://fungene.cme.msu.edu/ ) imple- menting the Needleman-Wunsch algorithm (12).,OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
The sequence data from this study have been submitted to the ENA Short Read Archive ( http://www.ebi.ac .uk/ena/ ) under accession no.,OADS,/arxiv_data1/oa_pdf/f3/42/mBio.00592-13.PMC3781835.pdf
Additionaldetails regarding the arrays can be found at http://pfgrc.jcvi.org/index .php/microarray/array_description/enterococcus_faecalis/version1.html .,OADS,/arxiv_data1/oa_pdf/1c/0b/mBio.00646-13.PMC3781836.pdf
Microarray data have been de- posited in NCBIs Gene Expression Omnibus (GEO; http://www.ncbi.nlm .nih.gov/geo ) and are accessible through GEO Series accession number GSE34561.,OADS,/arxiv_data1/oa_pdf/1c/0b/mBio.00646-13.PMC3781836.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a9/a7/jcav04p0585.PMC3781989.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/52/24/jcav04p0597.PMC3781990.pdf
OncoImmunology 2013; 2:e24720;  http://dx.doi.org/10.4161/onci.24720fashion.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
J  Clin Oncol 2013; 31:860-7; PMID:23341518; http://dx.doi.org/10.1200/JCO.2011.41.0902 3.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
J Natl Cancer Inst 2009; 101:1446-52; PMID:19815849; http://dx.doi.org/10.1093/jnci/ djp335 4.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
J Clin Oncol  2010; 28:105-13; PMID:19917869; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
Cancer Cell 2010; 18:485-98; PMID:21035406; http://dx.doi.org/10.1016/j.ccr.2010.10.002 7.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/74704.,OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
Proc Natl Acad Sci U S A  2011; 108:7142-7; PMID:21482773; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
J Clin Oncol  2009; 27:5685-92; PMID:19884557; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/6c/onci-2-e24720.PMC3782009.pdf
"OncoImmunology 2013; 2:e24850; http://dx.doi.org/10.4161/onci.24850During the past two decades, the notion that cancer would  merely constitute a cell-intrinsic disease has gradually been complemented by a model postulating that the immune  system plays a relevant role during all stages of oncogenesis  and tumor progression.",Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Allergy Clin Immunol 2003; 111(Suppl):S460-75;  PMID:12592293; http://dx.doi.org/10.1067/ mai.2003.1083.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026 35.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2013; 2:e23082;  PMID:23525565; http://dx.doi.org/10.4161/ onci.23082 36.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
OncoImmunology 2013; 2: In press; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Clin Pract Oncol 2006; 3:94-103; PMID:16462850; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Ann Surg Oncol  2012; 19:627-35; PMID:21879272; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Ann Surg 2012; 255:281-6; PMID:22241290; http://dx.doi.org/10.1097/SLA.0b013e318242ebe7 42.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Br J Cancer  2012; 107:37-42; PMID:22644293; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Br J Cancer 2013; 108:58- 63; PMID:23169299; http://dx.doi.org/10.1038/ bjc.2012.506 44.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Angiogenesis 2012; 15:265-73; PMID:22402885;  http://dx.doi.org/10.1007/s10456-012-9259-z 45.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Pediatr Blood  Cancer 2012; 59:44-51; PMID:21994039; http://dx.doi.org/10.1002/pbc.23339 46.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Am J Hematol  2012; 87:865-9; PMID:22674570; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Blood 2012; 119:5367-73; PMID:22422824; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Br J Haematol 2002; 116:468-74; PMID:11841454;  http://dx.doi.org/10.1046/j.1365-2141.2002.03264.x 24.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/ onci.22009 25.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology  2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology  2013; 2:e22789; PMID:23482847; http://dx.doi.org/10.4161/onci.22789 27.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2013; 2:e22789; PMID:23482847; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938 29.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757;  http://dx.doi.org/10.4161/onci.20931 30.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/ onci.20696 31.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
OncoImmunology 2013;  2:e23803; http://dx.doi.org/10.4161/onci.23803 32.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:1111-34; PMID:23170259;  http://dx.doi.org/10.4161/onci.21494 33.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
OncoImmunology 2012; 2:e23510; http://dx.doi.org/10.4161/onci.235106.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Allergy Clin Immunol 2006; 117(Suppl Mini- Primer):S441-5; PMID:16455343; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459 8.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Blood 2008; 111:485-91; PMID:18182579; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Immunol  2005; 6:1191-7; PMID:16369558; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Cancer 2004; 4:11-22;  PMID:14708024; http://dx.doi.org/10.1038/nrc1252 11.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Science 2013; 339:286-91; PMID:23329041;  http://dx.doi.org/10.1126/science.1232227 12.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nature 2002; 420:860-7; PMID:12490959; http://dx.doi.org/10.1038/nature01322 13.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626 14.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Annu  Rev Immunol 2013; 31:51-72; PMID:23157435; http://dx.doi.org/10.1146/annurev-immu- nol-032712-100008 15.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486 16.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Biologics 2008; 2:13- 27; PMID:19707424; http://dx.doi.org/10.2147/BTT.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Blood 2006; 107:1712-6;  PMID:16239431; http://dx.doi.org/10.1182/blood- 2005-07-2661 18.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Eur J Cancer  2012; 48:713-20; PMID:22248711; http://dx.doi.org/10.1016/j.ejca.2011.12.016 19.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Clin Oncol 2012; 30:1064-71; PMID:22393098;  http://dx.doi.org/10.1200/JCO.2011.36.8647,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer 2012; 118:3302-10; PMID:22072099; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Clin Oncol 2012; 30:4077-83; PMID:23008325;  http://dx.doi.org/10.1200/JCO.2011.38.2960 74.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer 2012; 118:3607-13; PMID:22086404; http://dx.doi.org/10.1002/ cncr.26659 75.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer Immunol Immunother 2012; 61:1113-24;  PMID:22198309; http://dx.doi.org/10.1007/s00262- 011-1185-1 76.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncology  2012; 82:139-46; PMID:22433252; http://dx.doi.org/10.1159/000336490 77.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer 2012; 118:4892- 900; PMID:22359313; http://dx.doi.org/10.1002/ cncr.27395 78.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Br  J Cancer 2012; 106:793-8; PMID:22315057; http://dx.doi.org/10.1038/bjc.2011.599 80.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Eur J Cancer  2013; 49:35-44; PMID:22918078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer Immunol Immunother 2012; 61:2261-71;  PMID:22678096; http://dx.doi.org/10.1007/s00262- 012-1286-5 82.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2013; 2:e23079;  PMID:23525192; http://dx.doi.org/10.4161/onci.23079 83.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Med 2011; 17:700-7; PMID:21552268;  http://dx.doi.org/10.1038/nm.236660.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
PLoS One 2012; 7:e39525; PMID:22848356;  http://dx.doi.org/10.1371/journal.pone.0039525 61.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
BJU Int 2012; 109:63-9;  PMID:21244601; http://dx.doi.org/10.1111/j.1464-410X.2010.10011.x 63.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Immunother 2012; 35:702-10; PMID:23090079; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Br J Cancer 2012; 106:284-9; PMID:22215065; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Med Oncol 2012; 29:799- 805; PMID:21607771; http://dx.doi.org/10.1007/ s12032-011-9982-0 67.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cytokine  2012; 57:290-3; PMID:22169779; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Sci T ransl Med 2012; 4:37ra74; PMID:22674552; http://dx.doi.org/10.1126/scitrans- lmed.3003649 69.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Lancet 2008; 372:117-26;  PMID:18620949; http://dx.doi.org/10.1016/S0140- 6736(08)61033-8 70.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Eur J Cancer 2012; 48:218-25; PMID:22056637; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Clin Oncol  2012; 30:3810-8; PMID:23008300; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Am J Hematol 2013; 88:113- 5; PMID:23225085; http://dx.doi.org/10.1002/ ajh.23361 48.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cell Cycle  2011; 10:2323-30; PMID:21654193; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Leukemia 2012; 26:893- 901; PMID:22033493; http://dx.doi.org/10.1038/ leu.2011.294 55.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Clin Cancer Res  2012; 18:1798-807; PMID:22383739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Clin Cancer Res 2012; 18:301-7; PMID:22096023; http://dx.doi.org/10.1158/1078- 0432.CCR-11-2295 57.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Onkologie  2012; 35:494-8; PMID:23007146; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Clin Cancer Res  2012; 18:2290-300; PMID:22374331; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Clin Oncol 2013; 31:490-8; PMID:23269987; http://dx.doi.org/10.1200/JCO.2012.45.2052,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:351-4; PMID:22737612;  http://dx.doi.org/10.4161/onci.19122 112.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:1161- 2; PMID:23170264; http://dx.doi.org/10.4161/ onci.20928 113.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Clin  Oncol 2011; 8:257-8; PMID:21403667; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Drug Discov  2009; 8:273-4; PMID:19337270; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:1420- 1; PMID:23243614; http://dx.doi.org/10.4161/ onci.21120 117.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Cancer 2008; 8:887-99;  PMID:18846100; http://dx.doi.org/10.1038/nrc2507 118.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Hematol Oncol  2004; 22:121-34; PMID:15991222; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Clin Genitourin Cancer 2009;  7:E7-9; PMID:19692326; http://dx.doi.org/10.3816/ CGC.2009.n.014 120.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Oncol 2010;  2010:689893; PMID:20224761; http://dx.doi.org/10.1155/2010/689893 121.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Bioconjug Chem 2013; 24:63-71; PMID:23116517;  http://dx.doi.org/10.1021/bc300488f 123.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Drug Discov Today  2012; 17:583-90; PMID:22289353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology  2012; 1:1223-5; PMID:23243584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2013; 2:e22691;  PMID:23524510; http://dx.doi.org/10.4161/onci.22691 126.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012; 1:563-5; PMID:22754788; http://dx.doi.org/10.4161/ onci.1936996.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Immunol 2012; 13:343-51;  PMID:22430787; http://dx.doi.org/10.1038/ni.2224 99.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Med 2013; 19:57-64; PMID:23202296; http://dx.doi.org/10.1038/nm.2999 100.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Immunol  2012; 189:5590-601; PMID:23152566; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Immunother 2012; 35:587-94; PMID:22892455; http://dx.doi.org/10.1097/CJI.0b013e31826b20b6 104.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nature 2012; 484:529-33; PMID:22446627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Science  2013; 339:328-32; PMID:23329049; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Clin Cancer Res  2008; 14:7624-34; PMID:19047087; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Rev Drug Discov 2010; 9:101-2;  PMID:20118960; http://dx.doi.org/10.1038/nrd3100 109.,OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
J Clin Oncol  2013; 31:1021-8; PMID:23401435; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Oncoimmunology 2012;  1:537-8; PMID:22754778; http://dx.doi.org/10.4161/ onci.1940784.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer Res 2009; 69:3563-9; PMID:19351841;  http://dx.doi.org/10.1158/0008-5472.CAN-08-3807 85.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nat Med  2011; 17:1094-100; PMID:21873989; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer Immunol Immunother  2012; 61:373-84; PMID:21927947; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Lancet Oncol 2012; 13:509-17; PMID:22326922; http://dx.doi.org/10.1016/S1470- 2045(12)70007-4 91.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Cancer Immunol Immunother 2012; 61:839-54;  PMID:22083345; http://dx.doi.org/10.1007/s00262- 011-1128-x 92.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nature 2013; 494:361- 5; PMID:23376950; http://dx.doi.org/10.1038/nature11824 93.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
Nature 2012; 487:500-4; PMID:22763439;  http://dx.doi.org/10.1038/nature11183 94.,Non-OADS,/arxiv_data1/oa_pdf/5b/22/onci-2-e24850.PMC3782010.pdf
OncoImmunology 2013; 2:e24678;  http://dx.doi.org/10.4161/onci.24678proteins and hence are inaccessible to con - ventional mAbs.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Cell 2012; 148:1081- 4; PMID:22424219; http://dx.doi.org/10.1016/j.cell.2012.02.034 2.,OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Nat Rev Cancer 2012; 12:278-87;  PMID:22437872; http://dx.doi.org/10.1038/nrc3236 3.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Sci T ransl  Med 2013; 5:77ra38; PMID:23515080; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Clin Cancer Res 2009; 15:5323-37; PMID:19723653; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Immunity 1997; 6:715-26;  PMID:9208844; http://dx.doi.org/10.1016/S1074- 7613(00)80447-16.,OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Expert Rev Mol Med 2012; 14:e6; PMID:22361332; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
J Immunol 2010; 184:2156-65; PMID:20065111; http://dx.doi.org/10.4049/jimmu- nol.0902414 8.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Blood 2011; 117:4262-72; PMID:21296998;  http://dx.doi.org/10.1182/blood-2010-07-2992489.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Blood 2010; 116:171-9; PMID:20400682; http://dx.doi.org/10.1182/blood- 2009-10-250993 10.,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
Sci T ransl Med 2013; 5:76ra33; PMID:23486779;  http://dx.doi.org/10.1126/scitranslmed.3005661,Non-OADS,/arxiv_data1/oa_pdf/d7/c5/onci-2-e24678.PMC3782011.pdf
"OncoImunology 2013; 2:e24658; http://dx.doi.org/10.4161/onci.24658a reduction in the metastatic potential of  cancer cells and in the levels of COX2, by angiogenesis inhibition as well as by the attenuation of pro-inflammatory path - ways involving, among several mediators, PGE 2.2 Previous studies have not inves - tigated the precise composition of the tumor microenvironment in response to low-dose aspirin.",Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
Nature 2008; 454:436-44;  PMID:18650914; http://dx.doi.org/10.1038/ nature07205 2.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
Nat Rev Clin Oncol 2012; 9:259-67; PMID:22473097; http://dx.doi.org/10.1038/nrcli- nonc.2011.199 3.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
Lancet 2011; 377:31-41;  PMID:21144578; http://dx.doi.org/10.1016/S0140- 6736(10)62110-1 4.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
Cancer Res 2004; 64:7210-5; PMID:15492235;  http://dx.doi.org/10.1158/0008-5472.CAN-04-1795 6.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
Carcinogenesis 2013; 34:1081-8; PMID:23349014;  http://dx.doi.org/10.1093/carcin/bgt009 7.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
PLoS One 2012; 7:e51297; PMID:23284678;  http://dx.doi.org/10.1371/journal.pone.00512978.,Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
"OncoImmunology 2013; 2:3, e23618; http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ef/67/onci-2-e24658.PMC3782012.pdf
OncoImmunology 2013; 2:e24890; http://dx.doi.org/10.4161/onci.24890Homeostatic t Lr4 signaling protects the intestinal epithelium in health.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Cell 2004; 118:229-41;  PMID:15260992; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Infect Immun 2000; 68:7010-7; PMID:11083826;  http://dx.doi.org/10.1128/IAI.68.12.7010-7017.2000 3.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
J  Biol Chem 2012; 287:37296-308; PMID:22955282; http://dx.doi.org/10.1074/jbc.M112.375881 4.,OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Gastroenterology 2007; 133:1869-81;  PMID:18054559; http://dx.doi.org/10.1053/j.gas- tro.2007.09.0085.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Nat Genet  2013; 45:478-86; PMID:23525077; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Gastroenterology  2007; 132:905-12; PMID:17324405; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Nat Genet  2000; 25:187-91; PMID:10835634; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Gastroenterology 2011; 141:2154-65;  PMID:21920464; http://dx.doi.org/10.1053/j.gas- tro.2011.08.043 10.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
Genes Immun  2007; 8:387-97; PMID:17538633; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/91/81/onci-2-e24890.PMC3782013.pdf
"OncoImmunology 2013; 2:e24743; http://dx.doi.org/10.4161/onci.24743including interferon γ (IFN γ), which  upregulated host FASL and hence caused  the apoptotic demise of FAS+ T cells.",Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Science 2011; 331:1565-70;  PMID:21436444; http://dx.doi.org/10.1126/sci- ence.1203486 3.,Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Nat Med 2013; 19:465-72; PMID:23455713; http://dx.doi.org/10.1038/nm.3105 4.,OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
J Exp Med 2003; 197:751-62; PMID:12629067; http://dx.doi.org/10.1084/jem.20021690 6.,Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Nat Med  2004; 10:909-15; PMID:15340416; http://dx.doi.org/10.1038/nm1100 7.,OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Clin Cancer Res  2010; 16:2861-71; PMID:20460488; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Cell Mol Life Sci 2012; 69:1565-75;  PMID:22527712; http://dx.doi.org/10.1007/s00018- 012-0965-x 9.,OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
J Immunol 2011; 187:2310-21;  PMID:21775679; http://dx.doi.org/10.4049/jimmu- nol.1100363 10.,Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
Nature 2011; 480:480-9;  PMID:22193102; http://dx.doi.org/10.1038/ nature10673,Non-OADS,/arxiv_data1/oa_pdf/cc/e0/onci-2-e24743.PMC3782014.pdf
"OncoImmunology 2013; 2:e25514; http://dx.doi.org/10.4161/onci.25514Introduction Regulatory T cells (Tregs), a small subset of CD4+ T cells, have  been shown to play an essential role in maintaining immune  homeostasis and tolerance.1 Studies in mice have established that  the absence of Treg results in severe autoimmune reactions.2 In  cancer, both the frequency and immunosuppressive activity of Tregs are increased.",Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
"Supplemental Material Supplemental materials may be found here:http://www.landesbioscience.com/journals/oncoimmunology/article/25514technology, using a human cytokine 10-plex mAb bead kit (Biosource/Invitrogen).",Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Expert  Opin Biol Ther 2012; 12:1383-97; PMID:22849383;  http://dx.doi.org/10.1517/14712598.2012.707184 2.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Immunol 2011; 187:2061-6;  PMID:21856944; http://dx.doi.org/10.4049/jimmu-nol.1003224 3.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Clin Cancer Res  2009; 15:6348-57; PMID:19825957; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Clin Cancer Res 2007; 13:6301-11; PMID:17975141; http://dx.doi.org/10.1158/1078- 0432.CCR-07-1403 6.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Blood 2012; 119:4430-40; PMID:22438251;  http://dx.doi.org/10.1182/blood-2011-11-392324 8.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Exp Med  2001; 193:1285-94; PMID:11390435; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Exp Med 2001; 193:1303- 10; PMID:11390437; http://dx.doi.org/10.1084/ jem.193.11.1303 10.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Nature 1997; 389:737-42; PMID:9338786; http://dx.doi.org/10.1038/39614 11.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Immunol  Rev 2001; 182:68-79; PMID:11722624; http://dx.doi.org/10.1034/j.1600-065X.2001.1820105.x12.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Exp Med 1976; 144:398-413; PMID:1085327; http://dx.doi.org/10.1084/ jem.144.2.398 13.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Gut 2012; 61:1163- 71; PMID:22207629; http://dx.doi.org/10.1136/ gutjnl-2011-300970 14.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Immunol 2011; 186:4557- 64; PMID:21389255; http://dx.doi.org/10.4049/jim- munol.1003797 15.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Cancer Res 2011; 71:736-46;  PMID:21156649; http://dx.doi.org/10.1158/0008-5472.CAN-10-1797 16.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Immunol 2010; 184:6709-18; PMID:20483736;  http://dx.doi.org/10.4049/jimmunol.0903612 19.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Immunol  2011; 186:6329-37; PMID:21525380; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
AIDS 2012; 26:2112- 5; PMID:22874519; http://dx.doi.org/10.1097/QAD.0b013e328358cc75 22.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
AIDS 2008; 22:2451- 60; PMID:19005268; http://dx.doi.org/10.1097/ QAD.0b013e328319edc023.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Am J T ransplant 2012; 12:669-81; PMID:22081907;  http://dx.doi.org/10.1111/j.1600-6143.2011.03842.x 24.,OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Annu Rev Immunol 1994; 12:337-65;  PMID:8011285; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Cell Death Differ  2006; 13:1017-26; PMID:16557268; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Exp Med 2010; 207:1701-11; PMID:20660617;  http://dx.doi.org/10.1084/jem.20091999 29.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Immunol  2011; 187:3511-20; PMID:21865550; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
J Biomed Biotechnol  2012; 2012:605045; PMID:23093850; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
Int J Cancer 2007; 120:2618-24; PMID:17294448; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
PLoS One 2010; 5:e9852; PMID:20352042;  http://dx.doi.org/10.1371/journal.pone.000985234.,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
AIDS 2007; 21:1683- 92; PMID:17690565; http://dx.doi.org/10.1097/ QAD.0b013e32825eabbc,Non-OADS,/arxiv_data1/oa_pdf/6a/cb/onci-2-e25514.PMC3782015.pdf
OncoImmunology 2013; 2:e24754; http://dx.doi.org/10.4161/onci.24754marrow and accumulation in lymph  nodes and within neoplastic lesions.4  Elevated levels of MDSCs result in the suppression of T-cell proliferation and activation and a net increase in the levels of pro-inflammatory mediators such as reactive oxygen species (ROS).,Non-OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Ann N Y Acad  Sci 2004; 1028:1-13; PMID:15915584; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
J Gerontol A Biol Sci Med Sci 1999; 54:M357-64; PMID:10462168; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Mech Ageing Dev  2007; 128:92-105; PMID:17116321; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Proc Natl Acad Sci U S A 2011; 108:17111- 6; PMID:21969559; http://dx.doi.org/10.1073/ pnas.1108121108 5.,OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
J Leukoc  Biol 2013; 93:633-7; PMID:23341539; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Exp Gerontol 1993; 28:313-21;  PMID:8224030; http://dx.doi.org/10.1016/0531- 5565(93)90058-L 7.,OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
J  Immunol 2011; 186:697-707; PMID:21148798;  http://dx.doi.org/10.4049/jimmunol.10029878.,Non-OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Cancer Immunol Immunother 2012; 61:827-38;  PMID:22080405; http://dx.doi.org/10.1007/s00262- 011-1143-y 10.,Non-OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
Cancer Res 2012; 72:2089-99;  PMID:22496463; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3019,Non-OADS,/arxiv_data1/oa_pdf/cc/d2/onci-2-e24754.PMC3782016.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first  six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80151- X Li, Z., D.I.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1002/eji.20063674 5 Mayerova, D., and K.A.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10   .1084/jem.2008086 6 McGargill, M.A., J.M.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10   .1038/7979 0 McMahan, C.J., and P.J.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80661- 5 Mingueneau, M., T. Kreslavsky, D. Gray, T. Heng, R. Cruse, J. Ericson, S.  Bendall, M.H.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1038/   ni.259 0 Mostoslavsky, R., and F.W.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/   j.it.2004.04.00 1 Nemazee, D., and K.A.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/S0952-7915(03)00008- 6 Page, D.M., L.P. Kane, J.P. Allison, and S.M.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80395- 7 Siegel, R.W., R. Jain, and A. Bradbury.",Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"505:467– 473. http://dx.doi.org/10.1016/S0014-5793(01)02806- X Terrence, K., C.P.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1084/jem.192.4.53 7 Uematsu, Y ., S. Ryser, Z. Dembi ć, P .",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/   0092-8674(88)90425- 4 Wang, F., C.Y.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi   .org/10.1073/pnas.95.20.1183 4this staining, and gating strategy for TCR  cells.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20130876/DC1.,Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1084/jem   .2005035 9 Bruno, L., H.J.",Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80260- 5 Buch, T., F .",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00312- 6 Buch, T., F.L.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1038/nmeth76 2 Croxford, A.L., O. Akilli-Ozturk, F. Rieux-Laucat, I. Förster, A. Waisman,  and T. Buch.",Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1002/eji.20073705 4 Daley, S.R., D.Y.",Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1084/jem.2012145 8 Eberl, G., and D.R.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"305:248– 251. http://dx.doi.org/10.1126/science.109647 2 Egawa, T., T. Kreslavsky, D.R.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1371/ journal.pone.000151 2 Groettrup, M., and H. von Boehmer.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"23:1393– 1396. http://dx.doi.org/10.1002/eji.183023063 3 Kim, H.J., B. Verbinnen, X. Tang, L. Lu, and H. Cantor.",Non-OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
"http://dx.doi.org/10.1038/nature0937 0 Kim, H.J., X. Wang, S. Radfar, T.J. Sproule, D.C. Roopenian, and H. Cantor.",OADS,/arxiv_data1/oa_pdf/40/6f/JEM_20130876.PMC3782038.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1158/1078-0432.CCR-08-014 9 Amcheslavsky, A., J. Jiang, and Y .T.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi   .org/10.1016/j.stem.2008.10.01 6 Barker, N., J.H.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nature0619 6 Barker, N., R.A. Ridgway, J.H.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nature0760 2 Becker, C., M.C.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.immuni.2004.07.02 0 Bertolotti, A., X. Wang, I. Novoa, R. Jungreis, K. Schlessinger, J.H.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/sj.emboj.760077 7 Biteau, B., C.E.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.stem.2008.07.02 4 Bollrath, J., T.J. Phesse, V .A.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.01.00 2 Brady, C.A., D. Jiang, S.S. Mello, T.M.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.03.03 5 Buczacki, S.J., H.I.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1038/nature1196 5 Calle, E.E., C. Rodriguez, K. Walker-Thurmond, and M.J. Thun.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20122341/DC1.,Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1152/   physrev.00001.201 1 Hodin, C.M., F .J.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1002/path.291 7 Hollien, J., J.H.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1083/jcb.20090301 4 Iwawaki, T., R. Akai, S. Yamanaka, and K. Kohno.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1073/pnas.090377510 6 Jiang, H., P.H.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.2337/db10-030 8 Kaser, A., and R.S.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1053/   j.gastro.2011.02.04 8 Kaser, A., A.H. Lee, A. Franke, J.N.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.cell.2008.07.02 1 Kim, T.H., S. Escudero, and R.A. Shivdasani.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1073/pnas.111389010 9 Kinzler, K.W ., and B. V ogelstein.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81333- 1 Kohno, K. 2010.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1093/jb/mvp19 6 Kuraishy, A., M. Karin, and S.I.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1182/blood-   2007-09-11194 8 Lee, A.H., N.N.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1073/pnas.133403710 0 Lee, S.H., L.L.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1053/j.gastro.2008.10.08 6 Lieberman, D.A.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1056/NEJMcp090217 6 Liu, Y., M. Adachi, S. Zhao, M. Hareyama, A.C. Koong, D. Luo, T.A.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
http://dx.doi.org/   10.1038/cdd.2009.1 4Cancer Genome Atlas Network.,OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nature1195 8 Cronin, S.J., N.T .",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1126/   science.117316 4 Danese, S., and C. Fiocchi.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"365:1713– 1725. http://dx.doi.org/10.1056/NEJMra110294 2 Durand, A., B. Donahue, G. Peignon, F. Letourneur, N. Cagnard, C.  Slomianny, C. Perret, N.F.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1146/annurev-pathol-011110-13023 5 Fu, Y ., S. Wey, M. Wang, R. Y e, C.P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1073/pnas.080769110 5 Garrett, W .S., S. Punit, C.A.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.07.01 5 Greenman, C., P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.cell.2004.07.01 3 Grivennikov, S.I., and M. Karin.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.cytogfr.2009.11.00 5 Grivennikov, S., E. Karin, J. T erzic, D. Mucida, G.Y .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.01.00 1 Grivennikov, S.I., F .R.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.01.02 5 Han, D., A.G. Lerner, L. V ande W alle, J.P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.cell.2009.07.01 7 Heazlewood, C.K., M.C.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1371/journal.pmed.005005 4 Heijmans, J., J.F .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"Cell Rep.  3:1128– 1139. http://dx.doi.org/10.1016/j.celrep.2013.02.03 1 Hetz, C., F .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nrm219 9 Salcedo, R., A. Worschech, M. Cardone, Y .",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1084/jem.2010019 9 Sangiorgi, E., and M.R.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/ng.16 5 Sato, T., J.H.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nature0963 7 Schepers, A.G., H.J.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1126/science.122467 6 Schröder, M., and R.J. Kaufman.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1146/ annurev.biochem.73.011303.07413 4 Schwitalla, S., A.A. Fingerle, P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1016/j.cell.2012.12.01 2 Sedelnikova, O.A., C.E.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1016/j.mrrev.2009.12.00 5 Siddiquee, K., S. Zhang, W .C.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1074/jbc.M70697620 0 Takeda, N., R. Jain, M.R.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1126/science.121321 4 Tashiro, E., N. Hironiwa, M. Kitagawa, Y .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1038/ja.2007.6 9 Tian, H., B. Biehs, S. Warming, K.G.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1038/nature1040 8 Todd, D.J., A.H. Lee, and L.H.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nri235 9 Tréton, X., E. Pédruzzi, D. Cazals-Hatem, A. Grodet, Y. Panis, A. Groyer,  R. Moreau, Y. Bouhnik, F. Daniel, and E. Ogier-Denis.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1053/j.gastro.2011.05.03 3 Upton, J.P., L. Wang, D. Han, E.S.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi   .org/10.1126/science.122619 1 Urano, F., X. Wang, A. Bertolotti, Y. Zhang, P. Chung, H.P.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"287:664– 666. http://dx.doi.org/10.1126/science.287.5453.66 4 Uysal-Onganer, P., and R.M.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
http://dx.doi.org/10.1111/j.1748-1716.2011.02297.,Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/onc.2012.13 0 Ma, Y ., and L.M.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nrc150 5 Mantovani, A.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.2174/15665241079131696 8 McGovern, D.P ., A. Gardet, L. Törkvist, P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/ng.54 9 Medema, J.P ., and L. Vermeulen.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/nature1021 2 Mimura, N., M. Fulciniti, G. Gorgun, Y .T.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1182/blood-   2011-07-36663 3 Montgomery, R.K., D.L.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"247:322– 324. http://dx.doi.org/10.1126/science.229672 2 Muñoz, J., D.E.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1038/emboj.2012.16 6 Narimatsu, M., H. Maeda, S. Itoh, T. Atsumi, T. Ohtani, K. Nishida, M. Itoh,  D. Kamimura, S.J.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1128/MCB.21.19.6615-6625.200 1 Ouko, L., T.R.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/   10.1074/jbc.M40287720 0 Ozcan, U., Q. Cao, E. Yilmaz, A.H. Lee, N.N.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1126/science.110316 0 Pickert, G., C. Neufert, M. Leppkes, Y .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1084/jem   .2008268 3 Pierce, J.W ., R. Schoenleber, G. Jesmok, J.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1126/science.114048 8 Romero-Ramirez, L., H. Cao, D. Nelson, E. Hammond, A.H. Lee, H. Y oshida,  K. Mori, L.H.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-04-160 6 Romero-Ramirez, L., H. Cao, M.P .",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10   .1016/j.ydbio.2009.12.00 8 Zheng, W., P. Rosenstiel, K. Huse, C. Sina, R. Valentonyte, N. Mah, L.  Zeitlmann, J. Grosse, N. Ruf, P. Nürnberg, et al.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/sj.gene.636426 3 Zhu, L., P .",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi.org/10.1038/   nature0758 9V allabhapurapu, S., and M. Karin.",OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"27:693– 733. http://dx.doi.org/10.1146/annurev.immunol.021908.13264 1 Walter, P., and D. Ron.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
"http://dx.doi   .org/10.1074/jbc.M40561620 0 Yilmaz, O.H., P. Katajisto, D.W. Lamming, Y. Gültekin, K.E.",Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
http://dx.doi.org/10.1007/s10620-007-9973- 3,Non-OADS,/arxiv_data1/oa_pdf/de/61/JEM_20122341.PMC3782039.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20122508/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1182/blood-2012-11-47025 2 Beijer, M.R., R. Molenaar, G. Goverse, R.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1002/   eji.20134332 5 Belz, G.T., and S.L.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10   .1038/nri314 9 Benson, M.J., K. Pino-Lagos, M. Rosemblatt, and R.J. Noelle.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2007071 9 Blomhoff, R., and H.K.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1002/   neu.2024 2 Bogunovic, M., F .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2007059 0 Copelan, E.A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1056/NEJMra05263 8 Dejardin, E., N.M. Droin, M. Delhase, E. Haas, Y .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/S1074-   7613(02)00423- 5 den Haan, J.M., S.M.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"192:1685– 1696. http://dx.doi.org/10.1084/jem.192.12.168 5 DePaolo, R.W ., V .",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/   10.1038/nature0984 9 Dudley, M.E., J.C. Yang, R. Sherry, M.S.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
http://dx.doi.org/10.1200/JCO.2008.16.544 9,Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1126/science.113608 0 Gatto, D., K. Wood, I. Caminschi, D. Murphy-Durland, P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1038/ni.255 5 Geissmann, F ., P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2003039 0 Germain, P ., C. Gaudon, V .",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1016/j.chembiol.2009.03.00 8 Ginhoux, F ., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2009175 6 Grainger, J.R., E.A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.03.00 3 Hall, J.A., J.R. Grainger, S.P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1016/j.immuni.2011.07.00 2 Iwata, M., A. Hirakiyama, Y .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.immuni.2004.08.01 1 Jaensson-Gyllenbäck, E., K. Kotarsky, F .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1038/mi.2010.9 1 Jung, S., D. Unutmaz, P .",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/   10.1016/S1074-7613(02)00365- 5 Kabashima, K., T.A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1016/j.immuni.2005.02.00 7 Kamphorst, A.O., P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.ab.2008.03.03 8 Kane, M.A., A.E.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1021/   ac702030 f Kastner, P ., H.J.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1182/ blood.V97.5.131 4 Klatt, N.R., J.D.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1038/mi.2012.3 8 Klebanoff, C.A., H.T.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.it.2004.12.00 3 Klebanoff, C.A., N. Acquavella, Z. Y u, and N.P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10   .1016/j.immuni.2011.08.01 3 Liu, K., G.D. Victora, T.A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1126/science.117054 0 Markey, K.A., M. Koyama, R.D.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1182/   blood-2011-12-39816 4 Merad, M., P .",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1146/annurev-immunol-020711-07495 0 Mielke, L.A., S.A. Jones, M. Raverdeau, R. Higgs, A. Stefanska, J.R. Groom, A.  Misiak, L.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2012158 8 Miller, J.C., B.D.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1038/   ni.237 0 Mirza, N., M. Fishman, I. Fricke, M. Dunn, A.M. Neuger, T.J.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-06-169 0 Mitsiadis, T.A., M. Lardelli, U. Lendahl, and I. Thesleff.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1083/jcb.130.2.40 7 Mora, J.R., M. Iwata, B. Eksteen, S.Y .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1126/science.113274 2 Mora, J.R., M. Iwata, and U.H.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1038/nri237 8 Mucida, D., Y .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/   10.1126/science.114569 7 Muranski, P ., A. Boni, P .A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1182/blood-2007-11-12099 8 Muranski, P ., Z.A.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.09.01 9 Naik, S.H., D. Metcalf, A. van Nieuwenhuijze, I. Wicks, L. Wu, M. O’Keeffe,  and K. Shortman.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/   j.bbalip.2011.05.00 4 Niederreither, K., and P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10   .1038/nrg234 0 Overwijk, W .W ., M.R.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"198:569– 580. http://dx.doi.org/10.1084/jem.2003059 0 Palmer, D.C., C.C.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1084/jem.2010235 8 Pooley, J.L., W .R.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi   .org/10.1084/jem.2012003 0 Sekine, C., Y .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"21:295– 301. http://dx.doi.org/10.1093/intimm/dxn14 8 Semba, R.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1002/   eji.20134363 1 Sun, C.M., J.A.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2007060 2 Tallman, M.S., and J.K. Altman.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1182/blood-2009-07-21645 7 Trier, J.S., and T.H.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1172/JCI10533 2 Varol, C., L. Landsman, D.K.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1084/jem.2006101 1 Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y .",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.02 5 Wingert, R.A., R. Selleck, J. Y u, H.D.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1371/ journal.pgen.003018 9 Wu, L., A. D’Amico, K.D.",Non-OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80649- 4 Zammit, D.J., L.S.",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
"http://dx.doi.org/10.1016/j.immuni.2005.03.00 5 Zhang, Y ., J.P .",OADS,/arxiv_data1/oa_pdf/7f/4c/JEM_20122508.PMC3782040.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1038/   nn201 4 Ajami, B., J.L.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1038/mi.2012.8 9 Baker, A.D., A. Malur, B.P .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1194/jlr.M00165 1 Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter,  K. Liu, C. Jakubzick, M.A.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.01 0 Bonfield, T .L., C.F .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1165/rcmb.2003­0148O C Bouwens, L., M. Baekeland, R. De Zanger, and E. Wisse.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1002/   hep.184006043 0 Bouwens, L., D.L.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1084/jem   .2009158 6 Costa, G., V .",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi   .org/10.1016/j.it.2012.01.01 2 Gautier, E.L., A. Chow, R. Spanbroek, G. Marcelin, M. Greter, C. Jakubzick,  M. Bogunovic, M. Leboeuf, N. van Rooijen, A.J.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi   .org/10.4049/jimmunol.120049 5 Gautier, E.L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft,  A. Chow, K.G.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1038/   ni.241 9 Geissmann, F., S. Jung, and D.R.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/S1074­7613(03)00174­ 2After sorting, fetal monocytes and fetal MFs from different donors were  mixed in a 1:1 ratio and administered i.n.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1165/rcmb.2007­0224R C Nugent, K.M., and E.L. Pesanti.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10   .1016/j.immuni.2012.10.01 6 Reed, J.A., M. Ikegami, E.R.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1126/science.121917 9 Serbina, N.V ., and E.G.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1038/ni130 9 Shibata, Y ., P .Y .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/S1074­7613(01)00218­ 7 Suzuki, T., T. Sakagami, B.K.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1084/jem.2008099 0 Takahashi, K., F .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/   10.1002/eji.20124284 7 Tarling, J.D., H.S.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1084/   jem.128.3.41 5 van oud Alblas, A.B., and R. van Furth.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1084/jem.149.6.150 4Geissmann, F ., M.G.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1126/science.117833 1 Ginhoux, F ., M. Greter, M. Leboeuf, S. Nandi, P .",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1126/science.119463 7 Godleski, J.J., and J.D.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/   10.1084/jem.136.3.63 0 Golde, D.W. 1979.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1378/chest.76.2.11 9 Golde, D.W ., M. T errito, T.N.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.7326/0003­4819­85­3­30 4 Gomez Perdiguero, E., C. Schulz, and F. Geissmann.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1002/glia.2239 3 Gonzalez­Rothi, R.J., and J.O.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"90:656– 661. http://dx.doi.org/10.1378/chest.90.5.65 6 Greter, M., J. Helft, A. Chow, D. Hashimoto, A. Mortha, J. Agudo­Cantero, M.  Bogunovic, E.L. Gautier, J. Miller, M. Leboeuf, et al.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.03.02 7 Greter, M., I. Lelios, P .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10   .1378/chest.76.2.15 6 Hashimoto, D., A. Chow, C. Noizat, P .",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/   10.1016/j.immuni.2013.04.00 4 Hoeffel, G., Y .",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1172/JCI11846 1 Kamath, A.T., S. Henri, F .",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi   .org/10.1073/pnas.95.25.1494 4 Lambrecht, B.N.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.03.00 8 Landsman, L., and S. Jung.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi   .org/10.1172/JCI521 2 Liu, K., C. Waskow, X. Liu, K. Yao, J. Hoh, and M. Nussenzweig.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
http://dx.doi.org/10.1038/ni146 2,Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.02 5 Vermaelen, K., and R. Pauwels.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1002/cyto.a.2006 4 Virolainen, M. 1968.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi   .org/10.1084/jem.127.5.94 3 Wang, Y ., K.J.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1038/ni.236 0 Willinger, T., A. Rongvaux, H. Takizawa, G.D. Yancopoulos, D.M.",Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/   10.1073/pnas.101968210 8 Yamamoto, T., M. Naito, H. Moriyama, H. Umezu, H. Matsuo, H. Kiwada,  and M. Arakawa.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.12.00 1 Yoshida, M., M. Ikegami, J.A.",OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
http://dx.doi.org/   10.1089/hum.1998.9.14­210 1,Non-OADS,/arxiv_data1/oa_pdf/8c/15/JEM_20131199.PMC3782041.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2008138 5 Basu, R., D.B.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.02 4 Bennett, C.L., and B.E.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/   j.it.2007.08.01 1 Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter,  K. Liu, C. Jakubzick, M.A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.01 0 Bogunovic, M., A. Mortha, P.A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1172/JCI11979 8 Bry, L., and M.B.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi   .org/10.1128/IAI.74.1.673-681.200 6 Cerovic, V., S.A. Houston, C.L.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/mi.2012.5 3 Chow, A., B.D.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
http://dx.doi.org/10.1038/nri308 7HBSS + 5% FBS + 1X sodium pyruvate + 25 mM Hepes + 50 µg/ml DNaseI +  0.05 mg/ml Collagenase VIII for 1 h at 37°C at 100 rpm.,Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1002/(SICI)1521-4141(199802)28:023.0.CO;2- N Gordon, S., and P .R.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/nri173 3 Hadis, U., B. Wahl, O. Schulz, M. Hardtke-Wolenski, A. Schippers, N. Wagner,  W .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/   j.immuni.2011.01.01 6 Hashimoto, D., J. Miller, and M. Merad.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/   j.immuni.2011.09.00 7 Heufler, C., F .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1002/eji.183026032 3 Higgins, L.M., G. Frankel, G. Douce, G. Dougan, and T.T.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.chom.2010.01.00 6 Hohl, T.M., A. Rivera, L. Lipuma, A. Gallegos, C. Shi, M. Mack, and E.G.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"6:470– 481. http://dx.doi.org/10.1016/j.chom.2009.10.00 7 Hsieh, C.S., S.E.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2008041 4 Johansson-Lindbom, B., M. Svensson, O. Pabst, C. Palmqvist, G. Marquez, R.  Förster, and W .W .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2005110 0 Jönsson, J.I., Z. Xiang, M. Pettersson, M. Lardelli, and G. Nilsson.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"31:3240– 3247. http://dx.doi.org/10.1002/1521-4141(200111)31:113.0.CO;2- E Jung, S., J. Aliberti, P .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1128/   MCB.20.11.4106-4114.200 0 Jung, S., D. Unutmaz, P .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/   S1074-7613(02)00365- 5 Kim, C.H., L. Rott, E.J.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.04.01 3 Kuziel, W .A., S.J.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1023/A:100894282896 0 Dai, X.M., G.R.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi   .org/10.1182/blood.V99.1.11 1 Denning, T.L., Y.C.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/ni151 1 Denning, T.L., B.A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"187:733– 747. http://dx.doi.org/10.4049/jimmunol.100270 1 Diehl, G.E., R.S.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/nature1180 9 Dunay, I.R., R.A. Damatta, B. Fux, R. Presti, S. Greco, M. Colonna,  and L.D.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.05.01 9 Egan, C.E., M.D.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/mi.2009.10 5 Farache, J., I. Koren, I. Milo, I. Gurevich, K.W.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1126/science.111772 9 Gautier, E.L., T. Shay, J. Miller, M. Greter, C. Jakubzick, S. Ivanov, J. Helft,  A. Chow, K.G.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/   ni.241 9 Geissmann, F., C. Auffray, R. Palframan, C. Wirrig, A. Ciocca, L. Campisi,  E. Narni-Mancinelli, and G. Lauvau.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/nri278 4 Geissmann, F., M.G.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1126/science.117833 1 Ginhoux, F., K. Liu, J. Helft, M. Bogunovic, M. Greter, D. Hashimoto, J.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"206:3115– 3130. http://dx.doi.org/10.1084/jem.2009175 6 Goldszmid, R.S., P .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/   ni.208 9 Peters, W ., J.G.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.186.11.181 9 Rivollier, A., J.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2010138 7 Satoh-Takayama, N., C.A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.11.00 1 Schulz, O., E. Jaensson, E.K.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2009192 5 Schulz, C., E. Gomez Perdiguero, L. Chorro, H. Szabo-Rogers, N. Cagnard,  K. Kierdorf, M. Prinz, B. Wu, S.E.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1126/science.121917 9 Serbina, N.V ., and E.G.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1038/ni130 9 Serbina, N.V., T.P.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09032 6 Shortman, K., and S.H.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1038/nri199 6 Simmons, C.P., N.S.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni   .2010.12.00 9 Steinman, R.M., D. Hawiger, and M.C.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1146 /annurev.immunol.21.120601.14104 0 Tamoutounour, S., S. Henri, H. Lelouard, B. de Bovis, C. de Haar, C.J.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/   10.1002/eji.20124284 7 Tsou, C.L., W .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1172/JCI2991 9Langlet, C., S. Tamoutounour, S. Henri, H. Luche, L. Ardouin, C.  Grégoire, B. Malissen, and M. Guilliams.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.4049/jimmunol.110274 4 Lee, S.H., P.M. Starkey, and S. Gordon.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.01.01 7 Lewis, K.L., M.L.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1111/j.0105-2896   .2009.00879. x Liu, K., G.D. Victora, T.A.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1126/science.117124 3 MacDonald, K.P., J.S.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1182/blood-2010-02-26629 6 Maldonado-López, R., T. De Smedt, P. Michel, J. Godfroid, B. Pajak,  C. Heirman, K. Thielemans, O. Leo, J. Urbain, and M. Moser.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/nature0475 4 McKenna, H.J., K.L.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2011267 5 Miller, J.C., B.D.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/   ni.237 0 Mundy, R., T.T.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
http://dx.doi.org/10.1111/j.1462-5822.2005.00625.,Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.18.1.45 1 Nakano, H., K.L.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/ni.170 7 Ota, N., K. Wong, P.A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1084/jem.2005201 6 Y ona, S., and S. Jung.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1097/MOH   .0b013e3283324f8 0 Y ona, S., K.W .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.12.00 1 Zhang, H.H., K. Song, R.L.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi   .org/10.4049/jimmunol.090415 6 Zheng, Y ., P .A.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/   10.1038/nm172 0 Zigmond, E., C. Varol, J. Farache, E. Elmaliah, A.T. Satpathy, G. Friedlander,  M. Mack, N. Shpigel, I.G.",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.02 6Tumanov, A.V ., E.P .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.chom.2011.06.00 2 Uematsu, S., K. Fujimoto, M.H.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi   .org/10.1038/ni.162 2 Varol, C., L. Landsman, D.K.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"204:171– 180. http://dx.doi.org/10.1084/jem.2006101 1 Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.02 5 Varol, C., E. Zigmond, and S. Jung.",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10.1038/nri277 8 Waskow, C., K. Liu, G. Darrasse-Jèze, P .",OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
"http://dx.doi.org/10   .1038/ni.161 5 Wiktor-Jedrzejczak, W ., A. Bartocci, A.W .",Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
http://dx.doi.org/10   .1073/pnas.87.12.482 8,Non-OADS,/arxiv_data1/oa_pdf/58/5c/JEM_20130903.PMC3782042.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1038/ni.177 1 Kawaida, R., T. Ohtsuka, J. Okutsu, T. Takahashi, Y. Kadono, H. Oda, A.  Hikita, K. Nakamura, S. Tanaka, and H. Furukawa.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1084/jem.2002132 1 Khosla, S. 2009.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1056/NEJMe090548 0 Kuroda, Y., C. Hisatsune, T. Nakamura, K. Matsuo, and K. Mikoshiba.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1128/IAI.01316-0 6 Maruyama, K., M. Fukasaka, A. Vandenbon, T. Saitoh, T. Kawasaki, T. Kondo,  K.K.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.02 2 Maruyama, K., T. Kawagoe, T. Kondo, S. Akira, and O. Takeuchi.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1074/jbc.M112.34779 9 Motyckova, G., K.N.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1074/jbc.M41289120 0 Osathanon, T., P. Ritprajak, N. Nowwarote, J. Manokawinchoke, C.  Giachelli, and P. Pavasant.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1002/jbmr.565002061 7 Satoh, T., O. Takeuchi, A. Vandenbon, K. Yasuda, Y. Tanaka, Y. Kumagai,  T. Miyake, K. Matsushita, T. Okazaki, T. Saitoh, et al.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1016/S1534-5807(02)00369- 6 Takeda, K., B.E.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80005- 9 Takeuchi, O., A. Kaufmann, K. Grote, T. Kawai, K. Hoshino, M. Morr,  P.F.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1016/j.cell   .2006.02.01 5 Beckstead, B.L., D.M.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1002/jbmr.53 1 Courtial, N., J.J. Smink, O.N.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1096/fj.11-19085 0 El Kasmi, K.C., A.M. Smith, L. Williams, G. Neale, A.D. Panopoulos,  S.S. Watowich, H. Häcker, B.M.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1101/gad.11.24.348 2 Gonzalo, P., M.C.",Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/   10.1016/j.devcel.2009.11.01 2 Grigoriadis, A.E., Z.Q.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1126/science.793968 5 Iwasaki, H., O. Takeuchi, S. Teraguchi, K. Matsushita, T. Uehata, K.  Kuniyoshi, T. Satoh, T. Saitoh, M. Matsushita, D.M.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10   .1038/ni.213 7 Iwasaki, R., K. Ninomiya, K. Miyamoto, T. Suzuki, Y. Sato, H. Kawana,  T. Nakagawa, T. Suda, and T. Miyamoto.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10   .1016/j.bbrc.2008.10.07 6 Karsenty, G., and E.F. Wagner.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
http://dx.doi.org/10.1038/ni.160 6,Non-OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/10.1084/   jem.2005064 5Yagi, M., K. Ninomiya, N. Fujita, T. Suzuki, R. Iwasaki, K. Morita, N.  Hosogane, K. Matsuo, Y. Toyama, T. Suda, and T. Miyamoto.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
"http://dx.doi.org/   10.1359/jbmr.07040 1 Zhu, H., Z.K.",OADS,/arxiv_data1/oa_pdf/1a/6a/JEM_20130512.PMC3782043.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
Online supplemental material is available at http://www.jem.org/cgi/   content/full/jem.20130783/DC1.,Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"133:1006– 1018. http://dx.doi.org/10.1016/j.cell.2008.03.03 8 Bavik, C., I. Coleman, J.P .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1158/0008­5472   .CAN­05­171 6 Brady, C.A., D. Jiang, S.S. Mello, T.M.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.03.03 5 Braig, M., and C.A.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nature0384 1 Cerwenka, A., J.L.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1038/nrc277 2 Coppé, J.P., K. Kauser, J. Campisi, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1074/ jbc.M60330720 0 Coppé, J.P ., C.K.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1371/journal.pbio.006030 1 Diefenbach, A., A.M. Jamieson, S.D.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"1:119– 126. http://dx.doi.org/10.1038/7779 3 Diefenbach, A., E.R.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/3509310 9 Diefenbach, A., J.K. Hsia, M.Y.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1002/immu.20031001 2 Gasser, S., S. Orsulic, E.J.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
http://dx.doi.org/10.1038/nature0388 4,Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1111/j.1600 ­065X.2007   .00563. x Guerra, N., Y .X.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10   .1016/j.immuni.2008.02.01 6 Hacke, K., B. Rincon­Orozco, G. Buchwalter, S.Y .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"9:82. http://dx.doi.org/10.1186/   1476­4598­9­8 2 Hilpert, J., L. Grosse­Hovest, F. Grünebach, C. Buechele, T. Nuebling,  T. Raum, A. Steinle, and H.R.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.4049/jimmunol.120079 6 Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, R.  Kimura, T. Miyagi, K. Mochizuki, Y. Sasaki, and N. Hayashi.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1002/ijc.1096 6 Jung, H., B. Hsiung, K. Pestal, E. Procyk, and D.H. Raulet.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nature1059 9 Kortlever, R.M., P .J.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1038/ncb144 8 Krizhanovsky, V., M. Yon, R.A. Dickins, S. Hearn, J. Simon, C. Miething,  H. Yee, L. Zender, and S.W.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1016/j.cell.2008.06.04 9 Krtolica, A., S. Parrinello, S. Lockett, P.Y.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1016/j.cell.2008.03.03 9 Laberge, R.M., P .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1007/s12307­011­0069­ 4 Li, H., T. Lakshmikanth, C. Garofalo, M. Enge, C. Spinnler, A. Anichini, L.  Szekely, K. Kärre, E. Carbone, and G. Selivanova.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.4161/cc.10.19.1763 0 Liu, D., and P .J.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
http://dx.doi.org/10.1158/0008­5472.,Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1016/j.cell.2013.03.02 0 Martinez de la T orre, Y ., C. Buracchi, E.M. Borroni, J. Dupor, R. Bonecchi,  M. Nebuloni, F .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1158/1078­0432.CCR­09­099 1 Michaloglou, C., L.C.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nature0389 0 Nardella, C., J.G.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi   .org/10.1038/nrc305 7 Narita, M., S. N ũnez, E. Heard, M. Narita, A.W .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1016/S0092­8674(03)00401­ X Pace, L., A. Tempez, C. Arnold­Schrauf, F. Lemaitre, P. Bousso, L. Fetler,  T. Sparwasser, and S. Amigorena.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1126/science.122704 9 Parrinello, S., J.P .",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1242/jcs.0163 5 Raulet, D.H. 2003.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nri119 9 Raulet, D.H., S. Gasser, B.G.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1146/annurev ­immunol ­032712 ­ 09595 1 Rodier, F., and J. Campisi.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1083/jcb.20100909 4 Rodier, F ., J.P .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1038/ncb190 9 Rodier, F., D.P.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1242/jcs.07134 0 Sagiv, A., A. Biran, M. Y on, J. Simon, S.W .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/onc.2012.20 6 Serrano, M., A.W .",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1016/S0092­8674(00)81902­ 9 Tang, X., M. Asano, A. O’Reilly, A. Farquhar, Y. Yang, and S. Amar.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.2174/15665241280248084 4 Textor, S., N. Fiegler, A. Arnold, A. Porgador, T.G.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1158/0008­ 5472.CAN­10­321 1 T okuyama, M., C. Lorin, F .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1371/   journal.ppat.100226 5 Ventura, A., D.G.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nature0554 1 Vivier, E., D.H. Raulet, A. Moretta, M.A.",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1126/science.119868 7 Wajapeyee, N., R.W .",Non-OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/   10.1016/j.it.2011.05.00 2Xue, W ., L. Zender, C. Miething, R.A. Dickins, E. Hernando, V .",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
"http://dx.doi.org/10.1038/nature0552 9 Yang, G., D.G.",OADS,/arxiv_data1/oa_pdf/3d/cc/JEM_20130783.PMC3782044.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
O n­lin­e su­pple­ men­tal material is available at http://www.jem.org/cgi/co n­ten­t/fu­ll/jem   .20130103/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"9:143– 150. http://dx.doi.org/10.1016/S1074­7613(00)80596­ 8 Ashwell, J.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1038/n­ri186 5 Blader, I.J., I.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1074/jbc   .M10095120 0 Bou­gdou­r, A., D. Mau­bon­, P .",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1084/   jem.2008282 6 Bou­gdou­r, A., E. Du­ran­dau­, M.P .",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/   j.chom.2013.03.00 2 Bran­cho, D., N. Tan­aka, A. Jaeschke, J.J. Ven­tu­ra, N. Kelkar, Y. Tan­aka, M.  Kyu­u­ma, T. Takeshita, R.A. Flavell, an­d R.J. Davis.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1101/gad.110730 3 Bu­tcher, B.A., B.A.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1371/jou­rn­al.ppat   .100223 6 Chan­g, C.I., B.E.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"9:1241– 1249. http://dx.doi.org/10.1016/S1097­2765(02)00525­ 7 Cou­lthard, L.R., D.E.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi   .org/10.1016/j.molmed.2009.06.00 5 Cu­adrado, A., an­d A.R.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1042/   BJ2010032 3 Diskin­, R., M. Leben­diker, D. En­gelberg, an­d O. Livn­ah.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.jmb.2006.08.04 3 Du­n­ay, I.R., R.A. Damatta, B. Fu­x, R. Presti, S. Greco, M. Colon­n­a,  an­d L.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.immu­n­i.2008.05.01 9 Emsley, P., B. Lohkamp, W.G.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1107/S090744491000749 3 Ferreiro, I., M. Joaqu­in­, A. Islam, G. Gomez­Lopez, M. Barragan­, L.  Lombardía, O. Domín­gu­ez, D.G.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"11:144. http://dx.doi   .org/10.1186/1471­2164­11­14 4 Fox, B.A., A. Falla, L.M.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1128/EC.00297­1 0 Fran­cis, D.M., B. Ró życki, D. Koveal, G. Hu­mmer, R. Page, an­d W .",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1038/n­chembio   .707 Garai, Á., A. Zeke, G. Gógl, I. Tör ő, F. Förd ős, H. Blan­ken­bu­rg, T. Bárkai,  J. Varga, A. Alexa, D. Emig, et al.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1126/scisign­al.200300 4 Gazzin­elli, R.T., M. Wysocka, S. Hayashi, E.Y.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1126/scien­ce.106728 9 Goldszmid, R.S., P. Caspar, A. Rivollier, S. White, A. Dzu­tsev, S. Hien­y, B.  Kelsall, G. Trin­chieri, an­d A. Sher.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/   j.mib.2011.07.00 2 Hu­n­ter, C.A., an­d L.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1038/n­rmicro285 8 Hu­yn­h, M.H., an­d V.B.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1128/EC.00358­0 8 Jen­sen­, K.D., Y. Wan­g, E.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/   j.chom.2011.04.01 5 Johan­n­essen­, M., M.P.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.cellsig.2004   .05.00 1 Khan­, I.A., J.A.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/S1074­7613(00)80200­ 9 Kim, L., L. Del Rio, B.A.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"65:3525– 3544. http://dx.doi.org/10.1007/s00018­008­8170­ 7 Lu­, G., Y.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/   10.1074/jbc.M50761020 0 Martin­, A.M., T. Liu­, B.C.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1111/j.1550­ 7408.2006.00230. x Masek, K.S., J. Fiore, M. Leitges, S.F .",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10   .1242/jcs.0320 6 Mashayekhi, M., M.M.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.imm u­n­i.2011.08.00 8 Melo, M.B., K.D.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.pt.2011.08.00 1 Min­ot, S., M.B.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1073/pn­as.111704710 9 Nelson­, M.M., A.R.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"76:828– 844. http://dx.doi.org/10.1128/IAI.01115­0 7 O’Do n­n­ell, A., Z. Odrowaz, a n­d A.D. Sharrocks.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1042/BST2011063 6 Phelps, E.D., K.R.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi   .org/10.1146/an­n­u­rev.micro.62.081307.16280 2 Reid, A.J., S.J.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi   .org/10.1371/jou­rn­al.ppat.100256 7 Remén­yi, A., M.C.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j.molcel.2005.10.03 0Robben­, P .M., M. LaRegin­a, W .A.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1084/jem.2005005 4 Rosowski, E.E., D. Lu­, L. Ju­lien­, L. Rodda, R.A. Gaiser, K.D.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1084/jem.2010071 7 Saeij, J.P., S. Coller, J.P. Boyle, M.E.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1038/n­i117 7 Scharton­­Kersten­, T.M., T.A.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1385/   IR:27:2­3:52 1 Silverman­, E.S., J. Du­, A.J.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1007/s00018­010­0426­ 3 Wiley, M., C. T eygon­g, E. Phelps, J. Radke, an­d I.J.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"206:2747– 2760. http://dx.doi.org/10.1084/jem.2009170 3 Yap, G.S., M.H.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
"http://dx.doi.org/10.1016/j   .micin­f.2005.10.03 1 Zhan­g, Y.Y., J.W.",OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
http://dx.doi.org/10.1016/j.str.2006.04.00 6,OADS,/arxiv_data1/oa_pdf/b1/19/JEM_20130103.PMC3782045.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/nri171 0 Frauwirth, K.A., J.L.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/S1074­7613(02)00323­ 0 Fujii, H., L. Shao, I. Colmegna, J.J. Goronzy, and C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/10.1111/j.0105­2896.2005.00245.,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1007/   s00018­012­0970­ 0 Goronzy, J.J., and C.M.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1016/j.rdc.2010.03.00 1 Greiner, E.F., M. Guppy, and K. Brand.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/j.smim.2012.12   .003 Hirata, T ., M. W atanabe, S. Miura, K. Ijichi, M. Fukasawa, and R. Sakakibara.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10   .1271/bbb.64.204 7 Hohensinner, P.J., J.J. Goronzy, and C.M.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.4049/jimmunol   .100182 2 Kabeya, Y ., N. Mizushima, T. Ueno, A. Yamamoto, T. Kirisako, T. Noda,  E. Kominami, Y .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10   .1093/emboj/19.21.572 0 Kessler, R., F .",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1007/   s11060­007­9471­ 7 King, C., A. Ilic, K. Koelsch, and N. Sarvetnick.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/S0092­8674(04)00335­ 6 Kochi, Y ., A. Suzuki, R. Yamada, and K. Yamamoto.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/nrrheum   .2010.2 3 Koetz, K., E. Bryl, K. Spickschen, W .M.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1073/   pnas.97.16.920 3 Kovacs, J.R., C. Li, Q. Yang, G. Li, I.G.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1073/pnas.091366810 7 Alves, N.L., I.A.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1158/1078­0432.CCR­05­014 9 Bell, B.D., S. Leverrier, B.M.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/10.1111/j.1600­065X.2012.01157.,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1146/annurev­physiol­030212­18365 3 Cavanagh, M.M., C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/j.coi.2012.04.00 3 Chesney, J., R. Mitchell, F .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/   10.1038/nri288 8,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.10.02 0 Seo, M., J.D.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1371/journal.pone   .002417 9 Seyler, T.M., Y.W.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1172/JCI2526 5 Shao, L., H. Fujii, I. Colmegna, H. Oishi, J.J. Goronzy, and C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10   .1084/jem.2008225 1 Shao, L., J.J. Goronzy, and C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1002/emmm.20100009 6 Singh, K., P .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.4049/jimmunol.090178 4 Singh, K., P .",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1002/iub.101 7 Tahvanainen, J., M. Pykäläinen, T. Kallonen, H. Lähteenmäki, O. Rasool,  and R. Lahesmaa.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/j.jim.2005.11.02 4 Takemura, S., P .A.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1172/   JCI6409 8 T elang, S., B.F .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"10:95. http://dx.doi.org/   10.1186/1479­5876­10­9 5 Tsukada, M., and Y .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/0014­5793(93)80398­ E van Gestel, A.M., C.J.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1002/1529­0131   (199810)41:10<1845::AID­ART17>3.0.CO;2­ K Van Schaftingen, E., L. Hue, and H.G.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1126/science.116080 9 Virgin, H.W ., and B. Levine.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/ni.172 6 Walsh, C.M., and B.D.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/10.1038/ni.238 6through degradation of proteins of the cell death machinery.,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/cdd.2011.7 8 Li, G., M. Yu, W.W. Lee, M. Tsang, E. Krishnan, C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/nm.296 3 Liu, F., J.Y.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1182/blood­2010­06­28858 9 MacIver, N.J., R.D.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1146/annurev­immunol­032712­09595 6 Magnoni, L.J., Y .",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1371/journal.pone   .003121 9 Michalek, R.D., V.A.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.4049/jimmunol.100361 3 Mizushima, N., and B. Levine.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1038/ncb0910­82 3 Moncada, S., E.A.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1042/BJ2012042 7 Mor, I., E.C.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1101/sqb   .2011.76.01086 8 Nakamura, H., Y. Makino, K. Okamoto, L. Poellinger, K. Ohnuma, C.  Morimoto, and H. Tanaka.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/   10.1016/j.berh.2007.05.00 3 O’Neill, L.A., and D.G.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi   .org/10.1038/nature1186 2 Okar, D.A., and A.J.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/S0968­0004(00)01699­ 6 Pearce, E.L. 2010.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1016/j.coi.2010.01.01 8 Prevoo, M.L., M.A.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1002/art.178038010 7 Pua, H.H., J. Guo, M. Komatsu, and Y.W.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.4049/jimmunol.080114 3 Rider, M.H., L. Bertrand, D. Vertommen, P .A.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1042/BJ2004075 2 Schmidt, D., J.J. Goronzy, and C.M.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/10   .1172/JCI11863 8,Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10   .1016/j.immuni.2011.09.02 1 W ang, T ., C. Marquardt, and J. Foker.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/261702a 0 Warburg, O.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1126/science.123.3191.30 9 Weyand, C.M., and J.J. Goronzy.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/   10.1038/ncprheum014 2Weyand, C.M., H. Fujii, L. Shao, and J.J. Goronzy.",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"http://dx.doi.org/10.1038/nrrheum.2009.18 0 Yalcin, A., B.F. Clem, A. Simmons, A.",Non-OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
"284:24223– 24232. http://dx.doi.org/10.1074/jbc.M109.01681 6 Y alcin, A., S. T elang, B. Clem, and J. Chesney .",OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
http://dx.doi.org/10.1016/j.yexmp   .2009.01.00 3,OADS,/arxiv_data1/oa_pdf/41/a6/JEM_20130252.PMC3782046.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/   10.1016/j.coi.2012.03.00 8 Aranburu, A., S. Ceccarelli, E. Giorda, R. Lasorella, G. Ballatore, and R.  Carsetti.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4049/jimmunol.100272 2 Berg, S.F., S. Mjaaland, and S. Fossum.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1182/blood-2011-04-34557 9 Borriello, F., M.P.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80333- 7 Bowick, G.C., and A.J.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4161/bbug.2.3.1536 7 Caminschi, I., and K. Shortman.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
http://dx.doi.org/10.1002/eji.20083903 5containing 2 × 105 NP-binding B cells were transferred i.v.,OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/   10.1084/jem.2012012 7 Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N.  Yoshida, T. Kishimoto, and H. Kikutani.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/   1074-7613(94)90095- 7 Kawamura, H., and J.A.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/j.cellsig.2004.01.00 5 Kuraoka, M., D. Liao, K. Yang, S.D.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4049/jimmunol.090154 8 Kuraoka, M., L. McWilliams, and G. Kelsoe.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1007/s12026-010-8185- 7 Lahoud, M.H., F. Ahmet, S. Kitsoulis, S.S. Wan, D. Vremec, C.N.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4049/jimmunol.110117 6 Le Bon, A., C. Thompson, E. Kamphuis, V. Durand, C. Rossmann, U.  Kalinke, and D.F.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/j.vaccine.2011.11.09 0 Mao, C., L. Jiang, M. Melo-Jorge, M. Puthenveetil, X. Zhang, M.C.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/S1074-7613(04)00019- 6 Markowitz, J.S., P.R.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/j.yapd.2012.04.01 7 Miyake, K., Y .",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1084/   jem.180.4.121 7 Miyake, K., Y. Yamashita, M. Ogata, T. Sudo, and M. Kimoto.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1111/j.1600-065X   .2011.01067. x Sancho, D., and C. Reis e Sousa.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"30:491– 529. http://dx.doi.org/10.1146/annurev-immunol-031210-10135 2 Sasaki, Y., S. Casola, J.L.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1084/jem.188.1.9 3 Chaplin, J.W., S. Kasahara, E.A.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4049/jimmunol.110019 8 Chappell, C.P ., K.E.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/   j.coi.2011.03.00 4 Denis, O., D. Latinne, F. Nisol, and H. Bazin.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1093/intimm/5.1.7 1 Dudziak, D., A.O.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1126/science.113608 0 Fink, K., K.S.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/   10.1002/eji.20063599 3 Finkelman, F.D., J. Ohara, D.K.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.4049/   jimmunol.090253 0 Han, J.H., S. Akira, K. Calame, B. Beutler, E. Selsing, and T. Imanishi-Kari.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.05.01 8 He, B., R. Santamaria, W. Xu, M. Cols, K. Chen, I. Puga, M. Shan, H.  Xiong, J.B. Bussel, A. Chiu, et al.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi   .org/10.1038/ni.191 4 Hebeis, B.J., E. Vigorito, and M. Turner.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi   .org/10.1042/BST032078 9 Hebeis, B.J., E. Vigorito, D. Kovesdi, and M. Turner.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1182/blood-2004-10-391 9 Herzenberg, L.A., S.J.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1038/ni77 6 Snider, D.P., and D.M.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1016/j.it.2012.07.00 5 Ueda, Y., D. Liao, K. Yang, A. Patel, and G. Kelsoe.",OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
"http://dx.doi.org/10.1182/blood-   2002-11-357 3 Zhang, J., Y.J.",Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
18:1417– 1424. http://dx.doi.org/10.1002/eji.183018091 8,Non-OADS,/arxiv_data1/oa_pdf/f7/b4/JEM_20130188.PMC3782047.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1074/jbc.274.31.2156 9 de Nadaï, P., A.S. Charbonnier, C. Chenivesse, S. Sénéchal, C. Fournier, J.  Gilet, H. Vorng, Y. Chang, P. Gosset, B. Wallaert, et al.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.11.01 4 Gombert, M., M.C.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1038/ni.198 4 Kodelja, V ., C. Müller, O. Politz, N. Hakij, C.E.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.02.04 0 Liu, T., H.A.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.08.00 7 Nibbs, R.J., T.W .",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20122842/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1038/4271 6 Bellinghausen, I., S. Reuter, H. Martin, J. Maxeiner, U. Luxemburger, O.  Türeci, S. Grabbe, C. Taube, and J. Saloga.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1016/j.jaci.2007.10.02 4 Bonecchi, R., M. Locati, and A. Mantovani.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10   .1016/j.ccr.2011.03.01 7 Chen, J., Y. Yao, C. Gong, F. Yu, S. Su, J. Chen, B. Liu, H. Deng, F.  Wang, L. Lin, et al.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"19:541– 555. http://dx.doi.org/10.1016/j.ccr.2011.02.00 6 Chenivesse, C., Y. Chang, I. Azzaoui, S. Ait Yahia, O. Morales, C. Plé, A.  Foussat, A.B.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.4049/jimmunol.100361 6 D’Ambrosio, D., A. Iellem, R. Bonecchi, D. Mazzeo, S. Sozzani, A. Mantovani,  and F .",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1002/art.2255 9 Prasse, A., C. Probst, E. Bargagli, G. Zissel, G.B.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi   .org/10.1084/jem.2003217 7 Schürpf, T., and T.A.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1038/emboj   .2011.33 3 Schutyser, E., A. Richmond, and J.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1189/jlb.120471 2Thomas, G.D., D. Rückerl, B.H.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1182/blood-   2012-07-44264 0 Tiffany, H.L., L.L.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1084/jem.186.1.16 5 Wei, L., G. Vahedi, H.W.",Non-OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.06.00 3 Zlotnik, A., and O. Y oshie.",OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
http://dx.doi.org/10.1016/j.immuni.2012.05   .008,OADS,/arxiv_data1/oa_pdf/e1/60/JEM_20130240.PMC3782048.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1002/eji.20053523 9 Jung, S., D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser,  S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi   .org/10.1016/S1074-7613(02)00365- 5 Kennedy, M.K., M. Glaccum, S.N.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/   10.1084/jem.2001191 5 Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin,  N. Romani, C.H.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10   .1016/j.immuni.2005.04.00 4 Krieg, C., S. Létourneau, G. Pantaleo, and O. Boyman.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1038/nm.302 5 Laggner, U., P. Di Meglio, G.K. Perera, C. Hundhausen, K.E.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"187:2783– 2793. http://dx.doi.org/10.4049/jimmunol.110080 4 Lande, R., J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1038/nature0611 6 Leonardi, C., R. Matheson, C. Zachariae, G. Cameron, L. Li, E. Edson- Heredia, D. Braun, and S. Banerjee.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1056/NEJMoa110999 7 Lodolce, J.P., D.L.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80664- 0 Lowes, M.A., A.M. Bowcock, and J.G.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1038/   nature0566 3 McInnes, I.B., and F.Y.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/   S0140-6736(00)02530- 7 Merad, M., M.G.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1038/ni85 2 Nestle, F.O., C. Conrad, A. Tun-Kyi, B. Homey, M. Gombert, O.  Boyman, G. Burg, Y.J.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1084/jem.2005050 0 Nestle, F.O., D.H. Kaplan, and J. Barker.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1056/NEJMra080459 5 Nguyen, K.B., T.P.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/0140-6736(91)92168- 2 Baslund, B., N. Tvede, B. Danneskiold-Samsoe, P. Larsson, G. Panayi,  J. Petersen, L.J.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1002/art.2124 9 Bouchaud, G., L. Garrigue-Antar, V. Solé, A. Quéméner, Y. Boublik, E.  Mortier, H. Perdreau, Y. Jacques, and A. Plet.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/j.jmb.2008.07.01 9 Bouchaud, G., E. Mortier, M. Flamant, I. Barbieux, A. Plet, J.P. Galmiche,  Y. Jacques, and A. Bourreille.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1053/j   .gastro.2010.02.04 4 Boyman, O., H.P.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1084/jem.2003148 2 Boyman, O., C. Conrad, G. Tonel, M. Gilliet, and F.O.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/j.it.2006.12.00 5 Boyman, O., C. Krieg, D. Homann, and J. Sprent.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"69:1597– 1608. http://dx.doi.org/10.1007/s00018-012-0968- 7 Burkett, P.R., R. Koka, M. Chien, S. Chai, D.L.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1084/   jem.2004138 9 Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V.R.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10   .1038/nm160 5 Di Meglio, P., G.K. Perera, and F.O.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1074/jbc.274.38.2697 8 Dubois, S., J. Mariner, T.A.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1016/S1074-7613(02)00429- 6 Gilliet, M., C. Conrad, M. Geiges, A. Cozzio, W. Thürlimann, G. Burg,  F.O.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi   .org/10.1001/archderm.140.12.149 0 Hoeve, M.A., N.D. Savage, T. de Boer, D.M.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1172/JCI6186 2 Papp, K.A., C. Leonardi, A. Menter, J.P. Ortonne, J.G.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/   10.1056/NEJMoa110901 7 Rubinstein, M.P., M. Kovar, J.F.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1182/blood-2003-08-281 4 Stoklasek, T.A., K.S.",Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
"http://dx.doi.org/10.1172/JCI6345 1 van der Fits, L., S. Mourits, J.S.",OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
http://dx.doi.org/10.1146/annurev.immunol.17.1.1 9,Non-OADS,/arxiv_data1/oa_pdf/17/02/JEM_20130291.PMC3782049.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi   .org/10.4049/jimmunol.120085 8 Gasse, P., N. Riteau, S. Charron, S. Girre, L. Fick, V. Pétrilli, J. Tschopp,  V. Lagente, V.F.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1164/rccm.200808-1274O C Holler, E., K. Landfried, J. Meier, M. Hausmann, and G. Rogler.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1186/1750-   1172-2-3 5 Kaplan, D.H., B.E.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1182/blood-2008-08-17215 5 Kool, M., T. Soullié, M. van Nimwegen, M.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi   .org/10.1084/jem.2007108 7 Martinon, F., V. Pétrilli, A.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1038/nature0451 6 Martinon, F., A.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/   10.1146/annurev.immunol.021908.13271 5 Pasquini, M.C., and Z. Wang.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/   10.1038/bmt.2008.37 3 Rampello, E., T. Fricia, and M. Malaguarnera.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi   .org/10.1038/ncponc058 1 Reichardt, W., C. Dürr, D. von Elverfeldt, E. Jüttner, U.V.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1038/bmt.2008.26 1 Shlomchik, W.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1038/nri200 0 Turner, B.E., M.E.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1097/TP   .0b013e318187478 7 Wilhelm, K., J. Ganesan, T. Müller, C. Dürr, M. Grimm, A. Beilhack,  C.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1038/   nm.224 2 Yu, Y., D. Wang, C. Liu, K. Kaosaard, K. Semple, C. Anasetti, and X.Z.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://www.nature.com/nri/journal/v4/n7/full/nri1391.htm l Beelen, D.W ., A. Elmaagacli, K.D.",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/   10.1084/jem.2011145 3 Davis, B.K., H. Wen, and J.P .",OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"29:707– 735. http://dx.doi.org/10.1146/annurev-immunol-031210-10140 5 Drexler, S.K., L. Bonsignore, M. Masin, A. Tardivel, R. Jackstadt, H.  Hermeking, P. Schneider, O.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1016/S0140-6736   (09)60237- 3 Ferrari, D., C. Pizzirani, E. Adinolfi, R.M.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
http://dx.doi.org/10.1126/science.122901 0,Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1182/blood-2011-03-34031 5 Zeiser, R., V.H.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi.org/10.1182/blood-2006-01-032 9 Zeiser, R., S. Youssef, J. Baker, N. Kambhan, L. Steinman, and R.S.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
"http://dx.doi   .org/10.1182/blood-2007-08-10600 5 Zeiser, R., D.B.",Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
http://dx.doi.org/10.1182/blood-2007-06-09448 2,Non-OADS,/arxiv_data1/oa_pdf/a5/73/JEM_20130084.PMC3782050.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publica - tion date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike  3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1084/jem.2006217 5 Jankovic, D., D.G.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
http://dx.doi.org/10.1038/mi.2010.,Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1096/fj.06-7452co m Liu, F., and J.L.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1016/   j.molmed.2007.02.00 1 Lugo-Villarino, G., R. Maldonado-Lopez, R. Possemato, C. Penaranda,   and L.H.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1172/JCI6306 7 Pérez, A.R., S.D.",Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1016/j.jneuroim.2011.03.01 0 Roos, D.S., R.G.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1016/   S0091-679X(08)61845- 2 Schulz, E.G., L. Mariani, A. Radbruch, and T. Höfer.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/   10.1016/j.immuni.2009.03.01 3 Sionov, R.V., O. Cohen, S. Kfir, Y. Zilberman, and E. Yefenof.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1084/jem   .2005043 3 Sternberg, E.M. 2006.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1038/nri181 0 Tian, J., W. Qi, X. Li, J.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1371/journal   .pone.003823 3 Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida,  R.A. Kastelein, C. Saris, and C.A.",Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00300- 5 Wüst, S., J. van den Brandt, D. Tischner, A. Kleiman, J.P. Tuckermann,  R. Gold, F. Lühder, and H.M. Reichardt.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80596- 8 Aliberti, J., C. Serhan, and A. Sher.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi   .org/10.1084/jem.2002118 3 Ashwell, J.D., F.W.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10.1084/jem.2001162 9 Bluestone, J.A.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
http://dx.doi.org/10.1111/j.1600-065X.2011.01019.,Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/10   .1016/j.mib.2007.09.01 3 Butcher, B.A., L. Kim, A.D. Panopoulos, S.S. Watowich, P.J.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"407:916– 920. http://dx.doi.org/10.1038/3503810 3 Cyktor, J.C., and J. Turner.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"79:2964– 2973. http://dx.doi.org/10.1128/IAI.00047-1 1 Franchimont, D., J. Galon, M. Gadina, R. Visconti, Y. Zhou, M. Aringer,  D.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
"http://dx.doi.org/   10.1016/j.immuni.2012.11.00 3 Jamieson, A.M., S. Yu, C.H.",OADS,/arxiv_data1/oa_pdf/c4/7d/JEM_20122300.PMC3782051.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1038/nm146 2 Crowe, C.R., K. Chen, D.A.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.4049/jimmunol.090099 5 de Vries, E., D.M.",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100132 9 Eierhoff, T., E.R.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi   .org/10.1371/journal.ppat.100109 9 Gencheva, M., C.J.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"11:79. http://dx.doi.org/10.1186/1471-2199-11-7 9 Hewson, C.A., J.J. Haas, N.W .",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1038/emm.2007.4 1 Jewell, N.A., T. Cline, S.E.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1128/   JVI.01703-0 9 Johnston, S.L.",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1513/pats.200502-018A W Khaitov, M.R., V .",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1111/j.1398-9995.2008   .01826. x Koff, J.L., M.X.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1152/ajplung.00025.200 8 Kumar, N., Y .",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1128/JVI.01969-1 0 Kumar, N., N.R.",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/   10.1128/AAC.00725-1 1 Langhammer, S., R. Koban, C. Y ue, and H. Ellerbrok.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1016/j.antiviral.2010.11.00 6 Liu, K., R.C.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1074/jbc   .M71025720 0 Monick, M.M., K. Cameron, J. Staber, L.S.",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1074/jbc.M40874520 0 Mordstein, M., E. Neugebauer, V .",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi   .org/10.1165/rcmb.2011-0405O C Burgel, P .R., and J.A.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1183/09031936.0017200 7 Choi, A.M., and D.B.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
http://dx.doi.org/10.1016/0014-5793(92)80799- M,OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10   .1128/JVI.00272-1 0 Shao, M.X., and J.A.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.4049/jimmunol.100398 8 Subauste, M.C., and D. Proud.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi   .org/10.1016/S1567-5769(01)00063- 7 Subauste, M.C., D.B.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1172/JCI11806 7Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26   .021607.09040 0 Wang, J., R. Oberley-Deegan, S. Wang, M. Nikrad, C.J.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.4049/jimmunol.090138 6 Zaheer, R.S., and D. Proud.",Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
"http://dx.doi.org/10.1165/   rcmb.2009-0203O C Zhu, L., P .K.",OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
http://dx.doi.org/10.1165/rcmb.2008-0223O C,Non-OADS,/arxiv_data1/oa_pdf/b3/46/JEM_20121401.PMC3782052.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
http://dx.doi.org/10.1111/j.1600-065X.1992.tb01406.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1002/ana.2073 6 Emonet, S.F ., L. Garidou, D.B.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1073/pnas.090008810 6 Farrell, M.A., L. Cheng, M.E.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/0140-6736(91)93249- 9 Feng, G., R.H. Mellor, M. Bernstein, C. Keller-Peck, Q.T.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)   00084- 2 Friedman, H., L. Ch’ien, and D. Parham.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"2:666. http://dx.doi   .org/10.1016/S0140-6736(77)92540- 5 Friese, M.A., and L. Fugger.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1093/brain/awh57 8 Garin, N., and G. Escher.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"105:431– 441. http://dx.doi.org/10.1016/S0306-4522(01)00127- 0 Gilmore, C.P ., I. Donaldson, L. Bö, T. Owens, J. Lowe, and N. Evangelou.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1136/jnnp   .2008.14876 7 Goverman, J.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1038/   nri255 0 Guidotti, L.G., T. Ishikawa, M.V .",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)80295- 2 Hauser, S.L., A.K.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1002/ana.41019061 0 Hommes, D.W ., T.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1136/gut.2005   .07939 2 Huang, S., W .",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1126/science.845630 1 Johnson, G.V ., and R.S.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1002/jnr.49033040 2 Joly, E., and M.B.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1126/science.189171 7 Kägi, D., B. Ledermann, K. Bürki, P .",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1038/   369031a 0 Kägi, D., B. Odermatt, P.S.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
http://dx.doi.org/10.1084/jem.183.5.214 3peripheral lymphoid organs and liver.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/0166-0934(91)   90018- U Bergthaler, A., D. Merkler, E. Horvath, L. Bestmann, and D.D.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1099/vir.0   .82428- 0 Bien, C.G., H. Urbach, M. Deckert, J. Schramm, O.D.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1212/WNL.58.2.25 0 Bien, C.G., T. Granata, C. Antozzi, J.H.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1093/brain/awh41 5 Binder, G.K., and D.E.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1126/science.105974 2 Brown, S.M., J.H.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1073/   pnas.76.5.236 4 Burdeinick-Kerr, R., and D.E.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1128/JVI.79.9.5374-5385.200 5 Campbell, G.R., I. Ziabreva, A.K.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1002/ana.2210 9 Chevalier, G., E. Suberbielle, C. Monnet, V .",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.1371/journal.ppat.100239 3 Cole, G.A., N. Nathanson, and R.A. Prendergast.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1038/238335a 0 Dalmau, J., and M.R.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S1474-4422(08)   70060- 7 Deb, C., R.G.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.1097/NEN.0b013e3181b5417 e Deb, C., R.G.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1371/journal   .pone.001247 8 Dewachter, I., D. Reversé, N. Caluwaerts, L. Ris, C. Kuipéri, C. Van den  Haute, K. Spittaels, L. Umans, L. Serneels, E. Thiry, et al.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1096/fj.07-09949 9 Murray, P.D., D.B.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.1126/science.762477 9 Neumann, H., H. Schmidt, A. Cavalié, D. Jenne, and H. Wekerle.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1084/jem.185.2.30 5 Neumann, H., I.M.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S0166-2236(02)   02154- 9 Nikić, I., D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, F.M.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.1078/0344-0338-0016 6 Owens, G.C., M.N.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"10:56. http://dx.doi.org/   10.1186/1742-2094-10-5 6 Panitch, H.S., R.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1111/j.0013-9580.2004   .33103. x Peschon, J.J., D.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1093/intimm/dxq06 1 Pinschewer, D.D., M. Schedensack, A. Bergthaler, E. Horvath, W .",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1093/brain/awq02 8 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1038/   342559a 0 Platanias, L.C.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1038/nri160 4 Probst, H.C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T.  Dumrese, E. Jones, and M.F.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1093/brain/123.4.68 7 Khanna, K.M., R.H. Bonneau, P.R.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00112- 2 Kim, E.Y., J.J. Priatel, S.J.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1093/brain/awl04 4 Liu, Y., I. Teige, B. Birnir, and S. Issazadeh-Navikas.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1038/nm140 2 Luche, H., O. Weber, T. Nageswara Rao, C. Blum, and H.J.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1002/eji.20063674 5 Mahad, D.J., I. Ziabreva, G. Campbell, N. Lax, K. White, P.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.1093/brain/awp04 6 Manning, P.T., E.M. Johnson Jr., C.L.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1002/ana.2268 1 McDole, J.R., S.C. Danzer, R.Y .",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.2353/ajpath.2010.10023 1 Medana, I.M., A. Gallimore, A. Oxenius, M.M.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1172/JCI2737 2 Meuth, S.G., A.M. Herrmann, O.J.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
http://dx.doi.org/10.1523/JNEUROSCI   .4339-09.200 9,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1084/jem.182.5.120 1 Ramana, C.V ., M.P .",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S1471-   4906(01)02118- 4 Rasmussen, T., J. Olszewski, and D. Lloydsmith.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1212/WNL.8.6.43 5 Reinisch, W., W. de Villiers, L. Bene, L. Simon, I. Rácz, S. Katz, I. Altorjay,  B. Feagan, D. Riff, C.N.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"16:233– 242. http://dx.doi.org/10.1002/ibd.2103 8 Rensing-Ehl, A., U. Malipiero, M. Irmler, J. Tschopp, D. Constam, and A.  Fontana.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi   .org/10.1002/eji.183026094 5 Scheikl, T., B. Pignolet, C. Dalard, S. Desbois, D. Raison, M. Yamazaki, A.  Saoudi, J. Bauer, H. Lassmann, H. Hardin-Pouzet, and R.S.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/   10.4049/jimmunol.110299 8 Schwab, N., C.G.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1093/brain/awp00 3 Sequiera, L.W., L.C.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/S0140-6736(79)   91667- 2Shinkai, Y ., G. Rathbun, K.P .",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/   0092-8674(92)90029- C Shrestha, B., and M.S.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10   .1128/JVI.01136-0 7 Sobottka, B., M.D.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.2353/ajpath.2009.09034 0 Stinchcombe, J.C., and G.M.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
http://dx.doi.org/10.1111/j.1749-6632   .1984.tb14778.,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1016/   S0140-6736(89)91292- 0 Watanabe-Fukunaga, R., C.I.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1038/356314a 0 Whitmire, J.K., J.T.",Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
"http://dx.doi.org/10.1084/jem.2004146 3 Zhang, S., J. Boyd, K. Delaney, and T.H.",OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
http://dx.doi.org/10.1523/   JNEUROSCI.1085-05.200 5,Non-OADS,/arxiv_data1/oa_pdf/0d/b5/JEM_20122143.PMC3782053.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.07.00 1 Chen, J., P .R.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-252 5 Foukas, L.C., M. Claret, W .",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi   .org/10.1038/nature0469 4 Graupera, M., J. Guillermet-Guibert, L.C.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi   .org/10.1038/nature0689 2 Herbert, S.P ., J. Huisken, T.N.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1126/science.117857 7 Hirschi, K.K., and P.A.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"105:3935– 3938. http://dx.doi.org/10.1182/blood-2004-10-395 5 Liu, Z.J., T. Shirakawa, Y .",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1128/MCB.23.1.14-25.200 3 Nasarre, P ., M. Thomas, K. Kruse, I. Helfrich, V .",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-   08-303 0Noguera-Troise, I., C. Daly, N.J. Papadopoulos, S. Coetzee, P .",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1038/nature0535 5 Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W.  Pearce, S.E.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi   .org/10.1016/j.ccr.2006.07.00 3 Potente, M., L. Ghaeni, D. Baldessari, R. Mostoslavsky, L. Rossig, F .",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/ 10.1101/gad.43510 7 Qayum, N., R.J. Muschel, J.H.",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1038/nature0531 3 Rodon, J., R. Dienstmann, V .",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1038/nrclinonc.2013.1 0 Schmid, M.C., C.J.",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi   .org/10.1016/j.ccr.2011.04.01 6 Takeshita, K., M. Satoh, M. Ii, M. Silver, F .P .",OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
"http://dx.doi.org/10.1161/01.RES.0000254788.47304.6 e Wüstehube, J., A. Bartol, S.S. Liebler, R. Brütsch, Y .",Non-OADS,/arxiv_data1/oa_pdf/cf/62/JEM_20121571.PMC3782054.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"After six months it   is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.01 0 Bray, J.R., and J.T.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi   .org/10.2307/194226 8 Bursch, L.S., L. Wang, B. Igyarto, A. Kissenpfennig, B. Malissen, D.H.  Kaplan, and K.A.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi   .org/10.1084/jem.2007196 6 Cerovic, V., S.A. Houston, C.L.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"6:104– 113. http://dx.doi.org/10.1038/mi.2012.5 3 Chang, S.-Y., and M.-N. Kweon.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1007/s10024-   004-3027- z Chow, A., B.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/nri308 7 Chung, H., S.J.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.cell.2012.04.03 7 Cole, J.R., Q. Wang, E. Cardenas, J.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1093/nar/gkn87 9 Coombes, J.L., and F. Powrie.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/   nri233 5 Coombes, J.L., K.R.R.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1084/jem.2007059 0 Denning, T.L., Y.-C. Wang, S.R.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/ni151 1 Denning, T.L., B.A.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/jimmunol.100270 1 Diehl, G.E., R.S.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/nature1180 9 Dresch, C., Y. Leverrier, J. Marvel, and K. Shortman.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.it.2012.04.00 9 Edelson, B.T., W. Kc, R. Juang, M. Kohyama, L.A. Benoit, P.A.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.cell   .2011.04.02 2 Excoffier, L., P.E.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"455:808– 812. http://dx.doi.org/10.1038/nature0724 0 Barthel, M., S. Hapfelmeier, L. Quintanilla-Martínez, M. Kremer, M.  Rohde, M. Hogardt, K. Pfeffer, H. Rüssmann, and W.-D. Hardt.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1128/   IAI.71.5.2839-2858.200 3 Basu, R., D.B.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.02 4 Bobr, A., I. Olvera-Gomez, B.Z.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/   jimmunol.100180 2 Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter,  K. Liu, C. Jakubzick, M.A.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1146/annurev.immunol.25.022106.14163 4 Jaensson, E., H. Uronen-Hansson, O. Pabst, B. Eksteen, J. Tian, J.L.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1084/jem   .2008041 4 Kaplan, D.H., M.C.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi   .org/10.1016/j.immuni.2005.10.00 8 Kaplan, D.H., M.O.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"204:2545– 2552. http://dx.doi.org/10.1084/jem.2007140 1 Kaser, A., O. Ludwiczek, S. Holzmann, A.R.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1023/ B:JOCI.0000018066.46279.6 b Khan, M.A., S. Bouzari, C. Ma, C.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1128/IAI.01141-0 7 Kinnebrew, M.A., C. Ubeda, L.A. Zenewicz, N. Smith, R.A. Flavell, and  E.G.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1086/65020 3 Kinnebrew, M.A., C.G.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.12.01 1 Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P .",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/   j.immuni .2005.04.00 4 Korn, T., E. Bettelli, M. Oukka, and V.K.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1146/   annurev.immunol.021908.13271 0 Lewis, K.L., M.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/jimmunol.100172 3 Lozupone, C., and R. Knight.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"71:8228– 8235. http://dx.doi.org/10.1128/AEM.71.12.8228-8235.200 5 Mangan, P .R., L.E.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/   nature0475 4 Miller, J.C., B.D.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/   10.1038/ni.237 0 Moon, J.J., H.H.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/   10.1126/science.107733 6 Fujimoto, K., T .",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/jimmunol.100403 6 Garrett, W.S., G.M.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.cell.2007.08.01 7 Ghilardi, N., N. Kljavin, Q. Chen, S. Lucas, A.L.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"206:3115– 3130. http://dx.doi.org/10.1084/jem.2009175 6 Guilliams, M., K. Crozat, S. Henri, S. Tamoutounour, P. Grenot, E.  Devilard, B. de Bovis, L. Alexopoulou, M. Dalod, and B. Malissen.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1182/   blood-2009-09-24527 4 Hadis, U., B. Wahl, O. Schulz, M. Hardtke-Wolenski, A. Schippers, N.  Wagner, W. Müller, T. Sparwasser, R. Förster, and O. Pabst.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/   jimmunol.110275 9 Haniffa, M., A. Shin, V. Bigley, N. McGovern, P. Teo, P. See, P.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.04.01 2 Hildner, K., B.T.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1126/science.116420 6 Honda, K., and D.R.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/   10.1146/annurev-immunol-020711-07493 7 Hu, W., T.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/   j.immuni.2011.10.01 3 Igyarto, B.Z., M.C.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/jimmunol.090188 4 Ivanov, I.I., Rde.L.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10   .1016/j.chom.2008.09.00 9 Ivanov, I.I., K. Atarashi, N. Manel, E.L. Brodie, T. Shima, U. Karaoz, D.  Wei, K.C.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
139:485– 498. http://dx.doi.org/10.1016/j.cell.2009.09.03 3,OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2007.07.00 7 Nelson, R.W., J.B. McLachlan, J.R. Kurtz, and M.K.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.4049/jimmunol.120218 3 Perona-Wright, G., K. Mohrs, and M. Mohrs.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1038/ni.186 6 Persson, E.K., H. Uronen-Hansson, M. Semmrich, A. Rivollier, K.  Hägerbrand, J. Marsal, S. Gudjonsson, U. Håkansson, B. Reizis, K.  Kotarsky, and W.W. Agace.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni   .2013.03.00 9 Schlitzer, A., N. McGovern, P. Teo, T. Zelante, K. Atarashi, D. Low,  A.W.S.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/   10.1128/AEM.01541-0 9 Schulz, O., E. Jaensson, E.K.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1084/jem.2009192 5 Semmrich, M., M. Plantinga, M. Svensson-Frej, H. Uronen-Hansson, T.  Gustafsson, A.M. Mowat, U. Yrlid, B.N.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi   .org/10.1084/jem.2011170 3 Sogin, M.L., H.G.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1084/jem.2007060 2 Ubeda, C., L. Lipuma, A. Gobourne, A. Viale, I. Leiner, M. Equinda, R. Khanin,  and E.G.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1084/jem   .2012050 4 Uematsu, S., K. Fujimoto, M.H.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi   .org/10.1038/ni.162 2 Van Maele, L., C. Carnoy, D. Cayet, P. Songhet, L. Dumoutier, I. Ferrero,  L. Janot, F. Erard, J. Bertout, H. Leger, et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.06.02 5 Wirtz, S., C. Neufert, B. Weigmann, and M.F.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
"2:541– 546. http://dx.doi.org/10.1038/nprot.2007.4 1 Zheng, Y., P.A.",OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
http://dx.doi.org/10   .1038/nm172 0,Non-OADS,/arxiv_data1/oa_pdf/a7/3d/JEM_20130728.PMC3782055.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1161/01.RES   .0000179534.17668.f 8 Asher, M.I., S. Montefort, B. Björkstén, C.K.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1042/BST037080 5 Azimi­Nezhad, M., M.G.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/j.cyto.2012.10.02 4 Banerjee, E.R.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/j.tips.2010.04   .009 Bartel, D.P .",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.00 2 Bonauer, A., G. Carmona, M. Iwasaki, M. Mione, M. Koyanagi, A. Fischer, J.  Burchfield, H. Fox, C. Doebele, K. Ohtani, et al.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1126/science.117438 1 Broide, D.H., D. Humber, S. Sullivan, and P. Sriramarao.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1165/ajrcmb   .18.2.282 9 Cardier, J.E., and J. Dempsey.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1128/MCB.05810­1 1 Chen, K., and N. Rajewsky.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1002/jcb.2308 9 Eguchi, M., H. Masuda, S. Kwon, K. Shirakura, T. Shizuno, R. Ito, M. Kobori,  and T. Asahara.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/   10.1016/j.yjmcc.2008.08.00 2 Fabian, M.R., G. Mathonnet, T. Sundermeier, H. Mathys, J.T.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi   .org/10.1016/j.molcel.2009.08.00 4 Fasanaro, P ., S. Greco, M. Lorenzi, M. Pescatori, M. Brioschi, R. Kulshreshtha,  C. Banfi, A. Stubbs, G.A.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1074/ jbc.M109.05277 9 Ferrara, N., H.P .",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/nm0603­   669 Fish, J.E., M.M.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/   nm.275 4 Amano, H., N.R.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/nature0331 5 Liu, J., M.A.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1126/science.110251 3 Lu, T.X., A. Munitz, and M.E.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.4049/jimmunol   .080356 0 Lukacs, N.W ., A. John, A. Berlin, D.C. Bullard, R. Knibbs, and L.M.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1084/jem.2002000 9 Mattes, J., A. Collison, M. Plank, S. Phipps, and P.S.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1196/annals.1392.02 4 Nicoli, S., C. Standley, P. Walker, A. Hurlstone, K.E.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1074/jbc.M110.14569 8 Redington, A.E., W.R. Roche, J. Madden, A.J.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1067/mai.2001.11226 8 Riley, K.J., G.S.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"31:2207– 2221. http://dx.doi.org/10.1038/emboj.2012.6 3 Rosenberg, H.F., S. Phipps, and P.S.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1164/rccm.200701­042O C Sokol, N.S., P .",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1101/gad.167170 8 Srivastava, D. 2006.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/   j.cell.2006.09.00 3 Stephens, R., and D.D.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"15:272– 284. http://dx.doi.org/10.1016/j.devcel.2008.07.00 8 Giraldez, A.J., R.M.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1126/science.110902 0 Hendrickson, D.G., D.J.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1371/journal.pone.000212 6 Holgate, S.T., and R. Polosa.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/nri226 2 Hoshino, M., Y .",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi   .org/10.1067/mai.2001.11562 6 Hoshino, M., M. Takahashi, and N. Aoike.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/   10.1067/mai.2001.11192 8 Ismail, H., M. Mofarrahi, R. Echavarria, S. Harel, E. Verdin, H.W .",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1161/ATVBAHA.112.25154 6 Jackson, R.J., and N. Standart.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1126/stke.3672007re 1 Jacobsen, E.A., S.I.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1084/jem.2007184 0 Jin, D.K., K. Shido, H.G.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"45:889– 897. http://dx.doi.org/10.1165/rcmb.2010­0402O C Karginov, F .V ., C. Conaco, Z. Xuan, B.H.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/   10.1073/pnas.070997110 4 Kim, H.Y., R.H. DeKruyff, and D.T.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/ni.189 2 Kumar, M., T. Ahmad, A. Sharma, U. Mabalirajan, A. Kulshreshtha, A.  Agrawal, and B. Ghosh.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/j.jaci.2011.04.03 4 Larbi, K.Y ., J.P .",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1189/jlb.030212 6 Lee, C.G., H. Link, P .",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1038/nm110 5 Lee, C.G., D. Hartl, G.R.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1084/jem.2008127 1 Ley, K., C. Laudanna, M.I.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
http://dx.doi.org/10.1038/nri215 6,Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1084/jem.180.1.37 1 Tang, F., P. Hajkova, S.C. Barton, K. Lao, and M.A.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1093/nar/gnj00 9 Teijaro, J.R., K.B.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.08.01 5 Thomson, D.W., C.P.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"39:6845– 6853. http://dx.doi.org/10.1093/nar/gkr33 0 Tibbles, H., A. Vassilev, and F .M.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/   10.1016/j.coph.2008.03.00 3 Ulfman, L.H., D.P .",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/   10.1165/rcmb.480 6 Vasudevan, S., and J.A.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi   .org/10.1093/nar/gkl59 0 Voelkel, N.F., R.W.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1152/ajplung.00185.200 5Walsh, E.R., N. Sahu, J. Kearley, E. Benjamin, B.H.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1084/jem.2007183 6 Wang, D., Z. Zhang, E. O’Loughlin, T. Lee, S. Houel, D. O’Carroll, A.  Tarakhovsky, N.G.",Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1101/gad.182758.11 1 Wang, S., A.B.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1016/j.devcel.2008.07   .002 Winter, O., K. Moser, E. Mohr, D. Zotos, H. Kaminski, M. Szyska, K. Roth,  D.M.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1182/blood­2009­12­   25945 7 Zhang, X., P. Shan, D. Jiang, P.W.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1074/jbc.M31294120 0 Zhang, X., P. Shan, G. Jiang, S.S. Zhang, L.E.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1096/fj.06­5668fj e Zheng, T., W. Liu, S.Y.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"http://dx.doi.org/10.1172/JCI590 9 Ziegelbauer, J.M., C.S.",OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
http://dx.doi.org/10.1038/ng.26 6,Non-OADS,/arxiv_data1/oa_pdf/28/22/JEM_20121200.PMC3782056.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original   work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/ab/cmt019.PMC3782062.pdf
http://sct.screening.nhs.uk/  (accessed  on 1 May 2012)  15 Dyson S. Screening under Pressure.,Non-OADS,/arxiv_data1/oa_pdf/3f/ab/cmt019.PMC3782062.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original   work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/26/c4/cmt024.PMC3782063.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8a/64/ddt371.PMC3782068.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/be/ddt349.PMC3782069.pdf
"Rec., autosomal recessive; FTD, frontotemporal dementia; IBMPFD, inclusion body myopathy with early-onset Paget disease and frontotemporal dementia data from AD & FTD mutation database (http://www.molgen.ua.ac.be/FTDMutations Accessed 29 July 2013) ( 164).R78 Human Molecular Genetics, 2013, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e9/be/ddt349.PMC3782069.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/be/ddt349.PMC3782069.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/15/jet047.PMC3782076.pdf
OncoImmunology 2013; 2:e24891; http://dx.doi.org/10.4161/onci.24891of pancreatic carcinomas by the immune  system.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
CA Cancer J Clin 2012; 62:10-29;  PMID:22237781; http://dx.doi.org/10.3322/ caac.20138 2.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Cancer Immunol Immunother 2011; 60:1419- 30; PMID:21644036; http://dx.doi.org/10.1007/ s00262-011-1028-0 3.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Cancer Res 2013; In press; PMID:23514705; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Cancer Cell 2012; 21:822-35; PMID:22698406;  http://dx.doi.org/10.1016/j.ccr.2012.04.0255.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Nat  Rev Drug Discov 2013; 12:130-46; PMID:23370250; http://dx.doi.org/10.1038/nrd3877 6.,OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
J Immunother 2012; 35:299-308; PMID:22495387; http://dx.doi.org/10.1097/ CJI.0b013e3182518e83 7.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Nature  2009; 461:1084-91; PMID:19847259; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
J Gastroenterol  Hepatol 2012; 27(Suppl 2):69-74; PMID:22320920;  http://dx.doi.org/10.1111/j.1440-1746.2011.07000.x9.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Antioxid Redox Signal 2013; In  press; PMID:23394620; http://dx.doi.org/10.1089/ ars.2012.5133 10.,Non-OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
Oncogene 2013;  In press; PMID:23318458; http://dx.doi.org/10.1038/ onc.2012.631,OADS,/arxiv_data1/oa_pdf/0a/56/onci-2-e24891.PMC3782129.pdf
OncoImmunology 2013; 2:e25032;  http://dx.doi.org/10.4161/onci.25032therapeutic settings.,Non-OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Nature 1999; 401:708-12; PMID:10537110; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Immunol Rev 2006; 211:214-24; PMID:16824130;  http://dx.doi.org/10.1111/j.0105-2896.2006.00391.x 3.,Non-OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Immunity 2010; 33:451- 63; PMID:21029957; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Cancer Res 2013; In press;  PMID:23539449; http://dx.doi.org/10.1158/0008-5472.CAN-12-2449 5.,Non-OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
J Clin Invest 2000; 105:R9-14; PMID:10727452;  http://dx.doi.org/10.1172/JCI90516.,Non-OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Nat Med 2013; 19:465-72;  PMID:23455713; http://dx.doi.org/10.1038/nm.3105 7.,OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
Clin  Cancer Res 2009; 15:6881-90; PMID:19903784; http://dx.doi.org/10.1158/1078-0432.CCR-09-1113,Non-OADS,/arxiv_data1/oa_pdf/6e/c6/onci-2-e25032.PMC3782130.pdf
"OncoImmunology 2013; 2:e25374; http://dx.doi.org/10.4161/onci.25374Introduction When dissecting the antigen specificity of tumor-infiltrating  lymphocytes (TILs) in melanoma patients, we detected T-cell responses against 18 different epitopes, predominantly from dif - ferentiation antigens such as melan A (also known as MART1) and gp100.",Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Supplemental Material Supplemental materials may be found here: http://www.landesbioscience.com/journals/oncoimmunology/article/25374were washed twice with PBS supplemented with 2% FBS.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Cancer Res  2012; 72:1642-50; PMID:22311675; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Immunother  2001; 24:323-33; PMID:11565834; http://dx.doi.org/10.1097/00002371-200107000-000083.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Exp Med  1996; 183:1173-83; PMID:8642259; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Exp Med 1999; 190:705- 15; PMID:10477554; http://dx.doi.org/10.1084/ jem.190.5.7055.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Exp Med  2008; 205:2673-82; PMID:18936238; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Clin Cancer Res  2006; 12:7380-8; PMID:17189411; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 20.,OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Clin Oncol  2005; 23:2346-57; PMID:15800326; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Blood 2005; 105:728-34;  PMID:15367432; http://dx.doi.org/10.1182/blood- 2004-07-2548 22.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Int J Cancer 2002; 101:280-6;  PMID:12209980; http://dx.doi.org/10.1002/ ijc.10605 14.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Immunother 2003; 26:257-69; PMID:12806279;  http://dx.doi.org/10.1097/00002371-200305000-00009 15.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Int J Cancer 1998; 78:209-15; PMID:9754654;  http://dx.doi.org/10.1002/(SICI)1097- 0215(19981005)78:2<209::AID-IJC15>3.0.CO;2-5 16.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Cancer Immunol Immunother  2006; 55:1185-97; PMID:16468035; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Vaccine 2002; 20:2463-73;  PMID:12057601; http://dx.doi.org/10.1016/S0264-410X(02)00185-87.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Proc Natl Acad Sci U S A  2001; 98:10302-7; PMID:11517329; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Immunother  2004; 27:220-6; PMID:15076139; http://dx.doi.org/10.1097/00002371-200405000-00006 9.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Clin Cancer Res 2007; 13:566-75;  PMID:17255279; http://dx.doi.org/10.1158/1078- 0432.CCR-06-1576 10.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
J Exp Med 1996; 183:2403-7; PMID:8642353;  http://dx.doi.org/10.1084/jem.183.5.2403 12.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
Cancer Immunol Immunother  2009; 58:553-66; PMID:18751701; http://dx.doi.org/10.1007/s00262-008-0578-2,Non-OADS,/arxiv_data1/oa_pdf/c8/09/onci-2-e25374.PMC3782131.pdf
"OncoImmunology 2013; 2:e24660; http://dx.doi.org/10.4161/onci.24660inducing effective antitumor immune  responses and breaking T-cell tolerance to TAAs, at least in animal models.",Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
PLoS One 2013; 8:e59280;  PMID:23555011; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Immunotherapy 2012; 4:5-7; PMID:22149993;  http://dx.doi.org/10.2217/imt.11.1506.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Nat Immunol  2005; 6:769-76; PMID:15995707; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Nature 2007; 449:419-26; PMID:17898760;  http://dx.doi.org/10.1038/nature06175 2.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Nat Med 1997;  3:558-61; PMID:9142127; http://dx.doi.org/10.1038/ nm0597-558 3.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Clin Dev Immunol 2009;  2009:657369; PMID:20182533; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
Cancer Immunol Immunother  2008; 57:1271-8; PMID:18256828; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/onci-2-e24660.PMC3782132.pdf
OncoImmunology 2013; 2:e25443; http://dx.doi.org/10.4161/onci.25443The essential role played by T  cells in anticancer immunity  is widely accepted.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nature 2008; 454:436-44;  PMID:18650914; http://dx.doi.org/10.1038/ nature07205 33.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nat Med 2011; 17:285-6; PMID:21383737;  http://dx.doi.org/10.1038/nm0311-285 34.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cell 2010; 140:883-99; PMID:20303878; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Semin Cancer Biol 2012; 22:33-40; PMID:22210179;  http://dx.doi.org/10.1016/j.semcancer.2011.12.005 36.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Cell 2010; 17:89-97; PMID:20129250;  http://dx.doi.org/10.1016/j.ccr.2009.12.008 37.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Annu Rev Immunol 2009; 27:83-117;  PMID:19007331; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nat  Rev Immunol 2008; 8:59-73; PMID:18097448;  http://dx.doi.org/10.1038/nri2216 39.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Immunol 2012; 188:5944-53;  PMID:22593620; http://dx.doi.org/10.4049/jimmu- nol.1103071 40.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunol  Res 2011; 49:281-92; PMID:21125343; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nat Rev Immunol 2008;  8:34-47; PMID:18064051; http://dx.doi.org/10.1038/ nri2206 42.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Res  2011; 71:3505-15; PMID:21444674; http://dx.doi.org/10.1158/0008-5472.CAN-10-4316 43.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol  Immunother 2013; 62:87-99; PMID:22772949;  http://dx.doi.org/10.1007/s00262-012-1313-6 44.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Am J Respir  Crit Care Med 2011; 183:1369-79; PMID:21278302;  http://dx.doi.org/10.1164/rccm.201010-1738OC 45.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Exp Med  2000; 192:475-82; PMID:10952717; http://dx.doi.org/10.1084/jem.192.4.47518.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunity 2008; 28:639-50;  PMID:18482568; http://dx.doi.org/10.1016/j.immu- ni.2008.03.017 19.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Int Immunol 2008; 20:729-37;  PMID:18375938; http://dx.doi.org/10.1093/intimm/ dxn031 20.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunity 2002; 16:219-30; PMID:11869683; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother 1982;  13:125-7; PMID:6984356; http://dx.doi.org/10.1007/ BF00205312 22.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
T ransplantation 1993; 55:1356-61; PMID:8100090;  http://dx.doi.org/10.1097/00007890-199306000- 00027 23.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nat Med 1998; 4:627-30; PMID:9585241;  http://dx.doi.org/10.1038/nm0598-627 24.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer  Res 2006; 66:7741-7; PMID:16885377; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer  Res 2009; 69:8420-8; PMID:19843863; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Proc Natl Acad Sci U S A 2011; 108:10662-7; PMID:21670304; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Cell 2005; 7:411- 23; PMID:15894262; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nature 2010; 464:302- 5; PMID:20220849; http://dx.doi.org/10.1038/ nature08782 30.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Immunol 2010; 184:4006-16;  PMID:20194720; http://dx.doi.org/10.4049/jimmu-nol.0903009 31.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother 2010; 59:479-86;  PMID:19957084; http://dx.doi.org/10.1007/s00262- 009-0801-9References 1.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Exp Med 1966; 123:75- 102; PMID:5323079; http://dx.doi.org/10.1084/jem.123.1.75 4.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cell Immunol 1972; 5:180-9; PMID:4403471; http://dx.doi.org/10.1016/0008-8749(72)90094-9 5.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Eur J Immunol 1981;  11:964-8; PMID:6173237; http://dx.doi.org/10.1002/eji.1830111203 7.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Nature 1985; 314:537-9; PMID:3157869;  http://dx.doi.org/10.1038/314537a0 10.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Clin Invest 1997; 100:2757-65; PMID:9389740; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Blood 2008; 112:1570-80;  PMID:18725575; http://dx.doi.org/10.1182/blood-2008-02-078071 14.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Exp Med 1999; 189:1-12; PMID:9874559;  http://dx.doi.org/10.1084/jem.189.1.1 17.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Proc Natl Acad Sci U S A 1994; 91:10962-6; PMID:7971992; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Proc Natl Acad Sci U S A  2005; 102:2010-5; PMID:15684084; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Exp Med  1996; 184:2271-8; PMID:8976182; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Rheumatol 2011; 38:633-41; PMID:21159836; http://dx.doi.org/10.3899/ jrheum.100729 78.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Autoimmun Rev 2012; 11:670-7; PMID:22155204;  http://dx.doi.org/10.1016/j.autrev.2011.11.018 79.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Res 2009; 69:5996-6004;  PMID:19567680; http://dx.doi.org/10.1158/0008- 5472.CAN-08-4619 82.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother 2011; 60:609-19; PMID:21253724; http://dx.doi.org/10.1007/s00262- 011-0972-z 83.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
N Engl J Med  2002; 346:235-42; PMID:11807147; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Ann Oncol  2004; 15:1109-14; PMID:15205206; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunity 2005; 23:7- 18; PMID:16039575; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
BMC Cancer 2009; 9:292; PMID:19698134; http://dx.doi.org/10.1186/1471- 2407-9-292 62.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother  2011; 60:1729-38; PMID:21779876; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Clin Cancer Res  2012; 18:3281-92; PMID:22553348; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Clin Cancer Res  2012; 18:2695-703; PMID:22351685; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
J Immunol 2013; 190:5847-55; PMID:23630345;  http://dx.doi.org/10.4049/jimmunol.1203279 66.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
World J Gastroenterol 2013; 19:8-11;  PMID:23326156; http://dx.doi.org/10.3748/wjg.v19.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Oncoimmunology 2012; 1:1186-8; PMID:23170274;  http://dx.doi.org/10.4161/onci.20641 68.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Oncoimmunology 2012; 1:1623-5; PMID:23264915;  http://dx.doi.org/10.4161/onci.21650 69.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Clin Cancer Res 2012; 18:2417-9; PMID:22442060;  http://dx.doi.org/10.1158/1078-0432.CCR-12-0566 70.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunol Rev 2006; 212:163-9; PMID:16903913;  http://dx.doi.org/10.1111/j.0105-2896.2006.00411.x 74.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Res 2006;  66:4488-95; PMID:16618776; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Clin Cancer Res 2009; 15:4277-87; PMID:19549767;  http://dx.doi.org/10.1158/1078-0432.CCR-09-0537 49.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother 2000; 48:541- 9; PMID:10630306; http://dx.doi.org/10.1007/PL00006672 50.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Immunity  2010; 32:129-40; PMID:20079667; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
"J Immunother 2004; 27:273-81; PMID:15235388; http://dx.doi.org/10.1097/00002371-200407000- 00003 54. von Bergwelt-Baildon MS, Vonderheide RH, Maecker  B, Hirano N, Anderson KS, Butler MO, et al.",OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Blood 2002; 99:3319-25;  PMID:11964299; http://dx.doi.org/10.1182/blood.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Clin  Exp Immunol 2005; 139:458-67; PMID:15730391;  http://dx.doi.org/10.1111/j.1365-2249.2005.02733.x 58.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Res 2006; 66:6843-50; PMID:16818662;  http://dx.doi.org/10.1158/0008-5472.CAN-06-0889 59.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer Immunol Immunother 1995; 41:339-47; PMID:8635191; http://dx.doi.org/10.1007/ BF01526553,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Cancer 2012; 118:63- 71; PMID:21976132; http://dx.doi.org/10.1002/ cncr.2620492.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Oncoimmunology 2012; 1:1156- 8; PMID:23170262; http://dx.doi.org/10.4161/ onci.21653 90.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
Front Oncol 2013;  3:107; PMID:23730621; http://dx.doi.org/10.3389/ fonc.2013.00107 91.,Non-OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
PLoS  One 2012; 7:e32639; PMID:22393427; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/63/d6/onci-2-e25443.PMC3782133.pdf
OncoImmunology 2013; 2:e24889; http://dx.doi.org/10.4161/onci.24889cells of melanoma patients can recognize  allogeneic melanoma cells and mediate cytotoxic functions.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
Science 2013; 339:286-91; PMID:23329041;  http://dx.doi.org/10.1126/science.1232227 2.,OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 3.,OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
J Exp Med 1998; 187:1349-54;  PMID:9547346; http://dx.doi.org/10.1084/ jem.187.8.1349 4.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
PLoS One 2011; 6:e19330;  PMID:21559411; http://dx.doi.org/10.1371/journal.pone.00193305.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
Cancer Res 2012; 72:3997-4007;  PMID:22850419; http://dx.doi.org/10.1158/0008- 5472.CAN-12-1377 6.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
Cancer Res 2013; 73:2468-79;  PMID:23384943; http://dx.doi.org/10.1158/0008- 5472.CAN-12-3450 7.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
J Clin Invest  2013; 123:1457-74; PMID:23454746; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
Blood 2013; 121:1563-73; PMID:23293080;  http://dx.doi.org/10.1182/blood-2012-07-442541 10.,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
Hepatology 2012; 56:157-64; PMID:22290731;  http://dx.doi.org/10.1002/hep.25627,Non-OADS,/arxiv_data1/oa_pdf/e6/c8/onci-2-e24889.PMC3782134.pdf
"OncoImmunology 2:e24963; http://dx.doi.org/10.4161/onci.24963does not require post-transplantation  immunosuppressive therapy, provides a convenient platform for the subsequent implementation of immunotherapies, such as the infusion into patients of donor lym - phocytes or antigen-specific T cells.",Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Blood 2007; 110:1924-32;  PMID:17505014; http://dx.doi.org/10.1182/blood- 2007-03-076844 9.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Blood 2013; 121:308-17; PMID:23160468; http://dx.doi.org/10.1182/blood- 2012-06-435040 10.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Blood 2008; 111:236-42; PMID:17875804;  http://dx.doi.org/10.1182/blood-2007-08-1082415.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Blood 2004; 103:4362-4; PMID:14976044;  http://dx.doi.org/10.1182/blood-2003-11-3862 6.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Biol Blood Marrow T ransplant 2003; 9:312-9;  PMID:12766881; http://dx.doi.org/10.1016/S1083-8791(03)00075-2 7.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Bone Marrow T ransplant 2000; 25:623- 32; PMID:10734296; http://dx.doi.org/10.1038/ sj.bmt.1702187References 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
"Lancet Oncol 2011; 12:1195-203;  PMID:21962393; http://dx.doi.org/10.1016/S1470-2045(11)70243-1 3. van Heijst JW, Ceberio I, Lipuma LB, Samilo DW,  Wasilewski GD, Gonzales AM, et al.",OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Nat Med 2013; 19:372- 7; PMID:23435170; http://dx.doi.org/10.1038/ nm.3100 4.,OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
Nat Clin Pract Oncol 2006; 3:668- 81; PMID:17139318; http://dx.doi.org/10.1038/ ncponc0666,Non-OADS,/arxiv_data1/oa_pdf/9a/76/onci-2-e24963.PMC3782135.pdf
"OncoImmunology 2013; 2:e24882;  http://dx.doi.org/10.4161/onci.24882Nine patients bearing unresectable,  chemotherapy-refractory, advanced BTCs  (intrahepatic bile duct cancer, extrahepatic bile duct cancer or gallbladder cancer) were enrolled in our trial.",Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
Clin Cancer Res 2013; 19:2224-31; PMID:23479678;  http://dx.doi.org/10.1158/1078-0432.CCR-12-35924.,Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
J T ransl Med 2012; 10:141; PMID:22776426;  http://dx.doi.org/10.1186/1479-5876-10-141 5.,Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
Jpn  J Clin Oncol 2012; 42:591-600; PMID:22636067; http://dx.doi.org/10.1093/jjco/hys069 6.,Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
J T ransl  Med 2012; 10:1; PMID:22214470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
Hum Vaccin Immunother 2013; 9:1- 9; http://dx.doi.org/10.4161/hv.23917 10.,Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
J Hepatobiliary Pancreat Sci 2012; 19:171-8;  PMID:21874278; http://dx.doi.org/10.1007/s00534- 011-0437-y,Non-OADS,/arxiv_data1/oa_pdf/95/07/onci-2-e24882.PMC3782136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/db/hft083.PMC3782146.pdf
"OncoImmunology 2013; 2;e25444 http://dx.doi.org/10.4161/onci.25444mice.2 Next, pre-existing Tregs specific  for a variety of antigens including dif - ferentiation (e.g., gp100, TRP2), cancer- testis (e.g., NY-ESO-1), overexpressed (e.g., CEA, EGFR, MUC1), universal (e.g., telomerase, surviving), and viral (e.g., HPV16-derived) antigens were detected in cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
OncoImmunology 2013;  In press; http://dx.doi.org/10.4161/onci.24962 2.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Curr Opin Immunol 2007; 19:217-23; PMID:17306521;  http://dx.doi.org/10.1016/j.coi.2007.02.004 3.,OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
"Cancer Microenviron  2012; PMID:23104434; http://dx.doi.org/10.1007/s12307-012-0122-y 4. van der Burg SH, Piersma SJ, de Jong A, van der Hulst JM, Kwappenberg KM, van den Hende M,  et al.",OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Proc Natl Acad Sci U S A 2007; 104:12087-92; PMID:17615234; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
J Exp Med 2005; 202:919-29; PMID:16186184;  http://dx.doi.org/10.1084/jem.20050463 6.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Cancer Res  2013; 73:539-49; PMID:23108136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Cancer Res  2009; 69:7895-8; PMID:19808962; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Oncoimmunology 2012; 1:642-8; PMID:22934256;  http://dx.doi.org/10.4161/onci.20298 10.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Cancer Res 2012; 72:3557-69; PMID:22573714;  http://dx.doi.org/10.1158/0008-5472.CAN-12-0277 11.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Oncoimmunology 2012; 1:659-69; PMID:22934258;  http://dx.doi.org/10.4161/onci.2038712.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Oncoimmunology 2012; 1:326-33; PMID:22737608;  http://dx.doi.org/10.4161/onci.18852 13.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Cancer Res 2009; 69:8085-93;  PMID:19808957; http://dx.doi.org/10.1158/0008- 5472.CAN-09-2226 15.,Non-OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
Nat Med 2012; PMID:22842478; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/93/bf/onci-2-e25444.PMC3782156.pdf
"OncoImmunology 2013; 2:e25474; http://dx.doi.org/10.4161/onci.25474Introduction Chemokines are chemo tactic cyto kines that facilitate cell migra - tion by directing their movement along concentration gradients.1  Chemokines have pleiotropic and context-dependent effects on  the pathobiology of cancer, including tumor-promoting and/or tumor-suppressing activities.",Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Immunotherapy  2009; 1:109-27; PMID:20635978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Inflamm Allergy Drug Targets  2007; 6:101-7; PMID:17692033; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
T umour  Biol 2004; 25:14-7; PMID:15192307; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Int J Cancer 1997; 71:257-66;  PMID:9139852; http://dx.doi.org/10.1002/ (SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D 6.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Nature 2011; 475:222-5; PMID:21654748; http://dx.doi.org/10.1038/nature10138 7.,OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Int J Biol  Markers 2012; 27:e179-85; PMID:22865298; http://dx.doi.org/10.5301/JBM.2012.9345 8.,OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Cancer Lett 2007; 252:86-92; PMID:17257744; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Semin Cancer Biol  2004; 14:149-54; PMID:15246049; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
J Immunol 2013; 190:6673-80; PMID:23686489; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
J Exp Med 2011; 208:1949-62; PMID:21930770; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Cancer Invest 2008; 26:237-49; PMID:18317964;  http://dx.doi.org/10.1080/07357900701708419 14.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
J Immunother 2001;  24:431-46; PMID:11759067; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
J Immunol  2009; 183:117-28; PMID:19542426; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Immunol Lett 2009; 123:97- 102; PMID:19428556; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
J Cell Mol Med 2009;  13(9B):3939-50; PMID:20196788; http://dx.doi.org/10.1111/j.1582-4934.2009.00685.x20.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Cancer Res  2007; 67:9417-24; PMID:17909051; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Cancer Cell  2011; 20:538-49; PMID:22014578; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Clin Dev Immunol  2012; 2012:948098; PMID:22778768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Expert Rev Mol Diagn 2011; 11:91- 100; PMID:21171924; http://dx.doi.org/10.1586/erm.10.97 25.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Nature 2011; 472:303-4;  PMID:21512566; http://dx.doi.org/10.1038/472303a 26.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
Am J Pathol 2003; 163:2113-26; PMID:14578209; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/36/56/onci-2-e25474.PMC3782157.pdf
"OncoImmunology 2013; 2:e24661; http://dx.doi.org/10.4161/onci.24661suggested to play an important role in this  setting.3 Thus, conditioning the injection  site, and perhaps indirectly draining LNs, may significantly improve the clinical effi - cacy of DC-based immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Adv Drug Deliv Rev 2010; 62:1080- 93; PMID:20800081; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
J Exp Med 2003; 198:615-21; PMID:12925677; http://dx.doi.org/10.1084/jem.20030448 3.,Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Expert Opin Biol Ther  2008; 8:865-74; PMID:18549318; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Clin Cancer Res 2013; 19:1525-33;  PMID:23382117; http://dx.doi.org/10.1158/1078- 0432.CCR-12-1879 5.,Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Clin Cancer Res  2009; 15:2531-40; PMID:19318472; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
NMR Biomed 2012; 25:1095-103; PMID:22315137; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
T rends Biotechnol 2010; 28:363-70; PMID:20427096;  http://dx.doi.org/10.1016/j.tibtech.2010.04.002,OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Clin Cancer Res 2011; 17:5725-35;  PMID:21771874; http://dx.doi.org/10.1158/1078- 0432.CCR-11-12618.,Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Biomaterials  2010; 31:7070-7; PMID:20566214; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
Blood 2012; 120:3945-8;  PMID:22995897; http://dx.doi.org/10.1182/blood- 2012-01-408260,Non-OADS,/arxiv_data1/oa_pdf/e3/d5/onci-2-e24661.PMC3782158.pdf
OncoImmunology 2013; 2:e25205; http://dx.doi.org/10.4161/onci.25205Introduction Non-small cell lung carcinoma (NSCLC) is the leading cause of  cancer-related mortality in the United States.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
"Supplemental Material Supplemental materials may be found here:http://www.landesbioscience.com/journals/oncoimmunology/article/25205analyzed by ELISA, as previously described.",Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Cancer  Cell 2011; 19:72-85; PMID:21251614; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
J Clin Oncol 2013; 31:490-8; PMID:23269987;  http://dx.doi.org/10.1200/JCO.2012.45.2052 4.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Cancer 2008; 113:1387-95; PMID:18671239;  http://dx.doi.org/10.1002/cncr.23712 5.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
N Engl J  Med 2012; 366:2455-65; PMID:22658128; http://dx.doi.org/10.1056/NEJMoa12006946.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690 7.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Clin Cancer Res 2013; 19:1021-34;  PMID:23460533; http://dx.doi.org/10.1158/1078-0432.CCR-12-2063 8.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Cell 2005; 122:947-56; PMID:16153702; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Nat Genet 2009; 41:1238-42;  PMID:19801978; http://dx.doi.org/10.1038/ng.465 10.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Cell Cycle 2010; 9:1480-6; PMID:20372069;  http://dx.doi.org/10.4161/cc.9.8.11203 11.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Am J Respir Crit Care Med 2010; 182:83- 91; PMID:20299530; http://dx.doi.org/10.1164/ rccm.201001-0005OC12.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Lab Invest 2011;  91:1796-804; PMID:21931300; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Br J Cancer 2011; 104:1410- 7; PMID:21468047; http://dx.doi.org/10.1038/ bjc.2011.94 14.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
J Exp Med  2007; 204:831-40; PMID:17389240; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Cancer J  2011; 17:397-402; PMID:21952290; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Sci T ransl Med 2012; 4:27ra37;  PMID:22461641; http://dx.doi.org/10.1126/scitrans- lmed.3003689 23.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
"Proc Natl Acad Sci U S A 2011; 108:16723- 8; PMID:21933959; http://dx.doi.org/10.1073/ pnas.1110814108 21. van Elsas A, Sutmuller RP , Hurwitz AA, Ziskin J, Villasenor J, Medema JP , et al.",OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
PLoS One 2012; 7:e36326;  PMID:22615765; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
PLoS  One 2013; 8:e61427; PMID:23620753; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
Int J Cancer 2001; 92:856-60;  PMID:11351307; http://dx.doi.org/10.1002/ijc.1282,Non-OADS,/arxiv_data1/oa_pdf/09/d0/onci-2-e25205.PMC3782159.pdf
"OncoImmunology 2013; 2:e25049; http://dx.doi.org/10.4161/onci.25049Introduction Human and murine tumor protein D52 (TP52, hereafter referred  to as D52) are expressed at detectable levels in multiple normal tissues and cells.",Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Immunol Immunother  2008; 57:799-811; PMID:17962942; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Clin Biochem 2008; 41:1224-36;  PMID:18710659; http://dx.doi.org/10.1016/j.clinbio- chem.2008.07.012 3.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Clin Ca Res 2008; 14:5050-60;  http://dx.doi.org/10.1158/1078-0432.CCR-07-49944.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Blood 2005; 105:2812-20;  PMID:15576473; http://dx.doi.org/10.1182/blood- 2004-07-2630 5.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Res 2004; 64:1589-94;  PMID:14996714; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3331 8.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Hum Immunol  2008; 69:811-4; PMID:18817828; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Exp Eye Res 2007; 85:626- 36; PMID:17720157; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Eur J Immunol 2010; 40:1375-85; PMID:20186876;  http://dx.doi.org/10.1002/eji.200839210 41.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cell Mol Immunol 2008; 5:401- 6; PMID:19118505; http://dx.doi.org/10.1038/cmi.2008.50 42.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Hum Immunol  2008; 69:745-50; PMID:18832002; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
J Leukoc Biol 2005; 78:1043-51; PMID:16204623;  http://dx.doi.org/10.1189/jlb.0705358 44.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Res 2005; 65:2938-46;  PMID:15805297; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2874 47.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Immunol  Immunother 2002; 50:682-90; PMID:11862420; http://dx.doi.org/10.1007/s00262-001-0240-823.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Semin Immunol  2010; 22:105-12; PMID:20226686; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Crit Rev Immunol  2007; 27:451-62; PMID:18197807; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Expert Rev Vaccines  2005; 4:493-502; PMID:16117706; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Immunol Today 1997; 18:175-82; PMID:9136454;  http://dx.doi.org/10.1016/S0167-5699(97)84664-6 27.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Clin Cancer Res 2007; 13:5991-4;  PMID:17947459; http://dx.doi.org/10.1158/1078- 0432.CCR-07-0686 30.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Crit Rev Oncog 2008; 14:33- 55; PMID:19105569; http://dx.doi.org/10.1615/CritRevOncog.v14.i1.30 31.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Res 2008; 68:7530-40; PMID:18794141; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1635 34.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Balancing between antitumor efficacy and autoimmune pathology  in T-cell-mediated targeting of carcinoembryonic anti- gen. Cancer Res 2008; 68:8446-55; PMID:18922918;  http://dx.doi.org/10.1158/0008-5472.CAN-08-1864 35.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Biochim Biophys Acta 1998; 1443:155-68;  PMID:9838088; http://dx.doi.org/10.1016/S0167- 4781(98)00211-5 11.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Biochem Biophys Res Commun 2006; 344:798- 806; PMID:16631610; http://dx.doi.org/10.1016/j.bbrc.2006.03.208 12.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Nature 2001; 412:822-6; PMID:11518967; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Res 2004; 64:3814-22;  PMID:15172988; http://dx.doi.org/10.1158/0008- 5472.CAN-03-3881 15.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Oncogene 2002; 21:7256- 65; PMID:12370817; http://dx.doi.org/10.1038/ sj.onc.1205900 16.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Int J Cancer 2005; 117:1049- 54; PMID:15986428; http://dx.doi.org/10.1002/ ijc.21250 17.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Genes Cancer 2012; 3:87-101; PMID:23050042; http://dx.doi.org/10.1177/1947601912456287 18.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
J Cell Biol 1963; 17:299-313; PMID:13985244; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Cancer Immunol  Immunother 2009; 58:1337-49; PMID:19169682;  http://dx.doi.org/10.1007/s00262-009-0659-x 20.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Vaccine 2009; 27:1825-33;  PMID:19201387; http://dx.doi.org/10.1016/j.vac- cine.2009.01.089 21.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Mol Cancer Res 2007; 5:133-44; PMID:17314271;  http://dx.doi.org/10.1158/1541-7786.MCR-06-0245 22.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
Clin Cancer Res 2009; 15:5323-37; PMID:19723653; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3d/52/onci-2-e25049.PMC3782160.pdf
OncoImmunology 2013; 2:e24659 http://dx.doi.org/10.4161/onci.24659condition induced by allogeneic stem cell  transplantation and donor lymphocyte infusion.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Clin Cancer Res  2013; 19:1467-75; PMID:23382115; http://dx.doi.org/10.1158/1078-0432.CCR-12-2177.5.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Nat Med 2003; 9:1144-50; PMID:12925844;  http://dx.doi.org/10.1038/nm915 7.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Clin Exp Immunol 2008; 152:381-7; PMID:18341610; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
J Clin Invest 2007; 117:1167-74; PMID:17476346;  http://dx.doi.org/10.1172/JCI31202 2.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Sci T ransl  Med 2010; 2:41ra52; PMID:20650872; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Blood 2011; 117:1061-70; PMID:20952687;  http://dx.doi.org/10.1182/blood-2010-07-293795 4.,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
Blood  2008; 112:2340-52; PMID:18617638; http://dx.doi.org/10.1182/blood-2008-01-133967,Non-OADS,/arxiv_data1/oa_pdf/c2/6c/onci-2-e24659.PMC3782161.pdf
"OncoImmunology 2013; 2:e24964;  http://dx.doi.org/10.4161/onci.24964of cytokine-based approaches represent  a primary advantage of immunotherapy over chemotherapy, despite the severe side effects that often accompany the use of these biological agents in the clinic.",Non-OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
Eur Urol 2011; 60:615-21; PMID:21741761;  http://dx.doi.org/10.1016/j.eururo.2011.06.0492.,OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
J Interferon Cytokine Res 2013; 33:171-80;  PMID:23570383; http://dx.doi.org/10.1089/ jir.2012.00873.,OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
Mol Cell Biol 2011; 31:2934- 46; PMID:21576359; http://dx.doi.org/10.1128/ MCB.05445-11,Non-OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
Blood 2010; 115:2864-71;  PMID:20139095; http://dx.doi.org/10.1182/blood- 2009-10-2505558.,Non-OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
Int J Biochem Cell Biol 2011; 43:1537- 49; PMID:21854869; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
IFNalpha/beta promotes cell survival by  activating NF-kappa B. Proc Natl Acad Sci U S A  2000; 97:13631-6; PMID:11095741; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
Drug Discov Today  2012; 17:583-90; PMID:22289353; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
PLoS One  2013; 8:e61446; PMID:23613854; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0c/e4/onci-2-e24964.PMC3782162.pdf
OncoImmunology 2013; 2:e24744; http://dx.doi.org/10.4161/onci.24744recognition and destruction by the  immune system.,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
T rends Mol Med 2010; 17:47- 55; PMID:20971039; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
J Immunol  2013; 190:3806-14; PMID:23455497; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
T rends Immunol 2011; 32:19- 25; PMID:21067974; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
J Immunol 2012; 189:4165-74;  PMID:22972920; http://dx.doi.org/10.4049/jimmu- nol.1201241 6.,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
Clin Cancer Res  2005; 11:1842-8; PMID:15756008; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
J Immunol 2012; 189:3054-63; PMID:22855708;  http://dx.doi.org/10.4049/jimmunol.1200701References 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
Proc Natl Acad Sci U S A  2003; 100:10388-92; PMID:12920180; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
Immunity  2003; 18:849-61; PMID:12818165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
Immunity 2003; 18:863-73;  PMID:12818166; http://dx.doi.org/10.1016/S1074- 7613(03)00147-X 4.,OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
J Exp Med 2011; 208:1683-94; PMID:21727190; http://dx.doi.org/10.1084/ jem.20100639,Non-OADS,/arxiv_data1/oa_pdf/b1/e6/onci-2-e24744.PMC3782163.pdf
"OncoImmunology 2013; 2:e24898; http://dx.doi.org/10.4161/onci.24898In a recent study aimed at addressing  these issues, we identified a monospecific  Treg population, which we termed “MJ23” Tregs, that was recurrently enriched in oncogene-driven murine prostate tumors.",Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Clin Cancer  Res 2012; 18:3022-9; PMID:22510350; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Annu Rev Immunol  2012; 30:733-58; PMID:22224762; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Science  2013; 339:1219-24; PMID:23471412; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Annu Rev Immunol  2009; 27:287-312; PMID:19302042; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Cancer Res 2012; 72:3557-69; PMID:22573714; http://dx.doi.org/10.1158/0008-5472.CAN-12-0277 7.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Cancer Res 2011; 71:736-46;  PMID:21156649; http://dx.doi.org/10.1158/0008- 5472.CAN-10-17978.,Non-OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
Nature 2012; 482:395-9; PMID:22318520; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/6d/onci-2-e24898.PMC3782164.pdf
"OncoImmunology 2013; 2:e24679; http://dx.doi.org/10.4161/onci.24679protein is also expressed by non-immu - nosuppressive Tregs.3 To circumvent both  these issues, we utilized FOXP3 and CD127  as Treg markers and observed an elevated frequency of CD4 +FOXP3+CD127− Tregs  in HCC patients.",Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Cancer Res  2013; 73:2435-44; PMID:23423978; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Cancer Res 2005;  65:2457-64; PMID:15781662; http://dx.doi.org/10.1158/0008-5472.CAN-04-3232 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Cancer Res 2009; 69:3995-4000; PMID:19383912; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Blood 2011; 118:5371-9;  PMID:21856865; http://dx.doi.org/10.1182/blood- 2011-04-3457776.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa1003466 7.,OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690 8.,OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Sci T ransl  Med 2012; 4:34ra62; PMID:22593175; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Clin Cancer Res 2009; 15:2148-57;  PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332 10.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
Clin Cancer Res  2008; 14:6674-82; PMID:18927310; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d2/a2/onci-2-e24679.PMC3782165.pdf
OncoImmunology 2013; 2:e25009; http://dx.doi.org/10.4161/onci.25009microbial challenges.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Lancet 2009; 373:1550-61;  PMID:19282026; http://dx.doi.org/10.1016/S0140- 6736(09)60237-3 2.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938;  http://dx.doi.org/10.1038/nri3175 3.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
J Immunol 2010; 185:2273-84; PMID:20644162; http://dx.doi.org/10.4049/jimmu- nol.1000901 4.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Cancer Res 2010; 70:4335-45; PMID:20484028;  http://dx.doi.org/10.1158/0008-5472.CAN-09-37676.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Blood 2011; 117:6532-41; PMID:21493801; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Blood 2011; 118:6971- 4; PMID:22039265; http://dx.doi.org/10.1182/blood- 2011-06-357814 8.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Blood  2010; 116:5738-47; PMID:20807889; http://dx.doi.org/10.1182/blood-2010-06-2878399.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Biol Blood Marrow  T ransplant 2013; 19:692-702; PMID:23376089;  http://dx.doi.org/10.1016/j.bbmt.2013.01.008 10.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
Hepatology  2012; 55:343-53; PMID:21953144; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dd/58/onci-2-e25009.PMC3782166.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/fc/dddt-7-973.PMC3782407.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 973–980Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  973Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3804 2Prevention of venous thromboembolism in  hospitalized acutely ill medical patients: focus   on the clinical utility of (low-dose) fondaparinux Marcello Di Nisio1,2 ettore Porreca3 1Department of Medical, Oral and  Biotechnological Sciences, University  G D’Annunzio of Chieti-Pescara,  Chieti, italy; 2Department of vascular  Medicine, Academic Medical Center,  Amsterdam, The Netherlands;  3Department of Medicine and  Aging, Centre for Aging Sciences,  internal Medicine Unit, University G  D’Annunzio Foundation, Chieti, italy Correspondence: Marcello Di Nisio   Department of Medical, Oral and  Biotechnological Sciences, University G  D’Annunzio of Chieti-Pescara, via dei  vestini 31, 66013 Chieti, italy   Tel +39 32 8329 0020   Fax +39 08 7135 7361   email mdinisio@unich.i tAbstract:  Venous thromboembolism (VTE) is a frequent complication among acutely ill  medical patients hospitalized for congestive heart failure, acute respiratory insufficiency,  rheumatologic disorders, and acute infectious and/or inflammatory diseases.",Non-OADS,/arxiv_data1/oa_pdf/dc/fc/dddt-7-973.PMC3782407.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dc/fc/dddt-7-973.PMC3782407.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/fc/dddt-7-973.PMC3782407.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/0a/clep-5-371.PMC3782504.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/c4/0a/clep-5-371.PMC3782504.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/ceg-6-173.PMC3782506.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 173–175Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  173CasE rEportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/CEG.S5092 9alteration of liver function due to H1N1   infection: a case report ahmed H alhammadi Mohamed a Hendaus anas a Kayoum Department of p ediatrics, section   of General pediatrics, Hamad   Medical Corporation, Doha, Qatar Correspondence: ahmed H alhammadi   Department of pediatrics, section of   General pediatrics, Hamad Medical   Corporation, Doha 3050, Qatar   tel +974 4439 2239   Fax +974 4443 9571   Email aalhammadi@hmc.org.q aAbstract:  H1N1 virus is known to affect the respiratory tract.",Non-OADS,/arxiv_data1/oa_pdf/9f/43/ceg-6-173.PMC3782506.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/9f/43/ceg-6-173.PMC3782506.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/43/ceg-6-173.PMC3782506.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/64/ceg-6-177.PMC3782509.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 177–184Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  177HypotHEsisopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/CEG.S4777 2A clinical case-based hypothesis: secretory igA  operates as an electronic transistor controlling  the selection or rejection of molecules   in the absorption process in the lumen   of gastrointestinal tract Alfred V Zamm Retired, Malibu, CA, UsA Correspondence: Alfred V Zamm   po Box 6050, Malibu, CA 90264, UsA   Email alfredzamm@aol.co mAbstract:  There is a clinical correlation between (1) an allergic patient’ s ability to resist  the development of symptoms that would have resulted from an allergenic challenge, (2) the  magnitude of geomagnetism at a geographic site, and (3) the amount of solar energy falling  on that site.",Non-OADS,/arxiv_data1/oa_pdf/16/64/ceg-6-177.PMC3782509.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/16/64/ceg-6-177.PMC3782509.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/64/ceg-6-177.PMC3782509.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpHIV/AIDS - Research and Palliative Care 2013:5 263–274HIV/AIDS - Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  263ReVIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S3631 1A review of cardiovascular and renal function  monitoring: a consideration of older adults   with HIV Clark D Kebodeaux1 Alexandria Garavaglia  wilson1 Daron L Smith2 Scott Martin Vouri1 1St Louis College of Pharmacy,   Division of Pharmacy Practice,   St Louis, MO, USA; 2St Louis College  of Pharmacy, Adjunct Faculty,   St Louis, MO, USA Correspondence: Scott Martin Vouri   St Louis College of Pharmacy,   4588 Parkview Place, St Louis,   MO 63110, USA   Tel +1 314 446 8551   Fax +1 314 446 8500   email scott.vouri@stlcop.ed uAbstract:  The prevalence of human immunodeficiency virus (HIV) infection in older and  elderly adults is significant worldwide.",Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"Available from: http://www.cdc.gov/mmwr/ preview/mmwrhtml/00018871.ht m. Accessed August 12, 2013.",OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"Available from: http://www.cdc.gov/hiv/topics/surveillance/resources/ reports/2006report/pdf/2006SurveillanceReport.pd f. Accessed  August 12, 2013.",OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
Available from:  http://www.cdc.gov/hiv/surveillance/resources/reports/2011report/ pdf/2011_HIV_Surveillance_Report_vol_23.pdf#Pag e=17.,OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
Available from: http://circ.ahajournals.org/content/125/1/ e2.full.pdf +html.,Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"Available from http://aidsinfo.nih.gov/contentfiles/lvguidelines/  AdultandAdolescentGL.pd f. Accessed August 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
"Available from: http://www.europeanaidsclinicalsociety.org/ images/stories/EACS-Pdf/EacsGuidelines-v6.1-2editio n. Accessed  August 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/12/hiv-5-263.PMC3782510.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/37/3a/ceg-6-195.PMC3782511.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 195–200Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  195OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S4920 2The long-term outcomes of a cohort   of sri lankan patients with ulcerative colitis:  a retrospective study at two national referral  centers and review of literature sudul Mananjala  senanayake1 anthony nilesh ranjeev  Fernandopulle2 Madunil anuk niriella1,3 nethini Thilanga  Wijesinghe3 amanda ranaweera3 Mohammadu nisar  Mufeena3 arunasalam Pathmeswaran4 nawarathnelage  Meththananda nawarathne2 arjuna Priyadarsin de silva1,3 hithanadura Janaka de  silva1,3 1University Medical Unit, Colombo  north T eaching hospital, ragama,   sri lanka; 2Gastroenterology Unit,   national hospital of sri lanka,   Colombo, sri lanka; 3Department  of Medicine, Faculty of Medicine,   University of Kelaniya, ragama,    sri lanka; 4Department of Public  health, Faculty of Medicine, University  of Kelaniya, ragama, sri lanka Correspondence: hithanadura Janaka   de silva   Department of Medicine, Faculty   of Medicine, University of Kelaniya,   PO Box 6, Thalagolla road,   ragama 11010, sri lanka   Tel +94 77 777 7862 (mobile);   +94 11 295 3409   Fax +94 11 295 8337   Email hjanakadesilva@gmail.co mBackground:  Inflammatory bowel disease, especially ulcerative colitis, is increasing in many  “non-Western” countries, including Sri Lanka.",Non-OADS,/arxiv_data1/oa_pdf/37/3a/ceg-6-195.PMC3782511.pdf
Available from: http://hinari-gw.who.int/whalecomotm.oxford - medicine.com/whalecom0/cgi/content/full/med-9780199204854- chapter-1512.,Non-OADS,/arxiv_data1/oa_pdf/37/3a/ceg-6-195.PMC3782511.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/37/3a/ceg-6-195.PMC3782511.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/3a/ceg-6-195.PMC3782511.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/d3/ceg-6-185.PMC3782512.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical and Experimental Gastroenterology 2013:6 185–192Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  185OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S4521 5application of colon capsule endoscopy (CCE)   to evaluate the whole gastrointestinal tract:   a comparative study of single-camera   and dual-camera analysis José María remes-Troche1 Victoria alejandra Jiménez- García2 Josefa María García-Montes2 Pedro hergueta-Delgado2 Federico roesch-Dietlen1 Juan Manuel herrerías- Gutiérrez2 1Digestive Physiology and Motility lab,   Medical Biological research institute,   Universidad Veracruzana, Veracruz,   México; 2Gastroenterology service,   Virgen Macarena University hospital,   seville, spain Correspondence: Juan Manuel herrerías- Gutierrez   Gastroenterology service, Virgen  Macarena University hospital,    avda Dr. Fedriani, s/n41071 sevilla, spain   T el +34 95 500 88 01   Fax +34 95 500 88 05   Email jmhg@us.e sBackground and study aims:  Colon capsule endoscopy (CCE) was developed for the   evaluation of colorectal pathology.",Non-OADS,/arxiv_data1/oa_pdf/47/d3/ceg-6-185.PMC3782512.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/47/d3/ceg-6-185.PMC3782512.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/d3/ceg-6-185.PMC3782512.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/7b/clep-5-363.PMC3782515.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 363–369Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  363REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S4889 0Screening for severe combined immunodeficiency  in neonates Brian T Kelly1 Jonathan S Tam1 James W Verbsky1,2 John M Routes1,2 1Department of Pediatrics,  2Department of Microbiology and  Molecular Genetics, Medical College  of Wisconsin, Milwaukee, WI, USA Correspondence: John M Routes   9000 West Wisconsin Avenue,   Suite 440, Milwaukee, WI 53226, USA   Tel +1 414 266 6840   Fax +1 414 266 6437   Email jroutes@mcw.ed uAbstract:  Severe combined immunodeficiency (SCID) is a rare disease that severely affects  the cellular and humoral immune systems.",Non-OADS,/arxiv_data1/oa_pdf/64/7b/clep-5-363.PMC3782515.pdf
"Available from: http://www.hrsa.gov/advisorycom - mittees/mchbadvisory/heri table disorders/recommendations/correspon - dence/combinedimmunodeficiency.pd f. Accessed April 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/64/7b/clep-5-363.PMC3782515.pdf
"Available from:  http://apps.who.int/iris/bitstream/10665/37650/1/WHO_PHP_34.pd f.  Accessed April 3, 2013.",OADS,/arxiv_data1/oa_pdf/64/7b/clep-5-363.PMC3782515.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/64/7b/clep-5-363.PMC3782515.pdf
OncoImmunology 2013; 2:e25238; http://dx.doi.org/10.4161/onci.25238Toll-like receptors (TLr s) have long been known for their  ability to initiate innate immune responses upon exposure to  conserved microbial components such as lipopolysaccharide  (LPS) and double-stranded r NA.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell 1985; 42:791-8; PMID:3931919;  http://dx.doi.org/10.1016/0092-8674(85)90275-2 2.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell 1985; 42:779-89;  PMID:3931918; http://dx.doi.org/10.1016/0092- 8674(85)90274-0 3.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell 1996; 86:973-83;  PMID:8808632; http://dx.doi.org/10.1016/S0092-8674(00)80172-5 4.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
DNA  Res 1994; 1:27-35; PMID:7584026; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nature  1997; 388:394-7; PMID:9237759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nature  1998; 395:284-8; PMID:9751057; http://dx.doi.org/10.1038/26239 8.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science  1995; 270:1804-6; PMID:8525370; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Mol Cell 2000; 5:1003-11;  PMID:10911994; http://dx.doi.org/10.1016/S1097- 2765(00)80265-8 11.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Proc Natl Acad Sci U S A 2005; 102:9577- 82; PMID:15976025; http://dx.doi.org/10.1073/ pnas.0502272102 12.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Sci Signal 2012;  5:pe11; http://dx.doi.org/10.1126/scisignal.2002963 19.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science  2012; 335:859-64; PMID:22344444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nature 2000; 408:740-5; PMID:11130078;  http://dx.doi.org/10.1038/35047123 21.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science  2004; 303:1529-31; PMID:14976261; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science 2004; 303:1526-9; PMID:14976262; http://dx.doi.org/10.1126/science.1093620 23.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:227-8; PMID:22720251; http://dx.doi.org/10.4161/onci.1.2.18169 24.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nature  2001; 413:732-8; PMID:11607032; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science  2008; 320:379-81; PMID:18420935; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:189- 94; PMID:22720240; http://dx.doi.org/10.4161/ onci.1.2.18495 29.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Immunol 2010; 10:826-37; PMID:21088683; http://dx.doi.org/10.1038/ nri287331.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Hepatol  2013; In press; PMID:23567086; http://dx.doi.org/10.1016/j.jhep.2013.03.033 32.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Mol Cell  Biol 2012; 13:780-8; PMID:23175281; http://dx.doi.org/10.1038/nrm3479 33.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Biol Chem 2002; 277:15028- 34; PMID:11836257; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Med 2010; 16:713-7;  PMID:20473308; http://dx.doi.org/10.1038/nm.2150 38.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Med 2007; 13:1042-9; PMID:17767165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Annu Rev Immunol 2013; 31:51-72; PMID:23157435;  http://dx.doi.org/10.1146/annurev-immu- nol-032712-100008 40.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Metastasis Rev 2011; 30:61-9;  PMID:21249425; http://dx.doi.org/10.1007/s10555- 011-9273-4 41.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1165- 6; PMID:23170266; http://dx.doi.org/10.4161/ onci.20929 42.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Cancer 2009; 9:57-63;  PMID:19052556; http://dx.doi.org/10.1038/nrc2541 43.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Hepatology 2012; 56:1971-82; PMID:22532075;  http://dx.doi.org/10.1002/hep.25801 44.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nature  2010; 464:104-7; PMID:20203610; http://dx.doi.org/10.1038/nature08780 45.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Neoplasma 2013; 60:459- 67; PMID:23581420; http://dx.doi.org/10.4149/ neo_2013_060 75.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
T umour Biol 2013; In press;  PMID:23592020; http://dx.doi.org/10.1007/s13277-013-0795-y 77.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Natl Cancer Inst  2012; 104:1796-807; PMID:23197495; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Drug Discov 2012; 11:215-33; PMID:22301798; http://dx.doi.org/10.1038/nrd3626 79.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2013; 2:e22945; PMID:23526132; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Immunol Immunother 2012; 61:2067-77;  PMID:22552381; http://dx.doi.org/10.1007/s00262- 012-1268-7 81.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Clin Immunol 2012; 32:848-54; PMID:22371291; http://dx.doi.org/10.1007/s10875- 012-9666-3 82.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Arch Dermatol Res 2013; 305:59-67;  PMID:23179584; http://dx.doi.org/10.1007/s00403- 012-1300-y 83.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS  One 2012; 7:e29918; PMID:22242189; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Clin Pathol 2012; 65:333-8; PMID:22267982; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Clin Neurosci 2012; 19:75-80;  PMID:22169598; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2011; 6:e24370;  PMID:21931695; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Hum Immunol 2012; 73:668- 72; PMID:22504414; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
BMC Cancer 2012; 12:57; PMID:22309608; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Korean Med  Sci 2012; 27:1333-8; PMID:23166414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Sci 2012; 103:653-8; PMID:22320262;  http://dx.doi.org/10.1111/j.1349-7006.2012.02210.x 67.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
BMC Cancer 2013; 13:219; PMID:23634849; http://dx.doi.org/10.1186/1471- 2407-13-219 68.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Mol Biol Rep  2012; 39:8425-30; PMID:22714906; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncology  2012; 82:35-40; PMID:22286521; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS  One 2013; 8:e60327; PMID:23565226; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
World  J Urol 2012; 30:225-32; PMID:21553150; http://dx.doi.org/10.1007/s00345-011-0690-3 72.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral  loads and susceptibility to hepatocellular carcinoma  in chronic hepatitis C. Int J Cancer 2012; 130:1470- 5; PMID:21500195; http://dx.doi.org/10.1002/ ijc.2614346.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Med 2003; 9:831-5; PMID:12835699;  http://dx.doi.org/10.1038/nm0703-831 47.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Immunol 2009; 9:535-42; PMID:19556980; http://dx.doi.org/10.1038/nri2587 49.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Immunol 2007; 7:353-64; PMID:17457343; http://dx.doi.org/10.1038/nri2079 50.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:699-716;  PMID:22934262; http://dx.doi.org/10.4161/ onci.20696 51.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell Death Differ 2012; 19:107-20; PMID:21760595;  http://dx.doi.org/10.1038/cdd.2011.96 52.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Cancer  2012; 12:860-75; PMID:23151605; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2013; 2:e22197; PMID:23482346;  http://dx.doi.org/10.4161/onci.22197 54.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Immunol Rev  2007; 220:47-59; PMID:17979839; http://dx.doi.org/10.1111/j.1600-065X.2007.00573.x 55.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Med 2007; 13:1050-9;  PMID:17704786; http://dx.doi.org/10.1038/nm1622 56.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:340- 5; PMID:22737610; http://dx.doi.org/10.4161/ onci.18434 59.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Sci 2007; 98:1790-4;  PMID:17711514; http://dx.doi.org/10.1111/j.1349- 7006.2007.00590.x 60.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Hum Genet 2009; 54:655- 9; PMID:19745833; http://dx.doi.org/10.1038/ jhg.2009.90,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1323- 43; PMID:23243596; http://dx.doi.org/10.4161/ onci.22009 118.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Urol 2013; In press; PMID:23545101; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Jpn J Clin Oncol 2012; 42:813-9; PMID:22761255; http://dx.doi.org/10.1093/jjco/hys097 121.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Eur Urol 2013; 63:462-72;  PMID:23141049; http://dx.doi.org/10.1016/j.euru - ro.2012.10.039 122.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Urol 2012; 187:862-7; PMID:22245325; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Expert Opin Investig Drugs  1998; 7:1475-82; PMID:15992044; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J T ransl  Med 2012; 10:28; PMID:22325452; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Drug Discov 2007; 6:431-2; PMID:17633789;  http://dx.doi.org/10.1038/nrd2332 127.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Med Sci Monit 2012; 18:PI5-9; PMID:22293891;  http://dx.doi.org/10.12659/MSM.882449 128.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Am Acad Dermatol  2012; 66:e131-7; PMID:22226430; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Dev Immunol  2011; 2011:609579; PMID:22110526; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science 2010; 327:1345-50;  PMID:20223979; http://dx.doi.org/10.1126/sci- ence.1177319 103.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:894-907; PMID:23162757;  http://dx.doi.org/10.4161/onci.20931 104.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
OncoImmunology 2013; 2:e24238; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:306-15; PMID:22737606; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2013; 2:e23082;  PMID:23525565; http://dx.doi.org/10.4161/onci.23082 107.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:179-88; PMID:22720239;  http://dx.doi.org/10.4161/onci.1.2.19026 108.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2013; 2:e23510; PMID:23687621;  http://dx.doi.org/10.4161/onci.23510 109.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1111-34; PMID:23170259;  http://dx.doi.org/10.4161/onci.21494 110.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2013; 2:e23803; PMID:23734328; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2013; 2: In press; http://dx.doi.org/10.146.onci.24850 112.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:493-506;  PMID:22754768; http://dx.doi.org/10.4161/ onci.20459 113.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012;  1:28-37; PMID:22720209; http://dx.doi.org/10.4161/ onci.1.1.17938 114.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2013; 2:e22789; PMID:23482847; http://dx.doi.org/10.4161/onci.22789 115.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
OncoImmunology 2013; 2:e24612; http://dx.doi.org/10.4161/onci.24612 116.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1557-76; PMID:23264902; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Breast Cancer Res T reat 2012; 135:481-93;  PMID:22847512; http://dx.doi.org/10.1007/s10549- 012-2181-7 88.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Br J Cancer 2013; 108:638- 43; PMID:23287987; http://dx.doi.org/10.1038/ bjc.2012.589 89.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
T umour Biol 2013; 34:1053-9; PMID:23338716; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oral Oncol 2012; 48:226- 32; PMID:22070917; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1161- 2; PMID:23170264; http://dx.doi.org/10.4161/ onci.20928 92.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Lancet 2009; 374:301-14; PMID:19586656; http://dx.doi.org/10.1016/S0140- 6736(09)61248-4 93.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:995-6; PMID:23162784;  http://dx.doi.org/10.4161/onci.20011 94.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Leukoc Biol  2003; 74:277-86; PMID:12885945; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Infect Immun  2003; 71:4238-49; PMID:12874299; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Immunol 2002; 3:196-200; PMID:11812998; http://dx.doi.org/10.1038/ni758 97.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1661-3; PMID:23264929; http://dx.doi.org/10.4161/onci.22033 98.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Dev Immunol 2012;  2012:230625; PMID:23193416; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Expert Opin  Investig Drugs 2007; 16:1391-403; PMID:17714025;  http://dx.doi.org/10.1517/13543784.16.9.1391,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Expert Opin Biol Ther  2007; 7:1257-66; PMID:17696823; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Semin Oncol 2010; 37:450- 4; PMID:21074059; http://dx.doi.org/10.1053/j.semi- noncol.2010.09.010 157.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:544-6; PMID:22754781;  http://dx.doi.org/10.4161/onci.19442 158.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Br J Cancer 2013; 108:1998-2004; PMID:23652314;  http://dx.doi.org/10.1038/bjc.2013.227 159.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Blood 2012; 119:355-63; PMID:22045986; http://dx.doi.org/10.1182/blood-2011-05-355222 160.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Blood 2013; 121:251-9;  PMID:23086756; http://dx.doi.org/10.1182/blood- 2012-05-432393 161.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunother 2012; 35:534- 43; PMID:22892450; http://dx.doi.org/10.1097/ CJI.0b013e318261e679 162.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunol 2012; 189:4719-27; PMID:23045613; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
T umour Biol 2012; 33:1607-18; PMID:22739939; http://dx.doi.org/10.1007/s13277- 012-0416-1 164.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Cancer Res  2012; 18:6668-78; PMID:23048078; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Cancer 2012; 130:765-74; PMID:21455984; http://dx.doi.org/10.1002/ ijc.26100 166.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Lett  2013; 331:239-49; PMID:23318200; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Cancer 2011; 129:2836- 46; PMID:21448901; http://dx.doi.org/10.1002/ ijc.25955 143.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Cancer 2013; 132:345-54; PMID:22729530; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Eur J Biochem 2000; 267:3370-7;  PMID:10824125; http://dx.doi.org/10.1046/j.1432- 1327.2000.01370.x 145.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Mol Microbiol  Biotechnol 2011; 20:24-8; PMID:21335976; http://dx.doi.org/10.1159/000324331 147.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Infect Dis 1975; 132:434-9; PMID:810520;  http://dx.doi.org/10.1093/infdis/132.4.434 149.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Cancer Res 2012;  18:6497-508; PMID:23032745; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Am J Hematol 2012; 87:953- 6; PMID:22718533; http://dx.doi.org/10.1002/ ajh.23280 151.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Biochem Soc T rans  2007; 35:1461-7; PMID:18031246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Drug Discov 2004; 3:549-50; PMID:15272498;  http://dx.doi.org/10.1038/nrd1445 154.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Invest New Drugs 2013; PMID:23397499;  http://dx.doi.org/10.1007/s10637-013-9933-z129.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Br J Dermatol  2012; 167:110-5; PMID:22385074; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Eur J Immunol  2012; 42:3049-61; PMID:22806397; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Cancer Res 2012; 18:6748-57; PMID:22767669;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1149 133.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Invest New Drugs 2012; 30:1641-5;  PMID:21748297; http://dx.doi.org/10.1007/s10637- 011-9717-2 134.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Immunol Immunother 2013; 62:1041-52; PMID:23591981;  http://dx.doi.org/10.1007/s00262-013-1415-9 135.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Obstet Gynecol 2012; 120:152- 9; PMID:22914404; http://dx.doi.org/10.1097/ AOG.0b013e31825bc6e8 136.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Lancet Oncol 2013; 14:346-53;  PMID:23499546; http://dx.doi.org/10.1016/S1470-2045(13)70067-6 137.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Urol  2013; 189:2077-82; PMID:23206424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Hepatobiliary  Pancreat Sci 2012; 19:465-75; PMID:21983893;  http://dx.doi.org/10.1007/s00534-011-0457-7 140.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncogene 2012; 31:1869-83; PMID:21892204;  http://dx.doi.org/10.1038/onc.2011.384 141.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Invest 2012; 30:126-30;  PMID:22148972; http://dx.doi.org/10.3109/0735790 7.2011.633292,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Biol Ther 2012; 13:727-36; PMID:22617774;  http://dx.doi.org/10.4161/cbt.20555 195.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Lett 2012; 317:157-64;  PMID:22115967; http://dx.doi.org/10.1016/j.can- let.2011.11.020 196.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Cancer Res 2013; 19:2905-16; PMID:23549880;  http://dx.doi.org/10.1158/1078-0432.CCR-12-1245 197.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Cell  2012; 22:466-78; PMID:23079657; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:1495-506; PMID:23264896; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2012; 7:e38890; PMID:22815694; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Breast Cancer Res T reat 2012; 133:853-63; PMID:22042369; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
BMC  Med 2012; 10:98; PMID:22938142; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2012; 7:e34207;  PMID:22470535; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1404-5; PMID:23243608;  http://dx.doi.org/10.4161/onci.21027 206.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2012; 7:e44176; PMID:23071493; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Oncol 2012; 2012:103298; PMID:22481916;  http://dx.doi.org/10.1155/2012/103298 181.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J T ransl  Med 2013; 11:25; PMID:23360557; http://dx.doi.org/10.1186/1479-5876-11-25 182.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:258-9; PMID:22720263;  http://dx.doi.org/10.4161/onci.1.2.18343 183.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell Death Differ 2012; 19:1482- 94; PMID:22421964; http://dx.doi.org/10.1038/ cdd.2012.22 184.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell Death Differ  2013; 20:823-33; PMID:23449395; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oral Oncol 2012; 48:678- 85; PMID:22387210; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Sci 2012; 103:1938-45; PMID:22853846;  http://dx.doi.org/10.1111/j.1349-7006.2012.02394.x 191.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Immunol Immunother  2013; 62:309-20; PMID:22923191; http://dx.doi.org/10.1007/s00262-012-1341-2 192.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Cell 2012; 21:504-16; PMID:22516259;  http://dx.doi.org/10.1016/j.ccr.2012.02.007 193.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Clin Cancer Res 2012; 18:499-509; PMID:22128302;  http://dx.doi.org/10.1158/1078-0432.CCR-11-1625 169.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Res 2012; 72:592-603; PMID:22139376; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunother  2013; 36:29-40; PMID:23211623; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunol 2013; 190:5866-73;  PMID:23610140; http://dx.doi.org/10.4049/jimmu-nol.1203470 173.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Pharm 2013; 445:171- 80; PMID:23376226; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Res 2012; 72:581-91;  PMID:22158905; http://dx.doi.org/10.1158/0008- 5472.CAN-11-0307 175.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2012; 7:e38111;  PMID:22666458; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Cancer 2013; 132:580- 90; PMID:22733292; http://dx.doi.org/10.1002/ ijc.27691 178.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Colorectal Dis 2013; 28:25-33; PMID:22777000; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunol  2012; 188:1592-9; PMID:22231700; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2013; 8:e54879; PMID:23408948;  http://dx.doi.org/10.1371/journal.pone.0054879 237.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1433-4; PMID:23243619;  http://dx.doi.org/10.4161/onci.21176 238.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:642-8; PMID:22934256;  http://dx.doi.org/10.4161/onci.20298 239.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:1191-3; PMID:23170276; http://dx.doi.org/10.4161/onci.20664 240.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Res 2012; 72:4304-10;  PMID:22738916; http://dx.doi.org/10.1158/0008- 5472.CAN-12-0257 241.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Hepatology  2013; 57:171-82; PMID:22859216; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012;  1:398-9; PMID:22737629; http://dx.doi.org/10.4161/ onci.19128 243.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Clin Invest 2012; 122:4118-29; PMID:23023703;  http://dx.doi.org/10.1172/JCI63606 244.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Exp Med 2012; 209:1671-87; PMID:22908323; http://dx.doi.org/10.1084/ jem.20111706 245.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2013; 2:e22567;  PMID:23483804; http://dx.doi.org/10.4161/ onci.22567 246.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Commun 2013;  4:1560; PMID:23463003; http://dx.doi.org/10.1038/ ncomms2566 248.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Immunol 2012; 13:343-51;  PMID:22430787; http://dx.doi.org/10.1038/ni.2224 249.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:1197-9; PMID:23170278; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:1223-5; PMID:23243584; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Biol Chem  2012; 287:43417-23; PMID:23135279; http://dx.doi.org/10.1074/jbc.M112.411009 225.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science 2012; 337:1111-5; PMID:22821982;  http://dx.doi.org/10.1126/science.1220363 226.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Leukemia  2012; 26:1584-93; PMID:22343732; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS  One 2012; 7:e48278; PMID:23133627; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:687-93; PMID:22934260; http://dx.doi.org/10.4161/onci.19854 229.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
J Immunol 2012; 188:3709-15; PMID:22407920; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Commun 2013;  4:1662; PMID:23575666; http://dx.doi.org/10.1038/ ncomms2677 231.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Immunol 2012; 13:1045-54; PMID:23023391;  http://dx.doi.org/10.1038/ni.2426 232.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Ann Surg Oncol 2012;  In press; PMID:22890596; http://dx.doi.org/10.1245/ s10434-012-2595-9 234.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Hepatology 2012; 55:1863- 75; PMID:22234969; http://dx.doi.org/10.1002/ hep.25572 209.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cell Biol Toxicol 2012; 28:269-77; PMID:22648782;  http://dx.doi.org/10.1007/s10565-012-9221-2 210.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Mol Cancer 2012; 11:33; PMID:22583829;  http://dx.doi.org/10.1186/1476-4598-11-33 211.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncol Res 2012; 20:15-24; PMID:23035361; http://dx.doi.org/10.3727/096504012X13425470196092 212.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
PLoS One 2012; 7:e50394;  PMID:23185615; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Cancer Immunol Immunother 2012; 61:893- 903; PMID:22095092; http://dx.doi.org/10.1007/ s00262-011-1156-6 216.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Biomaterials 2013; 34:746-55; PMID:23107297; http://dx.doi.org/10.1016/j.bioma- terials.2012.09.062 217.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Vaccine 2012; 30:4790- 9; PMID:22634298; http://dx.doi.org/10.1016/j.vac- cine.2012.05.027 218.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Blood 2012; 120:2899-908;  PMID:22760779; http://dx.doi.org/10.1182/blood- 2011-07-368720 219.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Blood 2013; In press; PMID:23580661; http://dx.doi.org/10.1182/blood-2012-07-441360 220.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Proc Natl Acad Sci U S A 2012; 109:E2110- 6; PMID:22753494; http://dx.doi.org/10.1073/ pnas.1209414109 221.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:780-2; PMID:22934281;  http://dx.doi.org/10.4161/onci.19731 265.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Arch Dermatol  2012; 148:592-6; PMID:22431716; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
"Oncoimmunology 2012;  1:362-3; PMID:22737615; http://dx.doi.org/10.4161/ onci.18482 267. de Vries IJ, Tel J, Benitez-Ribas D, Torensma R, Figdor CG.",OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Mol Immunol 2011; 48:810-7; PMID:21257206; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Blood 2010; 116:564-74;  PMID:20424184; http://dx.doi.org/10.1182/blood- 2009-11-251884258.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:726- 34; PMID:22934264; http://dx.doi.org/10.4161/ onci.20171 259.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012;  1:940-2; PMID:23162764; http://dx.doi.org/10.4161/ onci.20305 260.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Proc Natl Acad Sci U S A  2013; 110:E1857-66; PMID:23630282; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Int J Radiat Oncol Biol Phys 2012; 83:228-34; PMID:22000579;  http://dx.doi.org/10.1016/j.ijrobp.2011.05.055 262.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Science 2008; 320:226- 30; PMID:18403709; http://dx.doi.org/10.1126/sci- ence.1154986 263.,OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Nat Rev Drug Discov 2006; 5:471-84;  PMID:16763660; http://dx.doi.org/10.1038/nrd2059251.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:1167-8; PMID:23170267; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:1650- 1; PMID:23264925; http://dx.doi.org/10.4161/ onci.21970 253.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:121-2; PMID:22720231; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:550-1;  PMID:22754783; http://dx.doi.org/10.4161/ onci.19334 255.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology  2012; 1:984-5; PMID:23162780; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
Oncoimmunology 2012; 1:298-305; PMID:22737605; http://dx.doi.org/10.4161/ onci.19068 257.,Non-OADS,/arxiv_data1/oa_pdf/e0/6f/onci-2-e25238.PMC3782517.pdf
OncoImmunology 2013; 2:e26012;  http://dx.doi.org/10.4161/onci.26012,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Br J Cancer 2011; 105:93- 103; PMID:21629244 ; http://dx.doi.org/10.1038/ bjc.2011.189 2.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Nat Rev Cancer 2012; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 3.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Transl Med 2012; 10:1; PMID:22214470 ;  http://dx.doi.org/10.1186/1479-5876-10-1 4.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Cancer Immunol Immunother 2009; 58:49-59; PMID:18446337 ; http://dx.doi.org/10.1007/ s00262-008-0523-4 8.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Hum Vaccin Immunother  2013; 9:1049-57;  PMID:23454867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Cancer 2009; 115:3670- 9; PMID:19536890 ; http://dx.doi.org/10.1002/ cncr.24429 11.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Int J Cancer  2012; 130:2219-31;  PMID:22052568 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Lancet 2008; 372:145- 54; PMID:18602688 ; http://dx.doi.org/10.1016/ S0140-6736(08)60697-2 13.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2004; 22:403-15; PMID:14691123 ;  http://dx.doi.org/10.1200/JCO.2004.06.043,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Clin Cancer Res 2006;  12:2337s-41s;  PMID:16609055 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
PR Newswire 28 June available from http://www.prnewswire.com/news-releases/therion-reports- results-of-phase-3-panvac-vf-trial-and-announces- plans-for-company-sale-56997582.html 16.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Vaccine 2007; 25(Suppl  2):B97-109;  PMID:17916465 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol  2009; 27:3036-43;  PMID:19414675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2011; 29:2787-94; PMID:21632504 ; http://dx.doi.org/10.1200/ JCO.2010.33.3005 20.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2005; 23:6854-64; PMID:16192577 ;  http://dx.doi.org/10.1200/JCO.2005.17.186 22.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Expert Opin Biol Ther 2007; 7:397-404;  PMID:17309331 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2008; 26:955-62;  PMID:18281670 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Vaccine 2005; 23:2379-87;  PMID:15755632 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Expert Opin Biol Ther  2008; 8:839-44;  PMID:18476795 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
"com May 13, 2008 available from http://www.drugs.",Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Semin Cancer Biol 2003; 13:401- 7; PMID :15001158 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2006; 24:3107-12;  PMID:16754937 ; http://dx.doi.org/10.1200/ JCO.2005.04.4289 33.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Immunother 2010; 33:178-84; PMID:20145546 ;  http://dx.doi.org/10.1097/CJI.0b013e3181bfcea1 34.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol  2002; 20:4225-31;  PMID:12377966 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
J Clin Oncol 2004; 22:4717- 24; PMID:15483014 ; http://dx.doi.org/10.1200/ JCO.2004.06.003 38.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Cancer Immunol Immunother  1996; 42:303-9;  PMID:8706053 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Oncologist 2011; 16:1092- 100; PMID:21572124 ; http://dx.doi.org/10.1634/ theoncologist.2010-0307 40.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
Pancreas  2012; 41:374-9;  PMID:22228104 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/onci-2-e26012.PMC3782518.pdf
OncoImmunology 2013; 2:e25124;  http://dx.doi.org/10.4161/onci.25124as circulating immune cells are among the  first cell population to be exposed to intra - venously administered miRNAs.,Non-OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
Nat Med 2005; 11:1314-21;  PMID:16288283; http://dx.doi.org/10.1038/nm13252.,OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
Neuro Oncol 2010; 12:1113-25; PMID:20667896; http://dx.doi.org/10.1093/neu- onc/noq082,Non-OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
Nat  Med 2011; 17:64-70; PMID:21131957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
N Engl J Med 2005; 353:2012- 24; PMID:16282176; http://dx.doi.org/10.1056/ NEJMoa051918 8.,OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
Cancer Res 2007; 67:9630-6; PMID:17942891;  http://dx.doi.org/10.1158/0008-5472.CAN-07-12434.,Non-OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
Cancer  Cell 2006; 9:341-9; PMID:16697955; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/39/onci-2-e25124.PMC3782519.pdf
"OncoImmunology 2013; 2:e25409; http://dx.doi.org/10.4161/onci.25409discussed below, the properties of IL-27  might place it in a preferential position for directing effective antitumor immune responses while suppressing the differen - tiation of Tregs ( Fig.",Non-OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Cancer Chemother Pharmacol  2009; 64:11-25; PMID:19343348; http://dx.doi.org/10.1007/s00280-009-0983-z 3.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Immunity  2012; 37:960-9; PMID:23244718; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Clin Dev Immunol  2010; 2010:2010; PMID:20885915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Annu Rev Immunol 2011; 29:235-71; PMID:21219185; http://dx.doi.org/10.1146/annurev- immunol-031210-101324 6.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Cancer Res 2010; 70:7800-9; PMID:20924111;  http://dx.doi.org/10.1158/0008-5472.CAN-10-1681 7.,Non-OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Hum Gene Ther  1999; 10:697-709; PMID:10210138; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
Hum Gene Ther 1998; 9:707- 18; PMID:9551618; http://dx.doi.org/10.1089/ hum.1998.9.5-707 9.,OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
PLoS One 2013; 8:e57469;  PMID:23554861; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
J Immunol 2009; 182:4328-38;  PMID:19299733; http://dx.doi.org/10.4049/jimmu- nol.0800471,Non-OADS,/arxiv_data1/oa_pdf/05/c2/onci-2-e25409.PMC3782520.pdf
"OncoImmunology 2013; 2:e25123; http://dx.doi.org/10.4161/onci.25123factor receptor (EGFR) and vascular endo - thelial growth factor (VEGF) inhibitors.3,4 We have recently tested the combina - tion of IMOs and everolimus in models  of human RCC differing from each other with the respect to the VHL  gene status,  in vitro and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
J Exp Clin Cancer Res 2011; 30:84;  PMID:21929816; http://dx.doi.org/10.1186/1756- 9966-30-84 7.,Non-OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
Lancet 2008; 372:449-56; PMID:18653228;  http://dx.doi.org/10.1016/S0140-6736(08)61039-9References 1.,Non-OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
Nature  2006; 441:424-30; PMID:16724053; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
Biochem Soc T rans  2007; 35:1461-7; PMID:18031246; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
Clin Cancer  Res 2006; 12:577-83; PMID:16428503; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
Proc Natl Acad Sci U S A 2007; 104:12468-73; PMID:17636117; http://dx.doi.org/10.1073/ pnas.0705226104,OADS,/arxiv_data1/oa_pdf/02/d5/onci-2-e25123.PMC3782521.pdf
OncoImmunology 2013; 2:e25047;  http://dx.doi.org/10.4161/onci.25047BI-505) would not have been identified  through traditional approaches focused on altering the biological functions of antibody targets.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Cancer Cell 2013; 23:502-15; PMID:23597564;  http://dx.doi.org/10.1016/j.ccr.2013.02.0262.,OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Cancer Immunol Res 2013; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Cancer Cell 2010; 18:160- 70; PMID:20708157; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Leukemia 2013; 27:702- 10; PMID:22996336; http://dx.doi.org/10.1038/ leu.2012.2727.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Int J Cancer 2006; 119:349-58; PMID:16477633;  http://dx.doi.org/10.1002/ijc.21829 9.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Blood  2009; 114:3625-8; PMID:19710503; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Nat Med 2000; 6:443-6;  PMID:10742152; http://dx.doi.org/10.1038/74704 5.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
J Clin Oncol  2008; 26:1789-96; PMID:18347005; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
Blood 2011; 117:4519-29; PMID:21378274; http://dx.doi.org/10.1182/ blood-2010-07-296913,Non-OADS,/arxiv_data1/oa_pdf/34/c2/onci-2-e25047.PMC3782522.pdf
OncoImmunology 2013; 2:e25913; http://dx.doi.org/10.4161/onci.25913,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
N Engl J Med 2003; 348:203-13; PMID:12529460 ; http://dx.doi.org/10.1056/ NEJMoa020177 2.,OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
Cancer Res 2007; 67:8900-5;  PMID:17875732 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
J Exp Med 2011; 208:1683-94; PMID:21727190 ; http://dx.doi.org/10.1084/ jem.201006395.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
Int J Gynecol Cancer 2009; 19:1481- 6; PMID:19955922 ; http://dx.doi.org/10.1111/ IGC.0b013e3181ad0fa2 6.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
J Exp Med 2006; 203:871-81; PMID:16606666 ;  http://dx.doi.org/10.1084/jem.20050930 7.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
Cancer Lett 2012; 317:99-105; PMID:22108530 ;  http://dx.doi.org/10.1016/j.canlet.2011.11.017 9.,OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
Oncogene 2013; Forthcoming; PMID:23318460 ;  http://dx.doi.org/10.1038/onc.2012.600 10.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
N Engl J Med 2013; 369:122-33;  PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/9b/onci-2-e25913.PMC3782523.pdf
"OncoImmunology 2013; 2:e25156; http://dx.doi.org/10.4161/onci.25156Sunitinib, like other relatively unselec - tive TKIs,1 affects not only malignant  and endothelial cells but also immune  cells.",Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Cancer Res 2009; 69:2514-22;  PMID:19276342; http://dx.doi.org/10.1158/0008- 5472.CAN-08-4709 3.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Clin Cancer Res 2009; 15:2148-57; PMID:19276286; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1332 4.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Clin Cancer Res  2008; 14:6674-82; PMID:18927310; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
J Immunother 2010; 33:991-8; PMID:20948437;  http://dx.doi.org/10.1097/CJI.0b013e3181f4c208 6.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Cancer Microenviron  2012; PMID:23104434; http://dx.doi.org/10.1007/ s12307-012-0122-y 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Cancer Res  2013; 73:539-49; PMID:23108136; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Cancer Res 2010; 70:9599-610;  PMID:21118964; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1293 9.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
Clin Dev Immunol  2012; 2012:492920; PMID:23320019; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/99/onci-2-e25156.PMC3782524.pdf
OncoImmunology 2013; 2:e26013; http://dx.doi.org/10.4161/onci.26013,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Immunol Today 2000; 21:163-5; PMID:10740236 ;  http://dx.doi.org/10.1016/S0167-5699(00)01612-1 2.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Trends Immunol   2004 ; 25:98-104; PMID :15102369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Future Oncol  2006 ; 2:137-43; PMID:16556080 ;  http://dx.doi.org/10.2217/14796694.2.1.137 5.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Mol Ther  2009 ; 17:1333 - 9; PMID:19513019 ; http://dx.doi.org/10.1038/ mt.2009.130 6.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Blood   2011 ; 117:1146 -55; PMID:21088134 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Clin Infect Dis  2008 ; 46:1769 -81; PMID:18433307 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Virol  2013 ; 87:3668 -77; PMID:23302894 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Blood   2007 ; 110:1916 -23; PMID:17510320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Virol 2003 ; 77:13407 - 11; PMID:14645597 ; http://dx.doi.org/10.1128/ JVI.77.24.13407-13411.2003 14.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Immunity  2003 ; 18:499- 511; PMID:12705853 ; http://dx.doi.org/10.1016/ S1074-7613(03)00081-5 15.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Exp Med  2001 ; 194:F23-6; PMID :11535638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Mol Ther   2010 ; 18:1430 -9; PMID:20551919 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nat Med  2000 ; 6:821-5;  PMID:10888934 ; http://dx.doi.org/10.1038/77558 19.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Vaccine  2010 ; 29:304-13;  PMID:21034824 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nat Rev Microbiol  2010 ; 8:62-73; PMID:19966816 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nat Med  2011 ; 17:1128 - 31; PMID:21857654 ; http://dx.doi.org/10.1038/ nm.2447 22.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nature  2011 ; 473:523- 7; PMID:21562493 ; http://dx.doi.org/10.1038/ nature10003 25.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Eur  J Immunol  2006 ; 36:1453 -64; PMID:16637009 ;  http://dx.doi.org/10.1002/eji.200635874 26.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Science  2007 ; 318:116- 20; PMID:17916739 ; http://dx.doi.org/10.1126/ science.1146291 28.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Exp Med 2001 ;  194:953-66; PMID :11581317 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Trends Immunol  2012 ; 33:364- 72; PMID:22445288 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Oncoimmunology  2012 ; 1:419-31; PMID:22754760 ;  http://dx.doi.org/10.4161/onci.19534 33.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Virol 2007 ; 81:11925 - 36; PMID:17699574 ; http://dx.doi.org/10.1128/ JVI.00903-07 34.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Proc Natl Acad Sci U S A 2010 ; 107:12198 - 203; PMID:20616089 ; http://dx.doi.org/10.1073/ pnas.1004661107 35.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
PLoS One   2009 ; 4:e8159 ; PMID:19997562 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nat Immunol  2010 ; 11:373-84;  PMID:20404851 ; http://dx.doi.org/10.1038/ni.1863 37.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Virology   2007 ; 362:304-13; PMID:17292937 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Proc Natl Acad Sci U S A 2004 ; 101:5598 - 603; PMID :15034168 ; http://dx.doi.org/10.1073/ pnas.0400937101 39.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Blood   2011 ; 117:6542 -51; PMID:21493800 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Exp Med 2006 ; 203:1249 - 58; PMID:16636134 ; http://dx.doi.org/10.1084/ jem.20052433 41.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Mol Ther   2009 ; 17:1465 -72; PMID:19401673 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Cancer Res 2011 ;  71:2497 -506; PMID:21307131 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Virol 2009 ; 83:2962 -75; PMID:19144711 ;  http://dx.doi.org/10.1128/JVI.02030-08 44.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
J Virol  2009 ; 83:12027 -36; PMID:19759135 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Nat Rev Immunol 2008 ; 8:247-58;  PMID:18323851 ; http://dx.doi.org/10.1038/nri2274 48.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Expert Rev Vaccines  2011 ; 10:1307 -19; PMID:21919620 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
Mol Ther  2013 ; 21:887- 94; PMID:23295947 ; http://dx.doi.org/10.1038/ mt.2012.265 50.,OADS,/arxiv_data1/oa_pdf/d7/27/onci-2-e26013.PMC3782525.pdf
"OncoImmunology 2013; 2:e25083; http://dx.doi.org/10.4161/onci.25083to deliver an oncolytic virus, namely, the  vesicular stomatitis virus (VSV), to neo - plastic lesions.4 This resulted in a signifi - cant increase in the long-term survival of mice bearing metastatic colon carcinomas, when compared with systemic administra - tion of VSV alone, in the absence of sig - nificant toxicity.",Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Nat Rev Immunol 2012; 12:253-68; PMID:22437938;  http://dx.doi.org/10.1038/nri3175 2.,Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Nature  2013; 496:445-55; PMID:23619691; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Immunol Rev 2008; 222:180-91; PMID:18364002;  http://dx.doi.org/10.1111/j.1600-065X.2008.00608.x 4.,Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Cancer Res 2013; In press; PMID:23536556;  http://dx.doi.org/10.1158/0008-5472.CAN-12-15975.,Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Immunity 2011; 34:385-95;  PMID:21376641; http://dx.doi.org/10.1016/j.immu- ni.2011.02.004 6.,OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
J Clin Invest 2012; 122:787- 95; PMID:22378047; http://dx.doi.org/10.1172/ JCI59643 7.,Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Proc Natl Acad Sci U S A  2012; 109:2066-71; PMID:22308357; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
Br J Cancer 2013; In  press; PMID:23640395; http://dx.doi.org/10.1038/ bjc.2013.206 10.,Non-OADS,/arxiv_data1/oa_pdf/3d/61/onci-2-e25083.PMC3782526.pdf
OncoImmunology 2013; 2:e25961;  http://dx.doi.org/10.4161/onci.25961,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
N Engl J Med 2010; 363:711-23;  PMID:20525992 ; http://dx.doi.org/10.1056/ NEJMoa1003466 2.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Lancet  2011 ; 377:42-51;  PMID:21176949 ; http://dx.doi.org/10.1016/ S0140-6736(10)62175-7 3.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Clin Oncol 2008 ; 26:5233 -9; PMID:18809613 ;  http://dx.doi.org/10.1200/JCO.2008.16.5449 4.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nature  2001 ;  411:375-9; PMID:11357145 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunol Rev   2008 ; 222:162-79; PMID:18364001 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunity  2009 ; 30:636- 45; PMID:19464986 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Semin Cancer Biol 2008 ; 18:349-55;  PMID:18467122 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nature  2002 ; 419:734-8;  PMID:12384702 ; http://dx.doi.org/10.1038/ nature01112 9.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunol Rev  2004 ; 202:275-93; PMID:15546400 ;  http://dx.doi.org/10.1111/j.0105-2896.2004.00199.x 10.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Cell   2004 ; 5:241-51; PMID:15050916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Clin Oncol 2010 ; 28:3167-75; PMID:20516446 ;  http://dx.doi.org/10.1200/JCO.2009.26.7609 14.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Proc Natl Acad Sci U S A  2003 ; 100:8372 -7; PMID:12826605 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res  2012 ; 72:5209 -18; PMID :22915761 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res 2009 ; 15:1623 -34;  PMID:19208793 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-1825 17.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Biochem Biophys Res Commun  2010 ; 402:88-93;  PMID:20920468 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res  2010 ; 16:6019 -28; PMID:20924130 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2011 ;  71:3540 -51; PMID:21430066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Immunol  2010 ; 184:3442 - 9; PMID:20194714 ; http://dx.doi.org/10.4049/ jimmunol.0904114 23.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Proc Natl Acad Sci U S A  2006 ; 103:13132 -7; PMID:16916931 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2010 ; 70:2245 -55; PMID:20179192 ;  http://dx.doi.org/10.1158/0008-5472.CAN-09-3109 25.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Clin Invest 2011 ; 121:2371 - 82; PMID :21537079 ; http://dx.doi.org/10.1172/ JCI45559 26.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2007 ; 67:4507 -13; PMID:17483367 ;  http://dx.doi.org/10.1158/0008-5472.CAN-06-4174 27.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
BMC Cancer  2010 ; 10:464; PMID:20804550 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Immunol  2010 ; 184:6833 - 42; PMID:20483762 ; http://dx.doi.org/10.4049/ jimmunol.0904084 30.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2010 ; 70:109-18;  PMID:20028856 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-2326 31.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Exp Med  2011 ; 208:1949 -62; PMID:21930770 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Blood   2011 ; 118:4853 -62; PMID:21908423 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Rev Immunol 2009 ; 9:162-74; PMID:19197294 ;  http://dx.doi.org/10.1038/nri2506 34.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunology  2012 ;  136:437-47; PMID:22578109 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Exp Med 2006 ; 203:2691 - 702; PMID:17101732 ; http://dx.doi.org/10.1084/ jem.20061104 38.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Cancer Res Clin Oncol 2008 ;  134:525-33; PMID:17909857 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2009 ; 69:3963 -70;  PMID:19383920 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-2476 40.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Biol Ther  2011 ; 11:866-73; PMID:21372637 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res  2010 ; 70:129-38; PMID:20028855 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Mol Cancer Ther 2008 ; 7:3859 -66;  PMID:19074858 ; http://dx.doi.org/10.1158/1535- 7163.MCT-08-0538 43.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Int J Cancer 2013 ;  132:967-77; PMID:22870862 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res 2009 ; 15:641-9; PMID:19147770 ;  http://dx.doi.org/10.1158/1078-0432.CCR-08-1988 45.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Br J Cancer  2006 ; 95:272-81; PMID:16832418 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res  2009 ; 15:7624 -33; PMID:19996209 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Immunol Immunother   2009 ; 58:941-53; PMID:18979098 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Biotechnol   2007 ; 25:911-20; PMID:17664940 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res 2005 ; 11:4533 -44;  PMID :15958639 ; http://dx.doi.org/10.1158/1078- 0432.CCR-04-2237 52.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Immunol Immunother   2012 ; 61:19-29; PMID:21822917 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunol Cell Biol  2013 ;  91:105-14; PMID:23090488 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunology   2011 ; 132:226-39; PMID:21039467 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Immunol  Immunother  2013 ; 62:665-75; PMID :23151945 ;  http://dx.doi.org/10.1007/s00262-012-1372-8 59.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Science  2011 ; 331:1612 - 6; PMID:21436454 ; http://dx.doi.org/10.1126/ science.119844360.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Immunity   2010 ; 33:942-54; PMID:21145762 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res  2007 ; 67:7477 -86; PMID:17671218 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Int J Cancer 2004 ; 109:817- 25; PMID:15027114 ; http://dx.doi.org/10.1002/ ijc.20043 65.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Gene Ther   2001 ; 8:282-90; PMID:11313802 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Gene Ther  2002 ; 9:533- 42; PMID:12032664 ; http://dx.doi.org/10.1038/ sj.cgt.7700466 68.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Vaccine  2009 ; 27:6210 -6; PMID:19699331 ;  http://dx.doi.org/10.1016/j.vaccine.2009.08.002 69.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Mol Ther  2011 ; 19:650- 7; PMID:21266959 ; http://dx.doi.org/10.1038/ mt.2010.312 70.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Gene Ther  2005 ; 12:359- 68; PMID :15678154 ; http://dx.doi.org/10.1038/ sj.cgt.7700784 71.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Korean Med Sci 2011 ; 26:1270 - 6; PMID:22022177 ; http://dx.doi.org/10.3346/ jkms.2011.26.10.1270 72.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Rev Cancer 2009 ; 9:57- 63; PMID:19052556 ; http://dx.doi.org/10.1038/ nrc2541,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Immunother   2011 ; 34:279-88; PMID:21389870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Immunol Immunother  2011 ; 60:671-83;  PMID:21327636 ; http://dx.doi.org/10.1007/ s00262-011-0984-8 75.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
PLoS One  2009 ; 4:e7334 ;  PMID:19812695 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Rev Cancer 2009 ; 9:64-71;  PMID:19104515 ; http://dx.doi.org/10.1038/nrc2545 77.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res  2012 ; 72:1651-60; PMID :22315352 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Immunol Immunother   2011 ; 60:1461 -72; PMID:21656158 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Gene Ther   2008 ; 15:604-16; PMID:18305577 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Med  2005 ; 11:1073 - 81; PMID:16170322 ; http://dx.doi.org/10.1038/ nm129782.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Med   2006 ; 12:693-8; PMID:16680149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Cell  2012 ; 22:80- 90; PMID:22789540 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2011 ; 71:5697 -706; PMID:21742772 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-0103 85.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Clin Invest 2011 ; 121:4746 -57;  PMID:22056381 ; http://dx.doi.org/10.1172/ JCI58814 86.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Int J Cancer 2011 ; 128:105- 18; PMID:20309938 ; http://dx.doi.org/10.1002/ ijc.25333 87.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Rev Immunol  2010 ; 10:554-67; PMID:20616810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Int J Cancer 2009 ; 125:2614 - 23; PMID:19530254 ; http://dx.doi.org/10.1002/ ijc.2465690.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Nat Mater   2012 ; 11:895-905; PMID:22797827 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Cancer Res 2012 ; 72:5159 -64;  PMID:22826606 ; http://dx.doi.org/10.1158/0008- 5472.CAN-12-1952 92.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
J Transl Med  2012 ; 10:108; PMID:22640522 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
N Engl J Med  2013 ; 369:122-33; PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Am J Surg 2003 ; 185:476-80;  PMID:12727570 ; http://dx.doi.org/10.1016/ S0002-9610(03)00051-5 96.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Clin Cancer Res 2012 ; 18:1672 -83;  PMID:22291136 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-3050 97.,Non-OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
Mol Ther   2011 ; 19:751-9; PMID:21285960 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e3/d2/onci-2-e25961.PMC3782527.pdf
"OncoImmunology 2013; 2:e25235;  http://dx.doi.org/10.4161/onci.25235been reported to raise protective immune  responses against DFTD and the disease is presumed to be fatal, with metastasis occurring in ~65% of cases.",Non-OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
Nature 2006; 439:549;  PMID:16452970; http://dx.doi.org/10.1038/439549a3.,Non-OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
Cell 2012; 148:780-91; PMID:22341448;  http://dx.doi.org/10.1016/j.cell.2011.11.0654.,OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
PLoS Genet  2012; 8:e1002483; PMID:22359511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
T ranspl Int 2005; 18:1109-12; PMID:16101732;  http://dx.doi.org/10.1111/j.1432-2277.2005.00178.x7.,OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
Adv Cancer Res 2005; 93:189- 234; PMID:15797448; http://dx.doi.org/10.1016/ S0065-230X(05)93006-6 8.,Non-OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
Proc Natl Acad Sci U S A 2009; 106:17882- 5; PMID:19822752; http://dx.doi.org/10.1073/ pnas.09046581065.,OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
Biol Conserv 2006; 131:307-24;  http://dx.doi.org/10.1016/j.biocon.2006.04.010 6.,OADS,/arxiv_data1/oa_pdf/33/2d/onci-2-e25235.PMC3782528.pdf
OncoImmunology 2013; 2:e25752; http://dx.doi.org/10.4161/onci.25752Introduction Effective bacterial anticancer immunotherapies stimulate the  proliferation of tumor-associated antigen specific T cells that are capable of overcoming peripheral tolerance.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cancer Immunol  Immunother 2005; 54:577-86; PMID:15650885;  http://dx.doi.org/10.1007/s00262-004-0600-2 2.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cancer Immunol  Immunother 2005; 54:477-88; PMID:15750832;  http://dx.doi.org/10.1007/s00262-004-0610-0 4.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Exp  Cell Res 2011; 317:620-31; PMID:21376175; http://dx.doi.org/10.1016/j.yexcr.2010.12.017 6.,OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Proc Natl Acad Sci USA 1996; 93:13791- 6; PMID:8943014; http://dx.doi.org/10.1073/ pnas.93.24.13791 7.,OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cancer Res  2012; 72:3735-43; PMID:22593190; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
OncoImmunology 2012; 1:822-828; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
J Interferon Cytokine  Res 2008; 28:245-51; PMID:18439102; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cancer Sci 2006; 97:780-6; PMID:16863511; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cancer Res 2009; 69:3077-85; PMID:19293190;  http://dx.doi.org/10.1158/0008-5472.CAN-08-2281,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Gastroenterology  2010; 138:1429-40; PMID:19909745; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Cell Immunol 2002; 217:12-22;  PMID:12425997; http://dx.doi.org/10.1016/S0008-8749(02)00508-7.,OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Vaccine  2009; 27:3975-83; PMID:19389451; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
J Immunol Methods 2001; 253:163-75;  PMID:11384678; http://dx.doi.org/10.1016/S0022- 1759(01)00356-8 34.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
Curr Protoc Immunol 2001; Chapter  20:Unit 20 22. http://dx.doi.org/.1002/0471142735.,Non-OADS,/arxiv_data1/oa_pdf/81/82/onci-2-e25752.PMC3782529.pdf
5 The SH2/SH3  *Correspondence to: Gonzalo M. Rivera; Email: grivera@tamu.edu Submitted: 06/30/13; Revised: 07/12/13; Accepted: 07/12/13http://dx.doi.org/10.4161/bioa.25744Planar and apical-basal cellular polarization of epithelia  and endothelia are crucial during morphogenesis.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Opin Cell Biol 2009; 21:140- 6; PMID:19269802; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell  2010; 142:661-7; PMID:20813250; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Biochim  Biophys Acta 2005; 1747:1-25; PMID:15680235;  http://dx.doi.org/10.1016/j.bbapap.2004.10.005 4.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Genes Cells 1996; 1:595-613; PMID:9078388; http://dx.doi.org/10.1046/j.1365-2443.1996.00258.x 7.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Oncogene 2001; 20:6403-17; PMID:11607841;  http://dx.doi.org/10.1038/sj.onc.1204782 8.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell Biol 2003; 23:4586- 97; PMID:12808099; http://dx.doi.org/10.1128/ MCB.23.13.4586-4597.2003 10.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Cell Biol  2000; 2:441-8; PMID:10878810; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 2004; 164:407- 16; PMID:14757753; http://dx.doi.org/10.1083/ jcb.20030603213.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Cell Biol 2001; 3:856-9; PMID:11533668;  http://dx.doi.org/10.1038/ncb0901-856 14.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell Commun  Signal 2009; 7:1; PMID:19187548; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci 2009; 122:2727-40; PMID:19596797; http://dx.doi.org/10.1242/jcs.046680 17.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol  2009; 185:503-19; PMID:19414610; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci  2008; 121:3071-82; PMID:18768933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Requirement of Nck adaptors for actin  dynamics and cell migration stimulated by platelet- derived growth factor B. Proc Natl Acad Sci U S A  2006; 103:9536-41; PMID:16769879; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Invest Dermatol  2009; 129:1909-20; PMID:19242519; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci 2010; 123:1306-19;  PMID:20332103; http://dx.doi.org/10.1242/ jcs.062570 23.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nature  2006; 440:818-23; PMID:16525419; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Clin Invest  2006; 116:1346-59; PMID:16543952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Biol Chem 2006; 281:18236- 45; PMID:16636066; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell Biol 2007; 27:6001- 11; PMID:17591694; http://dx.doi.org/10.1128/ MCB.01807-06 28.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Biochemistry 2009; 48:6369-78; PMID:19505147;  http://dx.doi.org/10.1021/bi900831k 29.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell 2003; 112:453-65; PMID:12600310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
T rends Cell Biol 2002; 12:112-20; PMID:11859023; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 1999; 145:1009-26; PMID:10352018;  http://dx.doi.org/10.1083/jcb.145.5.1009 32.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Opin Cell Biol 1999; 11:117-21; PMID:10047519; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
"Curr Opin Struct Biol 1999; 9:244-9;  PMID:10322212; http://dx.doi.org/10.1016/S0959- 440X(99)80034-7 34. Cooper JA, Wear MA, Weaver AM.",OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell 2001; 107:703-5; PMID:11747805;  http://dx.doi.org/10.1016/S0092-8674(01)00605-5 35.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Rev Mol Cell Biol 2006; 7:713-26; PMID:16990851; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Biol Cell 2005; 16:4316-28; PMID:16000375;  http://dx.doi.org/10.1091/mbc.E05-02-0131 68.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell 2011; 42:650-61;  PMID:21658605; http://dx.doi.org/10.1016/j.mol - cel.2011.03.032 69.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell 2001; 106:489-98;  PMID:11525734; http://dx.doi.org/10.1016/S0092- 8674(01)00471-8 70.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Blood 2012; 120:3371-81; PMID:22936663; http://dx.doi.org/10.1182/blood-2012-03-419721 71.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Commun 2013; 4:1672;  PMID:23575676; http://dx.doi.org/10.1038/ncom - ms2683 72.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Protoc 2009; 4:1623-31;  PMID:19834477; http://dx.doi.org/10.1038/ nprot.2009.175 73.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Biol Chem 2006; 281:34009- 20; PMID:16966330; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell Biol 2003; 23:2658- 68; PMID:12665569; http://dx.doi.org/10.1128/ MCB.23.8.2658-2668.2003 75.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
EMBO J 2001; 20:5919-28; PMID:11689432;  http://dx.doi.org/10.1093/emboj/20.21.5919 76.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
"The Tek/Tie2 receptor signals  through a novel Dok-related docking protein, Dok-R. Oncogene 1998; 17:1097-108; PMID:9764820;  http://dx.doi.org/10.1038/sj.onc.1202115 77.",OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Opin Cell Biol 2012; 24:254-61; PMID:22196933; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Circ Res 2007; 100:782- 94; PMID:17395884; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nature 2009; 457:901-5; PMID:19118385; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Biol 2012; 22:837- 42; PMID:22521790; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Biol Chem  2004; 279:28715-23; PMID:15102844; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cold Spring Harb Perspect Biol 2009; 1:a000513; PMID:20066074; http://dx.doi.org/10.1101/cshper - spect.a000513 53.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Rev Mol Cell Biol 2007; 8:464-78; PMID:17522591; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Rev Mol Cell Biol 2008; 9:887-901; PMID:18946477; http://dx.doi.org/10.1038/ nrm2523 55.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 2011; 193:381- 96; PMID:21482721; http://dx.doi.org/10.1083/ jcb.201012159 57.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Cell Biol 2011; 13:383-93; PMID:21423176; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Annu Rev Biochem 2003; 72:743-81;  PMID:12676796; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 2011; 193:1289-303; PMID:21708980; http://dx.doi.org/10.1083/ jcb.201010059 60.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Biol 1997;  7:85-94; PMID:9024622; http://dx.doi.org/10.1016/ S0960-9822(06)00052-2 62.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Biol Chem  2001; 276:22748-55; PMID:11278553; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 1999; 145:851- 63; PMID:10330411; http://dx.doi.org/10.1083/ jcb.145.4.85136.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat  Rev Mol Cell Biol 2013; 14:7-12; PMID:23212475;  http://dx.doi.org/10.1038/nrm3492 37.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Annu Rev Biochem  2001; 70:649-76; PMID:11395419; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Annu  Rev Biochem 2010; 79:707-35; PMID:20533885;  http://dx.doi.org/10.1146/annurev.bio- chem.77.060407.135452 40.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Rev Mol Cell Biol 2007; 8:37- 48; PMID:17183359; http://dx.doi.org/10.1038/ nrm2069 41.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nature  2002; 418:790-3; PMID:12181570; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell 2009; 36:512-24; PMID:19917258;  http://dx.doi.org/10.1016/j.molcel.2009.10.024 43.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
PLoS One 2012; 7:e32808;  PMID:22448228; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci  2012; 125:2825-30; PMID:22454526; http://dx.doi.org/10.1242/jcs.106583 45.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nature 1999; 401:926-9; PMID:10553910;  http://dx.doi.org/10.1038/44860 47.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Biol 2004; 14:11- 22; PMID:14711409; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Cell  2009; 36:525-35; PMID:19917259; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cancer Res 2007; 67:4227-35;  PMID:17483334; http://dx.doi.org/10.1158/0008- 5472.CAN-06-3928 106.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci 2008; 121:369-78; PMID:18198194; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cancer Res 2006; 66:3034-43; PMID:16540652; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2177 109.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Hum Mol Genet  2003; 12:1981-93; PMID:12913069; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Mol Biol Cell 2009; 20:2413-27; PMID:19261807;  http://dx.doi.org/10.1091/mbc.E08-11-1136 111.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci 2012; 125:3265-70; PMID:22854039; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cancer Res 2009; 69:747-52;  PMID:19141649; http://dx.doi.org/10.1158/0008- 5472.CAN-08-198094.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Biol Chem 2003; 278:49936-44; PMID:14523024; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Proc Natl Acad Sci U S A 2010; 107:15529-34; PMID:20709959; http://dx.doi.org/10.1073/ pnas.1009743107 96.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Biol 2011; 21:R126- 36; PMID:21300279; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Curr Biol 2009; 19:668- 74; PMID:19345098; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Dev Cell  2009; 16:222-31; PMID:19217424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cold Spring Harb Perspect Med 2012; 2:a006619;  PMID:22474612; http://dx.doi.org/10.1101/cshper - spect.a006619 100.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci 2010; 123:1073-80; PMID:20332120; http://dx.doi.org/10.1242/jcs.059329 101.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol  2005; 168:441-52; PMID:15684033; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 2009; 186:571-87; PMID:19704022; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Proc Natl Acad Sci U S A 2007; 104:11933- 8; PMID:17606906; http://dx.doi.org/10.1073/ pnas.070107710482.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cell Motil Cytoskeleton 2008; 65:662-74; PMID:18613116; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci  2011; 124:3859-70; PMID:22100923; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J  Biol Chem 2006; 281:11260-70; PMID:16436382;  http://dx.doi.org/10.1074/jbc.M512885200 85.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Nat Cell  Biol 2004; 6:977-83; PMID:15448700; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Biol 1993; 120:1003- 10; PMID:7679387; http://dx.doi.org/10.1083/ jcb.120.4.1003 87.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Circ Res 2011; 108:1190-8; PMID:21441136; http://dx.doi.org/10.1161/ CIRCRESAHA.111.243352 88.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Cold Spring Harb Perspect Biol 2011; 3:3; PMID:21791698;  http://dx.doi.org/10.1101/cshperspect.a003970 89.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Front Biosci 2012; 17:805-23; PMID:22201775; http://dx.doi.org/10.2741/3958 90.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
J Cell Sci  2013; 126:1260-7; PMID:23378028; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Sci Signal 2013; 6:pe8; PMID:23512987; http://dx.doi.org/10.1126/scisig - nal.2004051 93.,OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
Blood 2012;  119:5599-607; PMID:22510875; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/be/70/bioa-3-57.PMC3782540.pdf
"www.landesbioscience.com BioArchitecture 69BioArchitecture 3:3, 69–76; May/June 2013; © 2013 Landes Bioscience ReseAR ch p ApeR ReseAR ch p ApeR *Correspondence to: Thomas J. Maresca; Email: tmaresca@bio.umass.edu Submitted: 06/28/13; Revised: 07/11/13; Accepted: 07/11/13http://dx.doi.org/10.4161/bioa.25734Faithful distribution of the genome requires that sister kineto - chores, which assemble on each chromatid during cell division,  interact with dynamic microtubules from opposite spindle poles in a configuration called chromosome biorientation.",Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2008; 180:665- 72; PMID:18283116; http://dx.doi.org/10.1083/ jcb.200712029 2.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Curr Opin Cell Biol  2009; 21:785-95; PMID:19846287; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
EMBO J 2009; 28:2511-31;  PMID:19629042; http://dx.doi.org/10.1038/ emboj.2009.173 4.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nat Rev Mol Cell  Biol 2008; 9:33-46; PMID:18097444; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell  2006; 127:983-97; PMID:17129783; http://dx.doi.org/10.1016/j.cell.2006.09.039 6.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell 2006; 127:969-82; PMID:17129782; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Dev Cell 2007; 13:663-76;  PMID:17981135; http://dx.doi.org/10.1016/j.dev- cel.2007.09.005 8.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Mol Biol Cell  2001; 12:1995-2009; PMID:11451998; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2000; 148:871- 82; PMID:10704439; http://dx.doi.org/10.1083/ jcb.148.5.871 11.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol  2001; 154:925-36; PMID:11535616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nature 1995; 373:630-2; PMID:7854422; http://dx.doi.org/10.1038/373630a0 14.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 1969;  43:40-50; PMID:5824068; http://dx.doi.org/10.1083/ jcb.43.1.40 15.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nature 2010; 468:576-9; PMID:21107429;  http://dx.doi.org/10.1038/nature09594 16.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell  2011; 146:568-81; PMID:21854982; http://dx.doi.org/10.1016/j.cell.2011.07.031 17.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nat Cell Biol 2004; 6:232-7; PMID:14767480; http://dx.doi.org/10.1038/ ncb1102,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol  1995; 129:1601-15; PMID:7790357; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nat Cell Biol 2000; 2:36-41;  PMID:10620805; http://dx.doi.org/10.1038/71357 43.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2001; 152:1255-66;  PMID:11257125; http://dx.doi.org/10.1083/ jcb.152.6.1255 44.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell  2008; 135:322-33; PMID:18957206; http://dx.doi.org/10.1016/j.cell.2008.08.038 45.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Curr Biol 2006; 16:1217-23;  PMID:16782013; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nature 2010; 467:805-10; PMID:20944740;  http://dx.doi.org/10.1038/nature09423 47.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol  2008; 182:1055-61; PMID:18794333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Dev Cell 2012; 23:968-80; PMID:23085020;  http://dx.doi.org/10.1016/j.devcel.2012.09.012 49.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell 2009; 136:865-75; PMID:19269365; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2001; 155:1159- 72; PMID:11756470; http://dx.doi.org/10.1083/ jcb.200105093 31.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Curr Biol 2004; 14:953- 64; PMID:15182668; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J  Cell Biol 2008; 183:819-34; PMID:19029334; http://dx.doi.org/10.1083/jcb.200804114 33.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Curr Biol 2005; 15:856-61; PMID:15886105; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol  2003; 161:267-80; PMID:12719470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2003; 161:281- 94; PMID:12707311; http://dx.doi.org/10.1083/ jcb.200208092 36.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J  Cell Biol 2009; 184:373-81; PMID:19193623; http://dx.doi.org/10.1083/jcb.200808130 37.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2009; 184:383-90; PMID:19188492; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nature 2013; 497:118-21;  PMID:23604256; http://dx.doi.org/10.1038/ nature12057 39.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Science  1997; 278:856-60; PMID:9346483; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Nature 2005; 438:384-8; PMID:16292315;  http://dx.doi.org/10.1038/nature0413218.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Curr Biol  2006; 16:1711-8; PMID:16950108; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2013; 200:203- 18; PMID:23337118; http://dx.doi.org/10.1083/ jcb.201211119 21.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Sci 2010; 123:825- 35; PMID:20200228; http://dx.doi.org/10.1242/ jcs.064790 22.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell  1995; 81:129-38; PMID:7720068; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 1992; 116:1167-80; PMID:1740471; http://dx.doi.org/10.1083/ jcb.116.5.1167 24.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
Cell 1990; 62:1053- 62; PMID:2144792; http://dx.doi.org/10.1016/0092- 8674(90)90383-P 25.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 1986; 103:581- 91; PMID:3733881; http://dx.doi.org/10.1083/ jcb.103.2.581 26.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 1994; 124:223- 33; PMID:8294508; http://dx.doi.org/10.1083/ jcb.124.3.223 27.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol  1996; 135:315-27; PMID:8896591; http://dx.doi.org/10.1083/jcb.135.2.315 28.,Non-OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 1993; 122:859- 75; PMID:8349735; http://dx.doi.org/10.1083/ jcb.122.4.859 29.,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
J Cell Biol 2000; 150:1233-50; PMID:10995431;  http://dx.doi.org/10.1083/jcb.150.6.1233,OADS,/arxiv_data1/oa_pdf/32/57/bioa-3-69.PMC3782542.pdf
"The impact of fetal chimerism resulting  from pregnancy on the outcome of organ transplantation in women of childbearing age is the subject of a Cutting Edge View Transplantation immunology William J. Burlingham department of Surgery; University of Wisconsin School of m edicine & Public h ealth; m adison, W i USA Correspondence to: William J. Burlingham; Email: burlingham@surgery.wisc.edu Submitted: 05/16/13; Revised: 07/20/13; Accepted: 08/01/13http://dx.doi.org/10.4161/chim.26155by Ma et al., which considers the immu - nologic consequences of the melange of  donor-, grandmother-, and fetal-derived cells present in the transplant recipient (p. 71).",Non-OADS,/arxiv_data1/oa_pdf/a9/fd/chim-4-61.PMC3782545.pdf
Science  1945; 102:400-1; PMID:17755278; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/fd/chim-4-61.PMC3782545.pdf
Science 2010; 330:1695-9; PMID:21164017;  http://dx.doi.org/10.1126/science.1196509 3.,Non-OADS,/arxiv_data1/oa_pdf/a9/fd/chim-4-61.PMC3782545.pdf
Biol Blood Marrow T ransplant 2013; 19:682- 91; PMID:23142329; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a9/fd/chim-4-61.PMC3782545.pdf
Proc Natl Acad Sci U S A 2012; 109:2509-14; PMID:22232664; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a9/fd/chim-4-61.PMC3782545.pdf
"Original ArticlepISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(5):311-315 http://dx.doi.org/10.3341/kjo.2013.27.5.311 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.311Ptosis Repair Using Preserved Fascia Lata with the Modified Direct  Tarsal Fixation Technique Ji Young Suh, Hee Bae Ahn Department of Ophthalmology, Dong-A University Medical Center, Busan, Korea Frontalis sling surgery is the treatment of choice for con - genital ptosis with poor levator function [1-3].",Non-OADS,/arxiv_data1/oa_pdf/b1/bd/kjo-27-311.PMC3782575.pdf
"Original ArticlepISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(5):316-321 http://dx.doi.org/10.3341/kjo.2013.27.5.316 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.316Comparative Analysis of Polymerase Chain Reaction Assay for  Herpes Simplex Virus 1 Detection in Tear Seung Yong Lee1,2, Mee Jung Kim1, Mee Kum Kim1,2, Won Ryang Wee1,2 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2Laboratory of Corneal Regenerative Medicine and Ocular Immunology, Seoul Artificial Eye Center, Seoul National University  Hospital Clinical Research Institute, Seoul, Korea Herpes simplex virus 1 (HSV) keratitis has been one of  the major causes of keratoplasty in South Korea [1].",Non-OADS,/arxiv_data1/oa_pdf/67/cc/kjo-27-316.PMC3782576.pdf
"Original ArticlepISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2013;27(5):322-330 http://dx.doi.org/10.3341/kjo.2013.27.5.322 © 2013 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.322Comparison of Clinical Outcomes of Same-size Grafting between  Deep Anterior Lamellar Keratoplasty and Penetrating Keratoplasty  for Keratoconus Baek Lok Oh1,2, Mee Kum Kim1,2, Won Ryang Wee1,2 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea 2Laboratory of Corneal Regenerative Medicine and Ocular Immunology, Seoul Artificial Eye Center, Seoul National University  Hospital Biomedical Research Institute, Seoul, Korea Penetrating keratoplasty (PKP) has been the definitive  surgical treatment option for keratoconus for the past few  decades [1-3].",Non-OADS,/arxiv_data1/oa_pdf/9b/b2/kjo-27-322.PMC3782577.pdf
